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Abstract
The aims of the study were to determine the seroprevalence and incidence of human brucellosis in Arusha
and Manyara regions, risk factors for human brucellosis, health-seeking behavior and clinical features of
human brucellosis cases and to evaluate different diagnostic tests for brucellosis. Other objectives included
determination of the knowledge of medical practitioners relevant for diagnosis of zoonoses and estimation of
the burden of disease caused by human brucellosis in Tanzania.
From cross-sectional studies, the Brucella seroprevalence in humans was 4.8% when determined by assays
in the field and 6.4 % at the Sokoine University of Agriculture (SUA) based on the Rose Bengal Plate Test
(RBPT). Based on the competitive ELISA (c-ELISA) test conducted at the Veterinary Laboratory Agencies
(VLA) the seroprevalence of brucellosis was 7.7%. The majority of RBPT positive individuals were
asymptomatic. Most of the c-ELISA positive individuals were above 15 years of age with the age group
16-30 years having the highest number of seropositive individuals. There was a significant association
between the seroprevalence of brucellosis in humans and the seroprevalence of brucellosis in goats at the
district level.
Prospective hospital studies indicated that the incidence of brucellosis was 11.2 cases/100,000 people per
annum. Joint pain, headache, backache, fever and fatigue were the main clinical features described by the
confirmed (c-ELISA positive) patients, but these were also most commonly reported by the c-ELISA
negative patients initially suspected as having brucellosis. Patients with brucellosis delayed going to hospital
with a median delay time of 90 days. Distance to the hospital, keeping animals and knowledge of brucellosis
were significantly associated with patient delay to present to hospital. More cases of brucellosis were
recorded in hospitals located in pastoral areas and brucellosis was more common among people engaging in
business.
Brucellosis was associated with assisting an aborting animal. It was shown that the closer the distance
between households, the higher the risk of brucellosis. People who were of Christian religion were found to
have a higher risk of disease compared to other religions.
The sensitivity and specificity of the RBPT in the cross-sectional survey were 39.4% and 98.8%
respectively, at the SUA laboratory 38.7% and 96.8% respectively and at the hospitals 44.3% and 89.5%
respectively. The sensitivities and specificities of the diagnostic tests for brucellosis at the hospitals were
also low. There was a poor agreement between the RBPT performed at SUA, the RBPT performed in cross-
sectional survey and the tests performed at the hospitals.
Medical practitioners in rural hospitals had poorer knowledge ofmost zoonoses when compared to the
practitioners in urban hospitals, including transmission of sleeping sickness, clinical presentations of anthrax
and rabies in humans. In both areas practitioners had poor knowledge of echinococcosis transmission to
humans, clinical features of echinococcosis in humans, and diagnosis of bovine tuberculosis in humans.
Brucellosis contributed to an estimated 3,644 -3,708 Disability Adjusted Life Years (DALY) burden in
Tanzania based on data collected from hospitals while data from the community resulted in an estimated
92,080 - 121,550 DALY burden in Tanzania. The majority of cases continued to have brucellosis clinical
features for a period of over two years, and out of these, five days spent as inpatients. Households used a
mean total of US $ 90.65 (92, 826 TShs.) to care for a single case of brucellosis per year and each health
provider used a mean total of US $ 858 (878,592 TShs.) per year to care for cases of brucellosis.
Brucellosis contributes to poverty and suffering particularly to the poor in the rural areas of Tanzania and yet
it is neglected. There is a need for increased health education on risk factors for transmission of brucellosis
to humans and the importance of going to hospital at an early stage of the disease. More efforts also need to
be directed towards improving the diagnosis and treatment of brucellosis to reduce prolonged human
suffering from brucellosis. This should include the adoption of standardized diagnostic and treatment
protocols. Restructuring and updating of disease recording systems and diagnostic laboratories so that they
diagnose and hence capture zoonoses such as brucellosis should be implemented. Efforts should be made to
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Zoonoses are diseases that can be transmitted between humans and vertebrate animals
(WHO, 1959; Palmer et al., 1998). In most cases, animals play an essential role in
maintaining the infection in nature, and they contribute in varying degrees to the
distribution and transmission of infection in human and animal populations
(Woolhouse and Gowtage-Sequeria, 2005). Zoonoses account for 61% (n=868) of all
human diseases and 75% of all emerging human pathogens (Taylor et al., 2001).
Zoonoses, however, are diseases where lack of uptake of the available control
strategies is constrained by more than just access and affordability in developing
countries (Schwabe, 1984). From a veterinary perspective, the most effective control
strategy in animal diseases is to deal with the animal itself, while in human disease it is
to deal with the patient. Zoonoses therefore, fall between the two sectors, which are
already over-stretched and under-funded (Schwabe, 1984).
In sub-Saharan African countries many of the known zoonoses, which are poorly
controlled in both livestock and human populations, endanger poor people's livelihoods
by affecting their livestock and compromising their health and survival. Zoonoses also
cause great economic losses to poor people particularly in the rural areas of sub-Saharan
African countries (Perry et al., 2001). The losses caused are both direct (morbidity,
mortality to both humans and livestock, and fertility problems, milk yield and ability of
an animal to work as a traction animal), and indirect, such as those due to the costs of
ineffective control measures, limiting production opportunities, and influencing the
choices made by livestock keepers and farmers (Perry et al., 2001; Shaw, 2004).
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Zoonoses such as bovine tuberculosis, brucellosis, anthrax, sleeping sickness, and
rabies are still widespread in Africa (Meslin, 1992; Barrett, 2006). In Tanzania, African
trypanosomiasis, plague, rabies, brucellosis, anthrax and hydatidosis have been
documented as being among the most common zoonotic diseases (Kilonzo and Komba,
1993), however little quantitative data is available to substantiate this finding. Bovine
tuberculosis, tetanus, taeniosis and trichinosis are also endemic in some parts of the
country although epidemiological data on their incidence is scarce (Kilonzo and
Komba, 1993). Multidisciplinary, inter-programmatic and cross-cultural efforts by the
health, agricultural, environmental and other sectors of society at the national level
have been suggested as ways of controlling and preventing zoonotic diseases (Meslin,
2005). Effective control of zoonoses also requires strong regional and international
cooperation and prompt notification of disease occurrence domestically, regionally and
globally (Meslin, 2005).
Rabies is mainly transmitted through a bite of a rabid animal which, in most parts of
the world, is by a dog bite. An estimated 35,000 to 50,000 human deaths are caused
by rabies each year (Knobel et al., 2005). More than 99% of all human rabies deaths
occur in the developing world, despite the availability of effective and economical
tools for prevention and control (Knobel et al., 2005). The low political commitment
to rabies control leads to a lack of accurate data and underestimation of the true
public health and economic impact of the disease in most of the developing world
(WHO, 2004; Miranda, 2005). The incidence of rabies in Tanzania was estimated to
be 100 times higher than officially recorded, with 1499 human deaths annually in
comparison with the 10-20 human cases typically reported each year by central
authorities (Cleaveland et al., 2002). Apart from human morbidity and mortality,
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rabies also contributes significantly to livestock loss (Laurenson et al., 1997; Knobel
et al., 2005).
Cystic echinococcosis (hydatidosis), caused by the larva stage of the tapeworm
Echinococcus granulosus is highly prevalent in many developing countries,
especially in poor communities (Eckert and Deplazes, 2004). It has been reported in
West African as well as the East African countries. In all these areas, hydatidosis is
prevalent in humans among the nomadic pastoralists (Magambo et al., 2006). Due to
the lack of well-documented data from many countries in Africa, the sub-Saharan
picture of the current hydatidosis situation is incomplete (Magambo et al., 2006).
Hydatidosis causes serious human suffering and considerable losses in agriculture and
human productivity (Budke, 2006). The transmission of the disease is linked with
general lack of knowledge on transmission factors and prevention measures among
the population at risk, poor inspection ofmeat before human consumption, the
abundance of stray dogs, and improper disposal of animal offal and home
slaughtering exercises which are common practises in many rural areas of developing
countries (Budke, 2006). The incidence of surgical cases of hydatidosis range from
0.1 to 45 cases per 100,000 people and the real prevalence ranges between 0.22% and
24% in endemic areas (Kachani, 2005). In Libya, Morocco and Tunisia the
prevalence of surgical hydatidosis ranged from l%-2% (Kachani, 2005). Intensive
strategies for health education on the transmission routes of hydatidosis, improvement
in abattoir conditions and management of the dog population have been cited as
among the most important control strategies (Kachani, 2005).
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Human anthrax is most common in enzootic areas in developing countries, among
people who work with livestock, eat undercooked meat from infected animals, or
work in establishments where wool, goatskins, and pelts are stored and processed
(Turnbull, 2002). West Africa is the most affected area of the world (Hugh-Jones,
1999). Anthrax is also a significant problem in other parts of Africa, Central America,
Spain, Greece, Turkey, Albania, Romania, central Asia, and the Middle East (Hugh-
Jones, 1999). Between 1979 and 1985, in association with the civil war and the
interruption of veterinary public health practices, Zimbabwe was the site of the
largest outbreak of anthrax, with about 10,000 human cases, almost all of which were
cutaneous infections (Davis and Elzer, 2002; Davies, 1985). In Tanzania, an epidemic
of 239 human cases of anthrax was reported in Rukwa region in 1985 due mainly to
consumption ofmeat from infected animals dying of the disease. Sporadic cases have
also been reported in different parts of the country (Webber, 1985).
Zoonotic tuberculosis (TB) caused by Mycobacterium bovis is present in most
developing countries, where surveillance and control activities are often inadequate or
unavailable; therefore, many epidemiologic and public health aspects of infection
remain largely unknown (Cosivi et al., 1998). Although prevalence data on animal
TB in developing countries are generally scarce, information on bovine TB
occurrence and control measures exists in some countries (Thoen et al., 2006). Of 55
African countries, 25 reported sporadic/low occurrence of bovine TB in 1999; six
reported enzootic disease; two, Malawi and Mali, were described as having a high
occurrence; four did not report the disease; and the remaining 18 countries did not
have data (Thoen et al., 2006).
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Of all nations in Africa, only seven apply disease control measures as part of a test-
and-slaughter policy and consider bovine TB a notifiable disease; the remaining 48
control the disease inadequately or leave it uncontrolled. Thus, approximately 85% of
the cattle and 82% of the human population of Africa are in areas where bovine TB is
either partially controlled or it is uncontrolled (Cosivi et al., 1998). The study
conducted by Kazwala et al., (2001) in Northern and Southern zones of Tanzania
revealed that 70.5% (n=149) of the Mycobacterial isolates of human cervical adenitis
recovered from all forms of tuberculosis were identified as M. tuberculosis, 16.0%
were identified as M. bovis, and 13.6% were other Mycobacterial species. There was
a significantly higher isolation rate (P < 0.05) ofM. bovis among strains recovered
from extra-pulmonary (26.8%) than pulmonary tuberculosis samples (4.3%)
(Kazwala et al., 2001).
The prevalence of Human African Trypanosomiasis (HAT) in Africa has been
estimated by the WHO to be 300,000 cases over the last ten years, an average of
30,000 new cases annually in the whole African continent (WHO, 2003). The figures,
however, are thought to be an underestimation as a result of a large number of people
(60 million) living in risk areas and having limited access to diagnostic and health
care facilities (Cattand et al., 2001). In Uganda it was estimated that for every case of
a Trypanosoma brucei rhodesiense death in hospital, about 12 additional cases occur
in the community undetected (Odiit et al., 2005). In Tanzania the disease is prevalent
in the western, north, and northwestern parts, the southern highlands and southern
regions, where over 6000 cases have been reported since 1979. Control strategies
against sleeping sickness in Tanzania include chemical control of vectors, treatment
of patients with trypanocides and avoidance of human tsetse contact (Kilonzo and
Komba, 1993).
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Plague caused by Yersinia Pestis is mostly endemic in central, northern and north¬
eastern Tanzania. A total of 8161 cases with 1885 deaths have been recorded since
1890. The disease is currently prevalent in Lushoto district where outbreaks have
been experienced since 1980, and in Singida district where it has been endemic since
1918 (Kilonzo and Komba, 1993). Integrated control measures such as rodent control
were possibly responsible for the 1989 decline of outbreaks in the area. Financial
constraints which led to deterioration of control activities from July 1989 probably
accounted for the severe outbreaks in 1990/91 which then spread to other parts of the
country (Kilonzo and Komba, 1993).
1.2 Farming systems in Tanzania
Livestock contribute to the livelihoods of at least 70% of the world's rural poor
(Miranda, 2005). Communities, especially in rural areas, have traditionally depended
on animals for food, transport and farm work. This dependence increased with
intensification in livestock production and the increase in the transport of livestock
and their products domestically and across the globe (Miranda, 2005). In Tanzania,
about 90% of the population live in rural and peri-urban areas, owning more than
80% of the total livestock population. Around 60 million hectares of rangeland is
suitable for livestock grazing on which approximately 106,000 households practise
pastoralism and approximately 268, 000 are engaged in agropastoralism (Ministry of
Agriculture and Cooperatives, 1995b). Tanzania has a large livestock population
comprising 13 million cattle, 3.7 million sheep, 6.4 million goats, 275,000 pigs and
22 million chickens. The livestock sector, which forms an important part of the
agricultural sector, contributes more than 18% of the Tanzanian Gross Domestic
Product (GDP) (Ministry ofAgriculture and Cooperatives, 1995a).
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The pastoralist economy is based on migration and livestock rearing. Although
humans and livestock migrate along conventional routes, movements can vary with
climatic and environmental conditions, for example in one dry season pastoralists
may visit certain wells and pastures and during the next dry season other wells and
pasture (Imperato, 1974). Pastoralists derive most of their sustenance and livelihood
directly from livestock. Agro-pastoralists systems combine crop and animal
production, using outputs from one to feed into the other, e.g. manure for crops and
fodder for livestock. This is the most common mixed farming system in Tanzania
(Imperato, 1974; Ole Kuney, 1994).
Pastoralists aim to keep their livestock herds as large as possible to secure adequate
milk and meat supplies and to gain influence and respect within their communities
(Stark and Protz, 1973). Studies, however, have shown the incidence of brucellosis to
be highest in the pastoral system where it decreases with herd size and as land
holding decreases (McDermot and Arimi, 2002).
1.3 Brucellosis
Brucellosis is an acute or chronically contagious disease of animals and humans,
caused by species of the genus Brucella (Corbel, 1989a). The genus can be divided
into six species, namely Brucella abortus, B. melitensis, B. canis, B. ovis, B. suis and
B. neotomae, based on pathogenesis and host predilection. In 1994, the isolation of
Brucellae was reported in marine mammals and was named "B. maris" (Aleixo et al.,
1999). Although recent bacterial nomenclature has re-classified these species as
biovars within a single species Brucella melitensis (Verger et al., 1998), this study
will continue to refer to the species as given above, which is still in common usage.
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Four of the species (Brucella abortus, B. melitensis, B. canis and B. suis ) can infect
man by direct or indirect contact with infected animals (Corbel and Brinley-Morgan,
1984). The primary and secondary host species for the six Brucella species are
shown in Table 1.1.
Although brucellosis can be found worldwide, it is more common in areas of the
Mediterranean basin, South and Central America, Eastern Europe, Asia, Africa, the
Caribbean and the Middle East. In most developing countries brucellosis is a zoonosis
of both public health and economic significance because animal diseases have not
been brought under control (Perry et al., 2002). As a consequence, there has been an
increase in the number of human cases of brucellosis in developing countries (Refai,
2002) because the occurrence of the disease in humans is largely dependent on
the animal reservoir (McDermot and Arimi, 2002). Brucellosis has been eradicated in
many developed countries including the UK since 1980-81 through vaccination
campaigns combined with test and slaughter policies in livestock (Emslie and Nel,
2002). Even in these countries, however, human infections still occur as a result of
imported cases from endemic areas (WHO, 1997).
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Table 1. 1: Brucella species and their hosts
Species Primary host Other hosts infected
B. abortus Cattle Camels, deer, sheep,
Goats, pigs, dogs,
humans and deer
B. melitensis Goats and sheep Cattle, humans
B. suis Swine, reindeer,
small rodents and
humans
B. canis Dogs Humans
B. ovis Sheep
B. neotomae Desert wood rats
B. maris Marine mammals Humans
1.4 History of brucellosis
History tells that Hippocrates first described a disease syndrome similar to
brucellosis around 450 BC. An early description of brucellosis was made by
Martson in 1859 (Vassalo, 1992). He wrote of illness, including his own, which
differed from typhoid fever. The aetiology of the disease in man was later
classified when Captain Bruce, in 1887, isolated B. melitensis from the spleen of a
dead soldier in Malta and from the blood of a living patient, and named it
Micrococcus melitensis (Nicoletti, 2002). In animals, Brucella was isolated by a
Danish Professor by the name of Bernard Bang in 1895 from the membranes and
uterus of cattle following abortion. He later confirmed the aetiology of the disease
when he produced it in healthy pregnant heifers using pure cultures of the bacillus.
He named it 'Abortus bacillus of Bang' (Nicoletti, 2002).
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In 1905, a scientist named Harrocks was able to demonstrate the Brucella
organism in milk, and this discovery was later followed by strict rules on
consumption of pasteurized milk resulting in a dramatic decrease in the incidence
of the disease in the Mediterranean area (Nicoletti, 2002). B. suis was discovered
by Traum in the United States in 1914 from aborted cows. The first case of B.
abortus was described by Keefer in the United States in 1924. The three species of
Brucella, B. abortus, B. melitensis and B. suis were clearly distinguished by
Huddleson in 1929. B. ovis was isolated from sheep in Australia in 1953, B.
neotomae from desert wood rats in United States in 1957, and B. canis from dogs
in the United States in 1968 (Nicoletti, 2002). More recently, a species of Brucella
was isolated in 1994 from marine mammals and was named "B. maris" (Aleixo et
al., 1999).
1.5 Brucella organisms
Brucellae are intracellular parasites that infect a wide variety of domesticated and free-
living animals. Brucellae grow intracellularly and localize in the reticulo-endothelial
system in the genital tract and the mammary glands of their respective primary hosts
(Hurvell et al., 1971; Verger et al., 1998). Growth of Brucellae occurs aerobically, often
enhanced by CO2. however no growth occurs under strict anaerobic conditions (Verger
and Grayon 1977).
Brucellae are small round or oval cocco-bacilli, they are arranged singly, sometimes in
pairs, short chains or small clusters, they do not produce capsules, spores or flagella.
Brucellae are gram negative, do not usually show bipolar staining, are not acid-fast but
may resist decolorization by weak solutions of acids or alkalis (Verger et al., 1998).
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1.6 Diagnosis of brucellosis
Clinical features and laboratory investigation form the basis for the diagnosis of
brucellosis in humans (FAO/WHO, 1985). Although the definitive diagnosis of
brucellosis is by culture and isolation of the causative organisms, the procedure is
challenging in that it requires special media, takes several weeks of incubation and has
low sensitivity (Gotuzzo et al., 1986; Araj et al., 1990). The laboratory diagnosis of
brucellosis therefore often depends on serologic tests. These include the Serum
Agglutination Tests (SAT) (Corbel and Brinley-Morgan, 1984), the Complement
Fixation Test (CFT) (Alton et al., 1983), the Fluoroscent Polarization Assay (FPA)
(Nielsen et al., 2000; Lucero et al., 2003) and the Enzyme-Linked immunosorbent
Assays (ELISA) tests (Lucero et al., 1999). Other tests include the radioimmunoassay
(Parratt et al., 1977), the indirect immunofluorescence assay (Colmenero et al., 1989),
and the 2-mercaptoethanol test (2ME) (Reddin et al., 1965).
1.6.1 The SAT
The SAT is the agglutination test used in sero-prevalence studies, and has been used
in sero-diagnosis of bovine brucellosis in Tanzania (Mahlau and Hammond 1962;
Starck and Protz, 1973). During the acute phase of the illness, repeated serum
samples should be collected to demonstrate a rising (greater than four -fold) titre of
Brucellae agglutination tests. High titres are usually encountered by the second or
third week of illness, with titres of 1/80 or higher (Corbel, 1972).
In the sub-acute or chronic phase of brucellosis, the standard agglutination test may
be particularly difficult to interpret or may be negative and other tests need to be
done to confirm the results. This is because the serum agglutination test depends
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very much on the presence of IgM immunoglobulin that could be low or absent in
chronic and sub-acute states. This also explains why the SAT is negative during the
incubation period and following abortion (Mittal and Tizard, 1983).
Other difficulties that can be encountered with the use of the SAT include cross-
reactions with bacteria related to the genus Brucella, and positive results in exposed
populations and in patients after they are cured (Diaz et al., 1982). This phenomenon
is probably due to the presence of common antigenic determinants in the
lipopolysaccharide fractions of Brucella abortus 99 and Yersinia enterocollitica 09
(Zheludkov, 1982). Strains of B. abortus also share antigenic properties with strains
of E. coli 0157 (Caroff et al., 1984).
In animals, serological tests cannot differentiate between cattle infected with
Brucella and cattle infected with microorganisms that serologically cross-react with
Brucella antigen, which is likely to affect test specificity. Hence, these cattle and
cattle with 'natural' antibodies jeopardize the Brucella-free status of a herd. Infected
cattle with serologically inconclusive test results, or which elude detection, are also a
hazard to Brucella-free herds (Bercovich, 1998). The most common agglutination
test for brucellosis in current usage is the RBPT (Davies, 1971) see sections 1.6.2
and 2.4.5.1.
1.6.2 The RBPT
The RBPT is an agglutination test that provides results in 2-4 minutes and is useful
as a first screening test (Davies, 1971). The RBPT was designed originally for
screening in veterinary medicine, but is now often used for the diagnosis of human
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brucellosis (Morgan et al., 1969; Oomen and Waghela, 1974). Its ease and speed of
use, as well as its low cost, have made it very popular in hospitals and field
conditions for the diagnosis of brucellosis (Colmenero et al., 1989). The protocol for
the RBPT performed in this study is described in section 2.4.5.1 and the performance
of the RBPT in different places has been discussed in chapter 7 of this thesis.
1.6.3 The c-ELISA test
The c-ELISA tests are based on primary binding assays, mainly to improve test
sensitivity and specificity. The c-ELISA test for the detection of serum antibodies to
the organisms of the genus Brucella has been shown to be a suitable test for human
brucellosis (Lucero et al., 1999) see section 2.4.5.2. The c-ELISA test uses a
monoclonal antibody (mAb) specific for a common and repeating epitope on the
polysaccharide portion of the smooth lipopolysaccharide molecule of Brucella (S-
LPS) to compete with antibody in the sample. This results in an assay with higher
specificity than other assays because it frequently eliminates cross-reactions with
other antigens (Lucero et al., 1999).
1.6.4 Culture ofBrucellae
Brucellae must be handled in level 3-laboratory containment facilities due to its potential
to cause infection in laboratory workers (Hall, 1990). When B. abortus infection is a
possibility, incubation should be in an atmosphere with 5-10% CO2. Blood cultures
should be maintained for at least 8 weeks before they are discarded as negative.
Isolation rates can be markedly improved ifmaterials from bone marrow or liver biopsy
are also cultured (Corbel et al., 1989a).
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In the past Brucellae used to be isolated by inoculation into guinea pigs, but now this
method is carried out only when the sample is heavily contaminated (Bercovich et al.,
1996). The isolation of Brucellae from milk, dairy products or veterinary material
usually requires selective media. Various selective media for culture ofBrucellae have
been used including those described by: Kuzdan and Morse (1953), Meyer (1974),
Farrel (1974) and Leech et al, (1984). Comparative trials have shown that these are a
satisfactory alternative to guinea-pig inoculation methods (Hunter and Kearns, 1977).
1.7 The viability of Brucellae and antibacterial sensitivity
Brucellae are killed after heating at 60°C for 10 minutes and are therefore killed in milk
by pasteurization at 72°C. Brucellae are moderately sensitive to acid and die out in most
cheeses undergoing lactic acid fermentation. They are very sensitive to sunlight but may
persist in soil or dust for 2-3 months and for longer in dead foetal material, especially at
low temperatures (Young, 1995a). They are sensitive to many disinfectants and
antibiotics, including ampicillin, co-amoxiclav, cephalosporins, aminoglycosides,
tetracyclines, chloramphenicol, ciprofloxacin, sulphonamides and cotrimoxazole; they
are relatively resistant to vancomycin, nalidixic acid and polymyxins (Young, 1995a).
1.8 Brucellosis in humans
B. melitensis is the most common species infecting man and is probably the most
virulent, followed by B. suis and B. abortus (Domenech et al., 1983). In humans,
brucellosis is typified by a wide range of clinical manifestations and can occur clinically
as an acute, sub-acute, chronic or subclinical disease. In addition, those repeatedly
exposed to the pathogen (such as veterinarians), may develop a hypersensitivity state,
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shown, for example, by the development of rashes on the arms after examining cows
(Trunnell et al., 1985; Mazokopakis et al., 2003).
Human brucellosis is notoriously a multisystemic disease with varied manifestations; the
onset may be either acute or insidious. The latter mode of presentation causes more
difficulties in diagnosis (Andriopoulos et al., 2006; Young et al., 2000b). Acute
brucellosis occurs mainly with B. melitensis infection and a minority of cases of B. suis
and B. abortus infection. The predominant clinical features of brucellosis include high
fever, headache, malaise, drenching sweats, fatigue and joint pain. Occasionally there is
splenomegaly and slight liver enlargement (Fallatah et al., 2005; Troy et al., 2005).
Other rare serious complications of brucellosis include, endocarditis, thrombophlebitis,
meningo-encephalitis, neuropsychiatric features such as depression and chronic arthritis
which can affect the spine (Charters, 1980; Fallatah et al., 2005). Acute brucellosis may
last for a period of 2 -3 weeks, and the chronic form up to one or two years, during
which the patient may be severely debilitated (Hurvell et al., 1971). The case-fatality rate
of untreated brucellosis is 2% or less (Jacobs et al., 1990).
Humans usually become infected with Brucellae through direct contact with infected
animals or their products. Unpasteurized milk and processed dairy foods from infected
animals are the major source of infection for the general population (Young, 1995b).
In man brucellosis was initially linked with drinking unpasteurized goat's milk but
later it became clear that any contaminated animal product could be the source of
infection, either by contact or by consumption (Mishal et al., 1999; Karimi et al.,
2003). Other routes of less importance include absorption via the mucous membranes
of the respiratory tract or conjunctiva (Hungerford, 1975).
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1.9 Risk factors for disease transmission to humans
Transmission of brucellosis to humans requires a close or direct contact with infected
animals and animal products. Risk factors for human disease are therefore expected to
relate to occupational hazards, and patterns of consumption of animal products
(Corbel, 1997). In Kuwait brucellosis as an occupational disease was found to be more
common in males than females and occurred in the ages 20-40 years (Lulu et al.,
1988). Infection was mainly found to be acquired through handling infected animals at
calving or abortion and handling carcasses or offal of infected animals. Infection in the
general population was found to be acquired through ingestion of contaminated dairy
products especially unpasteurized milk, creamy soft cheese and ice creams (Lulu et al.,
1988).
Unpasteurized milk and processed dairy foods from infected animals are the major
source of infection for the general population, and infected carcasses are the source of
infection for workers in the meatpacking industry (Busch and Parker, 1972).
Veterinarians can acquire brucellosis as a result of assisting births of infected animals,
as well as through inadvertent exposure to vaccines. Airborne transmission of bacteria
to humans has also been documented in clinical laboratories and abattoirs (Buchanan et
al., 1974). In Iran, positive results were found by RBPT, SAT titre (1:80) and 2ME
titre (> = 1:20) in those engaged in slaughter of animals (10%, 20% and 6%
respectively), butchers (6%, 4% and 1% respectively) and the general population (1%,
2% and < 1% respectively) (Karimi et al., 2003). In South Africa, 72% of occupational
infections of abattoir workers were found to be due to Brucellae species (Mauff, 1980).
The same proportion was attributed to brucellosis amongst veterinarians and farm
workers in Ethiopia (Seboxa, 1982).
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1.10 Under-diagnosis of zoonoses
In Africa, most human diseases are frequently under-diagnosed, particularly
among the poor, reflecting the limited capacity and coverage of the health services.
However, in the case of the zoonoses, this problem of under-diagnosis is further
aggravated by uneven geographical distribution of the poor and the inherent
difficulties in diagnosing some of these diseases (Schwabe, 1984). The low priority
accorded to zoonoses, and difficulties in diagnosis and hence treatment has made
the ultimate outcome for the poor infected with zoonotic diseases to be even
worse. The under-diagnosis of zoonotic diseases has greatly contributed to their
under-reporting in sub-Saharan Africa countries. Official figures of rabies,
brucellosis and trypanosomiasis incidences represent only a fraction of the actual
disease burdens in these countries (WHO 1998b; Cattand et al., 2001; Cleaveland
et al., 2002).
1.11 Burden of brucellosis
As described earlier, most zoonoses such as brucellosis are under-diagnosed in
Africa. Although human brucellosis is a modifiable disease in many countries,
official figures do not fully reflect the number of people infected each year, and the
true incidence has been estimated to be between 10 and 25 times higher than
reported figures indicate (WHO, 1997). Cases very often remain
unrecognized because of inaccurate diagnosis, and are thus treated as other
diseases or as "fever of unknown origin" (Colmenero, et. al., 1996). Animal
brucellosis also poses a barrier to trade of animals and animal products and could
seriously impair socio-economic development, especially of livestock owners, the
most vulnerable sector in many rural populations (WHO, 1997).
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Brucellosis causes production losses in infected herds, both as a result of abortions
in newly infected herds, and as a result of a high incidence of retained placenta and
endometritis (Corbel et al., 1989a). Brucellosis causes financial losses due to the
costs of animal treatment, reduced number of live calf births and concurrent human
infection. Humans succumb to prolonged periods of general body malaise,
headache, backache, fever and chills (Young et al., 2000b). Further, financial
resources are required to cater for human treatment making the economies of the
affected people, who are mainly the poor, to be even worse.
Official estimates put losses due to brucellosis in Latin America equivalent to
about US$ 600 million annually, which explains the priority given by animal
health services to reducing the incidence of the disease (WHO, 1997). The World
Health Organization reports an annual incidence of brucellosis in humans of 1 to
78 cases per 100,000 population in the Middle East, with six countries reporting an
annual total incidence of over 90,000 cases. Among the Latin American countries,
Argentina reports the largest incidence, followed by Mexico and Peru (WHO,
1997).
In Mongolia Roth et al., (2003) conducted an analysis of the economic benefits,
cost-effectiveness, and distribution of benefits as a result ofmass vaccination of
cattle. Results indicated that if the costs of vaccination of livestock against
brucellosis were allocated to all sectors in proportion to the benefits, the
intervention might be profitable and cost effective for the agricultural and health
sectors. So the benefits of the disease control need to account for dual benefits to
public health and livestock sectors.
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1.12 Brucellosis in animals
Brucellosis in animals is considered to be transmitted mainly through ingestion of the
organism from contaminated pastures and water (Blood and Radostits, 1989).
Transplacental transmission can occur in calves born to infected dams (Crawford et
al., 1986). Cows occasionally may be infected by coitus, licking or when inseminated
artificially with infected semen. Abortion, stillbirth, metritis, placentitis and infertility
characterize Brucellae infection in cattle (Hungerford, 1975).
Several factors have previously been identified as risk factors for brucellosis
including, environmental factors such climate, altitude, biotype, herd size, age of
cattle and husbandry methods, which play an important role in changing the
epizootological pattern (Mikolon et al., 1998; Blood and Radostits, 1989). In eastern
and western Uganda, a study conducted on goats randomly selected from 145 herds
showed that free browsing when compared to tethering or zero-grazing, and lack of
veterinary care were the most-important factors identified for B. melitensis herd
seropositivity (Kabagambe et al., 2001). In Mexicali Valley, California, risk factors
for brucellosis seropositivity of goats in herds were identified as importation of goats
from other Mexican states, the presence of La Mancha breed does, and the presence
of does born outside the herd. Increasing herdsize was also highly significant. In
addition, a significant positive association was found between the presence of
seropositive dogs (as assessed by the RBPT) and seropositive goats on the same
ranch (Mikolon et al., 1998).
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1.13 Wildlife and their role in zoonoses transmission
Diseases transmitted between humans, wild and domestic animals have important
impacts on public health, wildlife conservation and livestock economies
(Cleaveland et al., 2001; Alonso and Starkey, 1994). Some examples of diseases
that affect both domestic and wild animals are: classical swine fever (hog cholera)
in wild boars and domestic swine; myxomatosis and rabbit hemorrhagic disease in
domestic and wild rabbits; bovine viral diarrhoea (BVD) in cattle and roe deer;
contagious ecthyma in domestic sheep and goats and also in, e.g., chamois,
muskox, and reindeer; Mycobacterium bovis in cattle, wild boars, badgers, and
deer; and brucellosis in a broad range of livestock and wildlife (Frolich et al.,
2002).
Over a quarter of pathogens of humans and domestic mammals have a very broad
host range and are capable of infecting humans, domestic and wildlife hosts
(Cleaveland et al., 2001). If such diseases can spread within human populations or
if they spread frequently from animal reservoirs, they have serious socio-economic
impact (Bengis et al., 2002). There is, however, difficulty in managing wild
populations and their diseases in national parks and other protected areas. In some
instances, human intervention may be justifiable in order to protect native
populations, domestic animals, and humans from acquiring a disease (Alonso and
Starkey, 1994). Brucellosis has been known to exist in populations of wildlife
since the early part of the 20lh century. In the US, brucellosis has been virtually
eliminated in domestic livestock after decades of expensive governmental disease
prevention, control and eradication programmes. Now the most likely source of
transmission of brucellosis to humans, and the risk of reintroduction of brucellosis
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into livestock is from infected populations of free-ranging wildlife (Davis and
Elzer, 2002).
Studies on brucellosis in African game and cattle living in close contact were
conducted by Roth (1967) in Rhodesia, Sachs et al., (1968) in Tanzania and
Schiemann and Staak (1971) in Uganda. All these authors were able to isolate
species of B. abortus and B. melitensis from wildlife; they reached a conclusion
that wildlife might be the potential reservoirs of brucellosis in Africa. In Tanzania,
Mlengeya et al., (personal communication) found out that 41/103 (39.8%) of
buffalo sampled in the Arusha region tested positive for brucellosis using RBPT.
In a study conducted by Shirima et al., (2003), it was established that out of 90
wildlife sera tested for brucellosis using the RBPT, 13 % were positive for
brucellosis. These included 10% ofwildebeest, 28% buffalo and 13% impala. The
presence of Brucellae in wildlife indicated that wildlife could also play an
important role in the transmission of brucellosis to domestic animals and humans
in a place where they are in close contact.
1.14 Treatment of brucellosis
Although Brucellae are susceptible to antibiotics, human brucellosis continues to
pose a therapeutic problem because of the intracellular localization of the
Brucellae within the host's reticulo-endothelial cells, a site lelativcly inaccessible
to antibiotics (Khan et al., 1989; Hall, 1990). Inappropriate choice, dosage and
length of antimicrobial therapy, failure of patients to take prescribed drugs and,
very rarely, antibiotic-resistant Brucella strains are associated with unpredictable
relapses after treatment. Hence, the institution of a proper combination of
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antibiotics for longer periods is warranted to improve the outcome and prevent
relapses (Ariza et al., 1985).
Brucellosis therapy is related to the stage of the disease. In the acute stage,
antibiotics can achieve good therapeutic results, and in the chronic stage,
additional symptomatic treatment with special emphasis to neurological and
psychiatric management can be used with excellent results. Early diagnosis is
important so as to reduce severe disability and loss of work ability (Olszok and
Kucharz, 1994). Tetracyclines alone are effective for treatment of brucellosis, but
the combination of one of the tetracyclines e.g. doxycycline, with streptomycin is
currently regarded as the best treatment to reduce the relapse rate for patients
receiving antibiotic combinations (Hall, 1990). The combination of cotrimoxazole
with rifampicin or tetracycline and streptomycin with rifampicin is also effective
(Hall, 1990). Most strains of Brucellae are highly resistant to the penicillin and
cephalosporins. Kanamycin and gentamicin can replace streptomycin if resistance
develops (Hall, 1990).
Effectiveness and therapeutic value of doxycycline plus streptomycin, and
doxycycline plus rifampicin for the treatment of human brucellosis were assessed
by Colnrenero et al., (1989). The tolerance to both regimens was found to be good,
but the combination of doxycycline plus rifampicin offered a more convenient oral
administration (Colmenero et al., 1989).
In a study by Ariza et al., (1995) to establish the risk factors associated with
relapse of brucellosis, it was found that "less-effective" antibiotic therapy, positive
blood cultures during initial disease, being a male, and low platelet count were the
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main factors associated with relapse. However, these data showed that relapse of
brucellosis is sometimes difficult to diagnose and that it can be an insidious
disease. In addition to inappropriate antibiotic therapy, other factors, such as those
indicating a more aggressive disease and/or a deficient immunologic response,
seem to play an important role in the relapse of brucellosis (Ariza et al., 1995).
1.15 Brucellosis and HIV
As a systemic disease, HIV/AIDS presents with multiple clinical features, some of
which resemble brucellosis. A study conducted in Spain by Moreno et al., (1998)
showed that HIV infection does not seem to increase the incidence of brucellosis
because most cases of brucellosis were found to occur in asymptomatic patients
with relatively preserved immunity. It was therefore concluded that the
epidemiology, clinical presentation, diagnosis, response to therapy, and outcome of
brucellosis cases are similar to those observed in non-HIV infected patients. In a
study conducted in Kenya by Paul et al., (1995) it was established that there was
no association between Brucella antibody status and HIV status. It was therefore
concluded that Brucella serology may be helpful in the diagnosis of patients with
non-specific symptoms in East Africa, regardless of their HIV status. However
relapse in brucellosis was found to be related to the profound impairment of the
immune response induced by HIV infection, so HIV infection must be excluded in
patients with relapsing brucellosis in areas with a high prevalence of both
infections (Ibarra et al., 2003).
24
1.16 Brucellosis in different parts of the world
1.16.1 Brucellosis in Europe, America, Asia and Australia
Brucellosis is more common in countries that do not have good public health and
domestic animal health programmes (World Bank, 1985). Areas currently listed as
high risk are the Mediterranean basin (Portugal, Spain, Southern France, Italy,
Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia,
Africa, the Caribbean, and the Middle East (World Bank, 1985).
Brucellosis was once a major disease in developed countries, but has now been
eradicated and controlled in several countries through strict control regimens that
include pasteurization ofmilk, test-and-slaughter policy, vaccination, monitoring
and restriction of animal movements (Meldrum, 1970). For instance, the
prevalence of brucellosis in Greece was dramatically reduced by an eradication
programme, which included test and slaughter (Avdikou et al., 2005). In New
Zealand, because of the high prevalence of the disease, mass vaccination of calves
was employed prior to a test and slaughter policy (Adlam, 1978). In instances
where the prevalence rate was low, mass test and slaughter was often the first line
of action. Prevention of human infection was possible through mass eradication,
protective measures against contact with infected animals, animal products,
aborted materials and pasteurization (Young et al., 2000a).
The incidence of brucellosis caused by B. melitensis in sheep, goats and humans is
still a very significant problem in Macedonia and Greece. The disease is an
endemic problem in some regions of the former Yugoslavia and includes B. suis in
pigs and in Croatia, B. melitensis in sheep, goats and humans is found occasionally
(Taleski et al., 2002). In India brucellosis was first recognised in 1942, but it is
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now endemic throughout the country. However, there are no organized and
effective brucellosis control programmes in India (Renukaradhya et al., 2002).
The epidemiologic pattern of human brucellosis in the United States since the early
1970s may have shifted from an occupation-associated disease involving B. suis to
one more common in the general population (Alonso and Starkey, 1994). This
change may be attributed to the swine brucellosis eradication programme
implemented in 1961, and increased reporting of human B. melitensis infection,
which was considered to have been eradicated from U.S. sheep and goats in 1972.
Hispanic populations ofCalifornia are at increased risk for B. melitensis infection,
with imported soft cheese the most commonly reported vehicle of exposure
(Alonso and Starkey, 1994).
1.16.2 Brucellosis in Africa
Human brucellosis has been reported in many African countries with higher
prevalence around the Mediterannean basin. Living in close contact with cattle
exposes people who practice nomadic type of life-style to the high risk of brucellosis.
Nomads move with their cattle long distances and in so doing, the animals are liable
to acquire infection from a wide range of pastures. The infection is then easily
transmitted to humans due to different traditional practices (Cox, 1966). The habit of
eating raw meat, e.g. raw liver or other offal with spices (Marrara or umfitfit) was
found to be an important epidemiological factor in contracting the disease in central
Sudan. In this area the majority of patients were found to have a combined infection
of both B. abortus and B. melitensis (Mohd. 1989).
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Brucellosis has been reported in Kenya since 1913 (Barnett, 1950). A study
conducted in Kenya by Oomen (1976) showed that the most prevalent species of
brucellosis was B. melitensis and human brucellosis showed a tendency to run a
chronic course with most cases showing spine and hip joint involvement. Amongst
patients recorded with flu-like symptoms (n= 1,0337,875) in Narok hospital,
Kenya, between 1986 and 1992, 79.3% were diagnosed as suffering from malaria,
7.1% rheumatism, 2.4% pyrexia of unknown origin (PUO) and 0.8% were
diagnosed as suffering from brucellosis (Muriuki et al., 1997). The coexistence of
diseases which present with similar non-specific symptoms such as malaria,
syphilis, PUO and tuberculosis has been causing difficulties in the diagnosis of
brucellosis in many parts of Africa (Colmenero, et al., 1996; Young, 2000a).
In Uganda, Ndyabahinduka and Chu (1984) found that brucellosis was widespread
in the country. Positive agglutinin reactors among hospital patients in endemic
areas formed 18-24% of the total tested. A study conducted by Galukande, (2005)
showed that brucellosis contributed to serious spinal pathology in 17.2% of 204
patients who presented to Mulago hospital in Uganda with lower back pain. When
multiple tests were requested on patients having general malaise or body joint
pains and/or constant headaches (n=105), malaria was found to play a major role
(73%) followed by brucellosis (13.3%) and syphilis (4.3%) (Mutanda, 1998).
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1.16.3 Brucellosis in Tanzania
In Tanzania, brucellosis was first diagnosed in animals in 1928 from samples taken
from aborted cattle at Engare Nanyuki (Kitalyi, 1984). In humans, brucellosis was
first reported by Evans (1935) after reviewing the status of the disease in the then
Tanganyika. He stated that cultures obtained from humans had shown that B. abortus
and B. melitensis occurred in the country. Further reports of human brucellosis in the
country were obtained from monthly reports of the medical department of the Lake
Region and west region for 1959, 1960 and 1961 and from two patients at Kihesa
village in Iringa region (Anon, 1963). Several surveys have then been conducted on
animal brucellosis in different parts of Tanzania, with prevalences varying from 5%
to 20% (Table 1.2). However, these studies were conducted in more intensive farming
systems, and often in response to abortion problems and may therefore not be
representative of the majority of the indigenous cattle population, kept under
traditional husbandry systems.
28
Table 1. 2: Surveys of bovine brucellosis conducted in Tanzania
Region/Zone Test used Seroprevalence (%) Reference
Southern highlands SAT 13.2 Mahlau and
Hammond, 1962
Southern highlands SAT 20.5 Mahlau, 1967
Arusha and Manyara SAT 6.9 Staak and Protz, 1973




SAT 2-3 Otaru. 1985
Lake zone- Mwanza SAT 10.6 Msanga et al., 1986
Coastal regions
-Coast region SAT 2.3 Weinhaupl et al., 2000
-Dar es Salaam SAT 14.1 Weinhaupl et al., 2000
The findings are evidence that brucellosis has been in Tanzania for a long time at
varying degrees, however, despite this no clear control strategies have been put in
place. Currently the burden of human brucellosis in Tanzania is not known. A need
to identify and quantify the burden of brucellosis, the relative importance of
different risk factors, as well as evaluating diagnostic tools for brucellosis in
Tanzania form the basis for this study. Although a number of studies of human
brucellosis have been carried out in Tanzania, none has explored the relationship
between infection in humans and animals in different communities.
1.17 Control of brucellosis
The control measures of brucellosis in most African countries rely on public
awareness, campaigns on the importance of boiling milk and better diagnosis of
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human cases which are rarely implemented because health policy makers are not
aware of the burden imposed by zoonoses such as brucellosis (Coleman, 2002).
Control and eradication of brucellosis in domestic animals has important public
health implications. Test-and-slaughter programmes, in conjunction with
vaccination, are the major method of control (Crawford et al., 1986). Whole herd
depopulation can also be used when other methods have reduced disease
prevalence to low levels. Livestock populations can be screened for brucellosis by
serologic testing of individual animals, or by testing pooled samples such as bulk
milk (Crawford et al.. 1986).
Several vaccines are available for reducing infection in animal populations,
thereby reducing transmission potential to humans (Olsen and Stoffregen, 2005;
Crawford et al., 1986). These include, SI9, a laboratory-derived strain containing
B. abortus and Revl, a live attenuated B. melitensis vaccine. SI9 induces
reasonable protection against B. abortus, but produces persistent serological
responses which mimic active infection during testing (Schurig et al., 2002). A
similar problem occurs with the Revl strain which is still the most effective
vaccine against caprine and ovine brucellosis (Schurig et al., 2002; Mahajan et al.,
2005). RB51 is a mutant B. abortus strain vaccine, which has proved safe and
effective in the field against bovine brucellosis, and exhibits negligible interference
with diagnostic serology; it allows the differentiation of vaccinated and infected
cattle by means of serological tests (Moriyon et al., 2004).
The efficacy of the RB51 vaccine for the collective prophylaxis of brucellosis in
ruminants is controversial (Moriyon et al., 2004) and moreover, there is a lack of
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interest in this vaccine in countries which do not require differentiation of
vaccinated and infected animals. The classical live and attenuated B. abortus S19
vaccine is therefore considered to be the best available vaccine for controlling
brucellosis in cattle (Plommet and Plommet, 1989).
In many cases the control measures that have worked well in the developed world
can not be easily applied in developing countries where people depend on their
animals for their livelihood and replacements are difficult to obtain (Coleman,
2002). On the other hand, local customs, traditional habits and beliefs have been
impeding the wide application of such measures. Health education should be
intimately linked with all phases of prevention and control activities for zoonoses
(WHO, 1997). Protective clothing and careful handling of infected animals have
all been suggested by different studies as methods to reduce occupation-related
brucellosis and avoidance of infection in the general population as a whole
(Buchanan et al., 1974).
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1.18 Rationale and objectives of the study
1.18.1 Rationale
The study was motivated by members of the public and hospital staff in Arusha
and Manyara regions while conducting a study on tuberculosis. A significant
number of community members cited brucellosis as the most common disease
in their households after malaria. In hospitals, practitioners admitted to seeing a
significant number of patients with brucellosis in every single day. However, it
was evident from the visits that there were problems related to lack of
standardized diagnostic and treatment protocols for brucellosis which needed to
be studied and resolved.
Very few studies have been conducted on human brucellosis in Tanzania. This
was supported by lack of adequate data on human brucellosis in Tanzania. Most
of the studies conducted on brucellosis in Tanzania focused on quantifying the
magnitude of animal brucellosis in areas where animal abortions have been
reported, and mainly in more intensive farming systems instead of the majority
indigenous cattle population kept under traditional husbandry systems. Further
more, none of the studies used a population based random sample.
Tanzania is predominantly an agricultural country and the agricultural secloi
has been identified as a key industry for development and poverty alleviation.
The livestock sector, which is part of the agriculture sector, forms an integral
part of the Tanzanian economy (Ministry of Agriculture and Cooperatives,
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1995a). As the future lies mainly in agricultural development, diseases with
considerable effect on livestock productivity such as brucellosis should not be
ignored (Stark and Protz, 1973). Brucellosis is known to contribute to poverty
not only as a constraint to the productivity and development of the livestock
sector, but also by causing a direct human health burden (Stark and Protz,
1973). The present brucellosis control strategies need to be reviewed with the
establishment of a properly- planned, clearly defined and well enforced policy.
The public should be made aware of the seriousness of the disease and its
zoonotic potential so that participation in control strategies can be easier. It
was, therefore, felt that there was a need to conduct an epidemiological study
on brucellosis that would address several key questions such as those related to
diagnosis and treatment, risk factors for brucellosis, health seeking behaviour
and clinical characteristics of brucellosis cases and the burden caused by
brucellosis in Arusha and Manyara regions.
According to the livestock census of 1994/95, Arusha and Manyara regions are among
the regions keeping the majority of livestock in Tanzania. The regions have the
majority of pastoralist communities such as Maasai and Barbaigs, and many
agropastoral communities. The regions harbour the Ngorongoro and Tarangire National
Parks and border the Serengeti National Park and other extensive lands of free-ranging
wild animals. The people living in Arusha and Manyara regions are also known to keep
other animals such as dogs and pigs. Both wildlife and domestic animals have been
shown to be reservoirs of brucellosis (Roth, 1967; Sachs et al., 1968; Schiemann and
Staak 1971). The study area therefore provided an opportunity to study the role of
farming systems, wildlife and domestic animals in the transmission, risk factors and
other important factors related to brucellosis.
1.18.2 The objectives of the study were:
• To determine the sero-prevalence and incidence of human brucellosis in
Arusha and Manyara regions, Tanzania.
• To determine the burden caused by brucellosis in Arusha and Manyara
regions, in terms of DALYs lost and the economic burden associated with
the disease and its treatment in human populations.
• To determine the clinical history and health-seeking behavior of brucellosis
cases in Arusha and Manyara regions.
• To determine the knowledge of medical practitioners relevant to the
diagnosis of common zoonotic diseases.
• To identify and quantify the risk factors for brucellosis in humans.
• To evaluate the efficacy of different tests used in the diagnosis of human





Tanzania is divided into 26 administrative units called regions. Each region is then
divided into districts, divisions, wards, villages, sub-villages, ten-cell units and
finally households. Arusha and Manyara regions were involved with the study on
tuberculosis which was conducted prior the current study. Sampling was therefore
convenient in that it was easier to involve the same community, veterinary, hospitals
and political staffwith the current study. Arusha districts include Arusha, Karatu,
Monduli, Arumeru and Ngorongoro and Manyara districts include Babati, Mbulu,
Kiteto, Simanjiro and Hanang. The study involved Karatu, Ngorongoro, Babati,
Hanang and Mbulu districts (Figure 2.1).
Four study designs were employed in this study. These included the retrospective
hospital baseline data collection (preliminary hospital survey), the community (cross-
sectional) survey, the prospective hospital survey and the matched case-control
study. Baseline data for brucellosis were obtained from the preliminary hospital
survey and data for health-seeking behaviour and clinical characteristics of
brucellosis cases, evaluation of diagnostic tests, knowledge of practitioners of
zoonoses and estimation of burden caused by brucellosis were obtained from the
prospective hospital survey. In the case-control study, cases established in the
prospective hospital survey and the controls matched to cases by sex and districts
were followed up to their homesteads for blood sampling and questionnaire
administration.
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2.2 Study area and hospitals involved
Arusha and Manyara regions are located in the north area of Tanzania. Arusha and
Manyara regions formed a single region called Arusha prior to 2002. The regions lie
between 1.8° and 6° south of the equator and between 35° and 40° east of Greenwich
Meridian with a large area of landscape more than 1000m above sea level. Most of the
areas receive substantial rains from March to May, and lighter rains from September to
December, with the rest of the year being dry, typical of a semi arid area. The major
ethnic groups in Arusha and Manyara regions include Maasai, Mbulu (Iraqw), Barbaig,
Fyomi and Sonjo.
Maasai and Barbaigs are primarily livestock keepers, practising traditional pastoralism
and following a semi-nomadic lifestyle. The predominant form of land-use among the
other ethnic groups is agropastoralism with people keeping livestock, but also growing
crops for subsistence. People from these ethnic groups are more settled, do not move far
with cattle in search of pastures and have more permanent homesteads. Although ethnic
groups are not found exclusively in one district, the Maasai and Sonjo predominate in
much ofNgorongoro district, the Barbaig live mainly in Hanang, the Fyomi in Babati and
Hanang districts, and the Iraqwi in Karatu, Babati and Mbulu districts. In total the study
districts have 285 villages with a total population of 1,054,238 people.
Each district has either a district or a designated district hospital. District hospitals
involved with the study included Babati hospital in Babati, Mbulu hospital in Mbulu and
Katesh hospital in Hanang. The designated district hospitals included Dareda hospital in
Babati, Karatu Lutheran hospital in Karatu and Wasso hospital in Ngorongoro. Although
Endulen and Hydom hospitals are neither district nor designated district hospitals, they
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serve large catchments area in Ngorongoro and Mbulu districts respectively (Figure 2.2).
The majority of patients in the study area go to district or designated district hospitals
rather than dispensaries because the hospitals are better equipped and staffed than
dispensaries.
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Figure 2. 1: Map of Africa showing the location of Tanzania and the study area
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Figure 2. 2: Locations of the hospitals in the study
40
2.3 Preliminary hospital survey
The preliminary hospital survey was conducted between July and September 2002.
Data of the year 2001 from all the hospitals involved in the study were recorded and
interviews with practitioners of the hospitals were conducted to establish baseline
information on brucellosis in the study area. The objective of the study was to
establish baseline information on brucellosis in Arusha and Manyara regions,
including diagnostic and treatment protocols for brucellosis, the proportion of
patients diagnosed and treated for brucellosis at the hospitals, geographic distribution
and socio-demographic characteristics of brucellosis patients over one year, and the
costs for investigation and treatment charged by the hospitals.
In total, 11 practitioners agreed to be interviewed by the principal investigator of the
study. These included one medical officer and 10 medical assistants (see section
9.3.1 for the level of training that each receive). Four questions were asked during
the interview, these included the types of drugs used for the treatment of brucellosis,
diagnostic criteria for brucellosis, whether respondents had seen relapse or chronic
brucellosis patients and their opinions on when most patients presented to hospital.
As the hospitals visited did not store their data in electronic form, files with data of the
year 2001 were reviewed and all data recorded. These included data on all the patients
who attended to the hospitals during the study period, the number of brucellosis
patients, where they were coming from, when they were diagnosed and the treatment
they received. The costs of consultation, drugs and investigations were also recorded.
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2.4 Cross-sectional survey
2.4.1 Household cross-sectional survey
The cross-sectional study was conducted between May 2002 and July 2003. The
households to be visited were selected by a multistage cluster sampling using a table of
random numbers. The sampling frame comprised all of the 285 villages in the study area.
From the villages, a sample of 32 villages comprising 20 pastoral and 12 agropastoral
villages were randomly selected. In each village, two sub-villages were then randomly
selected. From each sub-village, two ten cell leaders were selected randomly and finally
two livestock keeping households were selected randomly from a list of all households
under each ten cell leader. At the randomly selected households, all members were
encouraged to be tested for brucellosis.
The first visit was made prior to blood sampling and delivery of the questionnaire.
Consultations were held with household leaders to provide information on the purpose of
the study and proposed blood sampling of household members and livestock. Consent
was sought for participation in the questionnaire study and for sampling of humans and
livestock. So as to motivate members to come forward for blood sampling, they were
promised by the research team that results and health education would be given on the
same day. Those who tested positive without symptoms were advised to go to hospital as
soon as symptoms developed and those with symptoms were advised to go to hospitals
for confirmation and treatment. Pain killers were given to those who agreed to be tested
and had pain.
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2.4.2 Questionnaire data collection
Open and closed ended questionnaires to establish knowledge, attitudes and practices of
the people towards brucellosis and other zoonotic diseases were administered by the
principal investigator. Respondents were members of households and information was
obtained by posing a question that was later discussed by members of the households and
a response given by one of them after they had agreed on the answer. In some
households, translators had to be used to ease communication between the investigator
and respondents. Translators were recruited on the same day the questionnaire was
administered and they were advised not to play part in modifying or influencing the type
of response given by the household members. Detailed information on questionnaire
data, results and analysis have been described by a co-investigator (Shirima., 2005).
2.4.3 Human blood sampling
Samples were collected from household members who volunteered for participation in
the study. This was not a random selection; for example, in some households, the head
of the household chose those who would be bled, in others some individuals were afraid
of being sampled and in others, some volunteers were particularly keen to participate
because of a history of clinical disease. Fourteen household leaders did not consent to
participate with the study activities; hence another household had to be selected
randomly as a replacement.
The site of fore-arm to be bled was thoroughly cleaned with cotton wool soaked with
methylated spirit (Bells Chemicals Co. Ltd., Dar es Salaam). Five millilitres of venous
blood was then taken from the brachial vein by using a disposable, sterile needle and
43
added into a plain sterile 5 ml vacutainer (Becton and Dickinson, UK). In some few
individuals, bleeding was done at the back of the hand because blood could not be drawn
from the brachial vein due to the vein being thrombosed or was not visible and not easily
accessible. Human samples were labelled with an identifier number to ensure patient
anonymity at the laboratory.
2.4.4 Livestock blood samples
Blood samples were collected from cattle, sheep and goats in the household, with the
number of each species sampled being determined according to the sample size needed
to detect infection in a herd, using 99% confidence and power of 80% and prevalence
of 5% (Martin et al., 1986). Sampling was carried out at dawn before the animals left
the boma and animals were sampled from within each age and sex class.
Randomisation of sampling was attempted, but this also cannot be considered strictly
random as only animals that could be manually caught and restrained were sampled.
Thus, particularly difficult animals were excluded from the study. Further details on
livestock sampling and results have been described by Shirima et al., 2005.
Animals were restrained within the premises, and on a few occasions a crush was used.
Five millilitres of blood were then taken from the jugular vein using a sterile needle and
plain vacutainers (Becton and Dickinson, UK) and for identification purposes the animal
was ear tagged using a metal tag (Ketchum, UK) that had a unique identifier number for
each animal.
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2.4.5 Processing and testing blood samples
Both human and livestock blood samples collected in labelled vacutainers were left to
settle at ambient temperature for a period of up to 30 minutes. Serum was later separated
by centrifugation with a mobile 12 v centrifuge (Vulcan technologies, USA), then split
into two aliquots. One aliquot was used at the household for the RBPT (see section
2.4.5.1). Results were conveyed to each subject tested with confidentiality maintained,
and animal results were conveyed to the head of the household. Owners were advised that
if they considered to sell an animal for meat in an auction or if they wanted to slaughter
an animal for meat at home, then a seropositive animal should be considered first because
keeping a seropotive animal will result in further transmission of brucellosis. They were
also advised that they should not sell the seropositive animal to a neighbour or in an
auction for keeping since the animals might transmit brucellosis to other animals.
Members were also advised to protect themselves while handling meet of seropositive
animals and their meet should be thoroughly cooked to kill the disease causing organisms
The two aliquots were preserved in cool boxes with ice at (-20°C) and one sent to the SUA
by using road transport and later to the VLA, Weybridge, the UK by using air transport. In
both laboratories, sera were tested using the RBPT (Davies, 1971) see section 2.4.5.1 and
the c-ELISA test (Perret, et al., 2001) see section 2.4.5.2.
2.4.5.1 The RBPT
The antigen for the RBPT was supplied by the VLA (Batch number 269 and SG276).
The protocol used in this test has been described by Davies (1971): Briefly, 30pl of
test antigen were placed beside 30pl of serum on a flat, white transparent surface and
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the drops were mixed using a clean piece of tooth pick in a zone of 2 cm in diameter.
The slide was rocked gently and the results were read within 4 minutes in good light.
One or two observers were used to verify the results. Any slide with a formation of
clumps (agglutinates) was taken as positive, while those without evidence of clumps
were classed as negative. A two point scale was used to report the positive results as
strong positive or weak positive depending on the density of agglutinates.
2.4.5.2 The c-ELISA test
The protocol for the c-ETISA test has been described by Perret et al., (2001). Briefly,
a polystyrene microtitre plate, pre-coated with B. melitensis lipopolysaccharide with
96 wells was used. In each microtitre well, 20pl of test serum was added in
duplicates using a single channel micropipette. Twenty microlitres of positive and
negative control antisera from the VTA were then added into six wells each. One
hundred microlitres of conjugate buffer was added into all the wells and the plate
was covered with a lid and incubated at room temperature for 30 minutes on a rotary
shaker at a 160 revolutions per minute. Plates were then rinsed and then thoroughly
dried by absorbent towel.
One hundred microlitres of substrate-chromogen solution were then dispensed into
each well, covered and left to react for 15 minutes at room temperature. A 100 pi of
stopping solution were then added to each well to stop the reaction. Any well that did
not show colour change indicated that the test sample was positive. An ELISA reader
(Multiscan RC version 6) was used to read the samples within 20 minutes at 450nm
filter with no blank. Based on conjugate control the positive/negative samples were
determined by a 60% cut-offof Optical Density (OD) (Based on 60% of the mean of
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the OD of the 4 conjugate control wells). Any sample with OD less than the value
was taken as a positive and more than 60% was taken as negative. If the binding ratio
was less than 10, or the mean OD of the 6 negative wells was less than 0.700, or the
mean OD of the 6 positive wells was greater than 0.100, the plate was rejected and
samples retested.
2.5 Health-seeking behaviour and clinical characteristics of brucellosis cases
2.5.1 Selection of patients and blood sampling
The study group was drawn by prospective hospital survey. All patients presenting to the
hospitals between June 2002 and April 2003 were enrolled into the study. Only patients
whose homes were in the study area (Mbulu, Babati, Karatu, Ngorongoro and Hanang
districts) were included in the analysis.
Following preliminary discussions with practitioners from the participating hospitals, it
was agreed that brucellosis should be considered a possible diagnosis for all patients
presenting with one or more of the following non-specific clinical features, including
fever, headache, joint pain, malaise, backache, fatigue and loss of appetite. For all
patients presenting with these clinical features (defined here as 'suspected brucellosis
cases' or 'suspects'), detailed data on clinical history, symptoms, impact of disease,
location of household and potential risk factors (such as occupation, age, sex) were
collected by the practitioners and data obtained recorded on forms designed for the
purpose (Appendix II). For each suspected brucellosis case, a blood sample was collected
for serological diagnosis of brucellosis (Figure 2.3). Additional laboratory tests for other
conditions, such as malaria and typhoid, were also carried out on the basis of the clinical
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judgement of the physician. Each patient was given a unique identification number,
which was used to identify data on the clinical forms and the blood sample.
2.5.2 Laboratory tests
All the investigations at the hospitals were carried out according to the hospital's
standard practices for routine diagnoses. These included serological tests for brucellosis,
a blood smear for diagnosis of malaria, and the Widal test for diagnosis of typhoid fever
(Schroeder, 1968). For amoebiasis, routine microscopic examination of stool samples
was conducted. As X-ray facilities were not available in most of the hospitals, the
diagnosis of pulmonary tuberculosis was based on presenting clinical features and
microscopic examination of sputum for the presence of acid-fast bacilli. Difficulties were
encountered when a cervical lymph node biopsy was taken to investigate tuberculosis. In
such a situation, a biopsy had to be sent to Kilimanjaro Christian Medical Centre in
Kilimanjaro for histopathology, hence diagnosis was delayed. Results of diagnostic tests
and the treatment regime initiated were recorded on the clinical form by the attending
physician (Appendix II). All patients with positive serological results for brucellosis
conducted at the hospitals were named as 'brucellosis seropositives' to distinguish them
from 'suspected brucellosis cases'.
2.5.3 Confirmation and definition of cases
Samples of blood taken from the suspected brucellosis cases were taken to the VLA
where the c-ELISA test was conducted (see section 2.4.5.2). In this investigation, all
suspects with any two or more of the clinical features including fever, headache, joint
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pain, waist pain, backache, malaise, fatigue and tested positive with the c-ELISA test at
the VTA were taken as brucellosis cases.
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2.5.4 Determination of persistence of antibodies to Brucella using the RBPT
Nine cases of brucellosis that were established at hospitals and received treatment for
brucellosis were followed-up to investigate the persistence of antibodies to Brucella. The
objective of the exercise was to determine for what time period cases will continue to test
positive for brucellosis. In this part of the study the RBPT was used to determine the
presence of antibodies to Brucella. The time span between the day treatment for brucellosis
commenced to the time the last RBPT positive result was obtained was termed "The duration
of antibodies to Brucella'". Any case who had remission of the original clinical features,
established by interview and physical examination, was considered to have recovered from
brucellosis.
2.5.5 Calculation of distance between hospitals and households
The GIS coordinates of the households and of the hospitals were recorded from a hand-held
Garmin® GPS machine. All coordinates were then transferred to Excel spread sheets and the
distance between the hospitals and the households calculated in kilometers using ArcGIS 9
software (ESR1, Redlands, California).
2.6 Case-control study
2.6.1 Study design and case selection
This was designed as a matched case-control study. Ail patients who presented to the
selected hospitals between July 2002 and June 2003 with clinical features suggestive of
brucellosis were recorded and investigated. Any person with a positive serological result by
the c-ELISA test conducted at the VLA, and showing at least two of the clinical features:
headache, fever which is recurrent or continuous, sweating, joint pain, joint swelling,
general body malaise or backache, was defined as a case.
2.6.2 Selection of controls
For every case, a community-based control was selected. A control was an individual in the
same district as the case, having a negative brucellosis serological result by the c-ELISA test
and matched by sex. To get an appropriate control, a multistage cluster sampling technique
was conducted. Random selection was performed at each level that included district, village,
sub-village, ten-cell unit and household. As all the cases were drawn from hospitals, the
criteria for selection of controls included them coining from a hospital-going household. Any
persons from households with a history of member/s going to traditional healers only when
falling sick were excluded from the study. To avoid selection of a non-compliant control, all
members of each household were encouraged to have their blood taken for brucellosis
serology. One control of the same sex as the matched case was selected randomly from
among those who agreed to participate in the blood sampling.
2.6.3 Follow-up of cases and controls
Blood sampling and testing for brucellosis in both humans and livestock was conducted
using the RBPT in the field and at the SUA in Morogoro (Davies, 1971), the c-ELISA test
for brucellosis at the VLA and HIV testing using a direct ELISA test (The Vironostica
Uniform II Plus O), at the Muhimbili University College of Health Sciences in Dar es
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Salaam. A questionnaire on potential risk factors was also administered during the follow-
up period (Appendix I). In each household the number of livestock to be bled was
determined by using the power of 80% with 95% confidence and prevalence of brucellosis
of 5% to detect infection in a herd (Martin et al., 1986).
2.6.4 Laboratory tests
2.6.4.1 The RBPT and the c-ELISA test
The methods involved in the RBPT and the c-ELISA tests have been described in sections
2.4.5.1 and 2.4.5.2 respectively of this thesis.
2.6.4.2 Human Immunodeficiency Virus (HIV) testing
Antibodies against HIV type 1 and type 2 were tested using a direct ELISA test the
Vironostica Uniform II Plus O test. The kits for the test were supplied by bioMerieux bv of
the Netherlands. Briefly, 100 pi of specimen diluent containing stabilizing protein and
detergent (gentamicin sulfate) were added by a pipette into all wells of a plate including
control wells. Fifty microlitres of test samples were then added by a pipette into all wells
except one column which was left for three negative controls and one anti-HIV positive
control. Fifty microlitres of negative control was then added into the upper three wells of
the last column followed by fifty microlitres of the positive control
The mixture was shaken by a microshaker for 15 minutes and incubated at 37°C for 60
minutes. Each well was then washed and soaked with phosphate buffer six times, each
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time the contents of the wells were aspirated into a waste flask and the wells refilled
with phosphate buffer. A hundred microlitres of Tetramethylbenzidine in citric acid was
added into each well and incubated at 15°C -30°C for 30 minutes. To stop the reaction,
100 pi of sulphuric acid was added into each well and the contents mixed by tapping the
side of a plate. The reader was then blanked against air and the absorbance of the
solution was read at 450nm with 620-700nm as reference
Manually the results were obtained by the following method:
For qualification of Negative Control (NC) values:
1. NC must be <0.250. Eliminate any NC>= 0.250
2. Determine the NCX value of the remaining controls
3. NC must be within the range of 0.6 to 1.4 times NCX,
Assay validity
An assay was valid if
1. More than half the number of negative controls remain
2. PCI -NCX>= 0.400
3. PC2 - NCX >= 0.400 (if used)
Cut-off point
If the test is valid the cut-off point is obtained by: NCX + 0.100.
A test sample is reactive if sample absorbance is >= cut-off point and nonreactive if
sample absorbance is < cut-off point.
A reactive result indicates that the sample tested either contains anti-HIV-1, anti HIV-2
and or anti-HIV 1 group O, and a non reactive result indicates that the sample tested was
negative or contains the above antisera below detectable limits of the test.
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2.7 Evaluation of diagnostic tests for brucellosis
2.7.1 Data collection
Serological data for evaluation of diagnostic tests were obtained from both the cross-
sectional study and the hospital clinical study. The cross-sectional study was conducted
between July 2002 and June 2003. Subjects for blood sampling were obtained by multi-stage
cluster sampling from the regional to household levels. At the randomly selected households,
all family members were encouraged to be tested for brucellosis (see chapter 3). In the
clinical study, all patients presenting with clinical features suggestive of brucellosis
(brucellosis suspects) were tested for brucellosis using antigen purchased by the hospital and
Rose Bengal antigen supplied by the project. An aliquot of serum was stored for further
analysis at the SUA and at the VLA.
2.8 Estimation of the burden caused by brucellosis
Data for DALY estimation, clinical history and costs of treatment were obtained from the
follow-up of cases and the cross-sectional survey. Detailed methodology has been described
in chapter 8 of this thesis.
2.9 Knowledge of practitioners of common zoonotic diseases
The study was carried out in the districts ofNgorongoro, Karatu and Arusha in Arusha
region, Mbulu, Babati and Simanjiro in Manyara region and Moshi in Kilimajaro regions in
northern Tanzania, and Dodoma urban in Dodoma region in Central Tanzania. Details of the
hospitals involved and methodology applied are discussed in chapter 9 of this thesis.
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2.10 Ethical issues
The study was approved by the National Institute for Medical Research (NIMR) ethical
committee, and was conducted in accordance to NIMR ethical guidelines. Consent was
sought before patients enrolment and before any diagnostic procedure.
2.11 Data analysis
All data were entered and initial analysis done on Microsoft Office Excel 2003
spreadsheets (Microsoft Corporation, Redmond, Washington DC). Different softwares
were then used depending on the type of analysis required and data set available. In
univariate and multivariate analysis Minitab version 1.4 (Minitab Inc. 2000, Release 14
for Windows, State College, Pennsylvania) was used and Egret for Windows version 2.0
(Cytel Software Corporation, Cambridge Massachusetts) for conditional logistic
regression. Chi-square tests were used to analyze all count data and Fisher's exact test
was used where 2x2 tabular results produced expected counts of less than 5. A p-value
of <0.05 was considered statistically significant.
Egret for windows version 2.0.3 was used to run a conditional logistic regression in the
analysis of data for the case-control study. The univariable relationships between all
independent variables and brucellosis were estimated by including them individually in a
model with brucellosis serological result as the dependent variable. Forty-four risk sets
were obtained from the cases and controls studied. Using risk sets as a matching variable,
and cases and controls as outcome variables, a number of models were fitted to test their
significance as risk factors for a brucellosis positive serological result. Since a few
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samples were available for HIV testing, the univariate analysis using HIV results was
carried out separately using Minitab version 1.4 and the results were interpreted
separately without being included in the multivariate analysis. All the 95% confidence
intervals were calculated using Epi Info 6 software (CDC, Antanta, Georgia).
In multivariable analysis, models were created by a backward stepwise procedure.
Variables that had a p-value of ^0.2 from the univariable analysis were considered for
inclusion in the final models. Values were retained if on their removal there was a
significant increase of the residual deviance of the model with likelihood ratio statistics
(LRS) of p>0.05 and they were removed from the model if they caused an insignificant
increase or decrease in the residual deviance with LRS of p < 0.05.
In the evaluation of diagnostic tests for brucellosis, Win Episcope 2 (CLIVE, Learning
Technology Section, College of Medicine and Veterinary Medicine, University of
Edinburgh) was used to draw a Receiver operating characteristic (ROC) curve and the
cut-off point with the best results of both Se and Sp was calculated using the method by
described by Hanley and McNeil (1982).
2.12 Questionnaires
Questionnaires have been described in respective chapters and included in appendices 1-
V. In summary, all the questionnaires were a combination of closed and open-ended
questions in English. Interviews were however conducted by the principal investigator in
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Swahili which is the language spoken in most parts of Tanzania. In some areas where
Swahili was not commonly used, an interpreter was used.
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3. Preliminary hospital survey
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3.1 Summary
Objective: The objective of the study was to establish baseline information on
brucellosis in Arusha and Manyara regions, including diagnostic and treatment
protocols for brucellosis, the proportion of patients diagnosed and treated for
brucellosis at the hospitals, geographic distribution and socio-demographic
characteristics of brucellosis patients over one year, and the costs for investigation
and treatment charged by the hospitals.
Methodology: A review of hospital records and interviews with hospital medical
staffwere conducted in Arusha and Manyara regions between July 2002 and
September 2002.
Results: Of 170,345 patients who attended hospitals in Babati, Dareda, Karatu,
Hydom, Wasso, Endulen and Mbulu hospitals in the year 2001, 619(0.36%) were
diagnosed as having brucellosis. The majority of brucellosis cases were in the age
group 16-30 years compared to other age groups. Different hospitals used several
different antigens and techniques to test for brucellosis including titration method and
serum/rapid agglutination tests. There was a wide disparity in treatment protocols.
Drugs used for the treatment of brucellosis differed amongst the hospitals with
respect to doses and duration of treatment.
Conclusion: Evaluation of brucellosis treatment regimes and diagnostic tools with
an aim of establishing and hence adopting standardized treatment and diagnostic
protocols should be carried out. The government and hospitals should ensure that the
recommended drugs and reagents for the tests are available to the hospitals
throughout the year. There is a need to carry out a study that will establish to what
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extent brucellosis is a problem, not only to the hospital-attending population but also
in the communities in Arusha and Manyara regions. Other areas where research is




Hospitals involved and the methodology used in this study are described in the
second chapter of this thesis. In summary, a review of hospital records and interview
with hospital clinical staff was conducted between July 2002 and September 2002.
In total 11 practitioners agreed to be interviewed by the principal investigator of the study.
These included one medical officer and 10 medical assistants. Four questions were asked
during the interview, these included the types of drugs they used for the treatment of
brucellosis, diagnostic criteria for brucellosis, whether they have seen relapse or chronic
brucellosis patients and their opinions on when most patients presented to hospital.
As hospitals visited did not have data in electronic form, files with data of the year 2001
were reviewed and all data recorded. These included data on the number of brucellosis
cases, where they originated, when they were diagnosed and the treatment they received.
The costs of consultation, drugs and investigations were also recorded.
All the data collected were entered and analysed on Microsoft Office Excel 2003
spreadsheets (Microsoft Corporation, Redmond, Washington, USA). Chi-square tests were
used to analyze all data and Fisher's exact test was used where 2x2 tabular results were
obtained with any expected counts of less than 5. A p-value of <0.05 was considered
statistically significant. The average cost of treatment in the study was calculated from the
sum of the total costs for consultation, diagnosis and treatment for all hospitals divided by
the number of hospitals.
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3.3 Results
3.3.1 Soeio-demographic characteristics and distribution of brucellosis patients
Of the patients who presented to the hospitals in the study area between January 2001
and December 2001, 619 (0.36%) were diagnosed as suffering from brucellosis based
on clinical history, clinical features, and a positive hospital serological test for
brucellosis. For the purpose of this study all patients who were diagnosed and treated
for brucellosis based on clinical features and positive hospital serology were named
"brucellosis patients". Endulen hospital had the greatest proportion of brucellosis
patients 1.8% (182/9923), followed by Dareda hospital 1.77 % (165/9297), and
Karatu and Babati hospitals both with 0.4% (100/26963) and (40/8985) brucellosis
patients respectively (Table 3.1). During the period of study, Katesh hospital did not
have the antigen for testing brucellosis, so there was no available data on brucellosis
from Katesh hospital.
Of brucellosis patients, 415 (67%) were female and 204 (33%) were male (%2 =22.17,
df=4, P<0.01). Of these, 34 (5.4%) were 15 years of age and below, i.e. school age,
223 (36%) were 16-30 years of age, 138 (22.3%) were 31-45 years of age, 179 (29%)
of age 46-60 and 45 (7.3%) more than 60 years of age (Table 3.2).
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Karatu 100 25 75 26,963 0.40
Mbulu 46 17 29 14.944 0.30
Hydom 51 13 38 88,265 0.05
Katesh - - - - -
Babati 40 8 32 8,985 0.40
Dareda 165 46 119 9,297 1.77
Wasso 35 8 27 11,968 0.30
Endulen 182 70 112 9,923 1.80
Overall 619 204(30%) 415(70%) 170,345 0.36
Table 3. 2: Age and sex distribution of brucellosis patients in the year 2001
Age group Number of patients
(years) Males Female Total Percentage (%)
=< 15 15 19 34 5.4
16-30 66 163 223 36.0
31 -45 60 72 138 22.3
46-60 43 136 179 29.0
>60 20 25 45 7.3
Total 204 415 619 100.0
There was a significant difference in the number of seropositive patients identified
between the two periods of the year i.e. the first and last quarters versus the middle
two quarters of the year (x2= 13.1, df=6, p<0.05), with most brucellosis patients seen
in the last quarter of the year (Table 3.3).
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Table 3. 3: Distribution of brucellosis patients in the year 2001
Hospital Jan - April - July - Oct. - Total
March June September December
Karatu 29 (29%) 20 (20%) 23 (23%) 28 (28%) 100
Mbulu 7 (15%) 6(13%) 18 (39%) 15 (33%) 46
Hydom 9 (18%) 13 (25%) 10(20%) 19 (37%) 51
Babati 8 (20%) 12(30%) 9 (23%) 11 (27%) 40
Dareda 42 (26%) 53 (32%) 30(18%) 40 (24%) 165
Endulen 56 (31%) 23 (13%) 39 (21%) 64 (35%) 182
Wasso 8 (23%) 4(11%) 9 (26%) 14(40%) 35
Total 159(25.7%) 131(21.2%) 138(22.3%) 191 (30.9%) 619
(percentage)
3.3.2 Knowledge of practitioners of clinical features of brucellosis and time of
testing
Out of 1 1 clinicians interviewed, 10 thought brucellosis presents with non-specific
clinical features that resemble malaria and typhoid such as headache, fever, joint pain
and malaise, but they admitted to usually investigating for malaria and typhoid prior
to brucellosis because they thought malaria and typhoid were much more prevalent. It
was therefore not surprising to note that all practitioners thought brucellosis patients
presented with clinical features of more than one month in duration.
3.3.3 Diagnostic criteria for brucellosis
All the practitioners interviewed mentioned the criteria for investigating and hence
diagnosing brucellosis as a history of fever, joint pain, headache, general body
malaise, fatigue and a positive blood test for brucellosis (see table 3.4 for the tests).
By using the hospital tests (Table 3.4), the presence of clumps and the titre of 1:80
and above was used by the practitioners as positive tests for brucellosis.
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Different hospitals were found to use different antigens and techniques to test for
brucellosis; some used a titration method while others used a plate or slide
agglutination method. However antigens with the following brand names were seen
in hospital laboratories, with Chronolab " containing B. abortus antigen being
commonly used. Others included Merox® with B. melitensis and Biosystem® with B.
melitensis and B. abortus, antigens (Table 3.4)
Table 3. 4: Tests for brucellosis in different health facilities in Arusha and
Manyara regions
Hospital Test used/method Antigen Alternative antigen Antigen
contained and method contained
Karatu Merox® , titration B. abortus and Rose Bengal B. abortus
B. melintesis (Nairobi), titration
Mbulu Chronolab®, PA B. melitensis New market®, PA B. melitensis
Hydom New market'1, titration B. melitensis Eurocell A , titration B. abortus
Katesh Chronolab®, PA B. abortus
Dareda Chronolab"1, PA B. melitensis Rose Bengal B. abortus
(Nairobi) PA
Babati Chronolab" , PA B. abortus
Wasso Biosystem®, titration B. melitensis Eurocell A®, titration B. abortus
Endulen Chronolab", PA B. abortus Humatex®, PA B. abortus
PA - Plate/slide Agglutination
- Brand names for antigens used in hospitals
Alternative antigens - Antigens used if the antigen of first choice from supplier is not
available.
3.3.4 Therapeutic regimens used and their costs
In all the hospitals visited there was no clear policy for treating brucellosis patients. It
was observed that within a single hospital practitioners used different regimens in
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treating brucellosis patients. The different brucellosis treatment regimes, their costs
and costs for treatment are summarized in Tables 3.5 and 3.6 respectively.
On average brucellosis patients in the study area used a total of 5,771* Tshs. for
consultation, investigation and treatment of brucellosis (range 1,000-12,000 TShs.).
Other indirect costs such as transportation costs, costs for accommodation and meals
for patients and persons escorting them were not included.
*
The exchange rate was US $ 1 for 1880 TShs. in 2001
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Table 3. 5: Therapeutic regimens used and costs charged by each hospital
Hospital Drugs Dosage/Duration Cost
Karatu missionary
hospital
1. Streptomycin injection 1 g once a day for
two weeks
7,000 TShs.
2. Doxycycline tablets 100 mg twice a day for
four weeks
2,800 TShs.








500 mg four times a
day for four weeks.
100 mg twice a day for
four weeks











1 g once a day for
two weeks
100 mg once a day
for four weeks
500 mg three times a







960 mg twice a day
for two weeks
Dareda hospital 1. Ciprofloxacin tablets
2. Doxycycline tablets
500 mg twice a day
for ten days










200 mg once a day for
six weeks
500 mg three times a
day for three weeks






Hospital Drugs Dosage/Duration Cost








the cost is 5,000
TShs.
Endulen hospital I. Streptomycin injection
2. Doxycycline tablets
doxycycline tablets
200 mg once a day for
six weeks
1 g once a day for two
weeks in combination
with




the cost is 5,000
TShs.
If patient under 12 years
of age
Cotrimoxazole alone for
three to four weeks
TShs. - Tanzanian shillings
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Table 3. 6: Costs for diagnosis and treatment
Hospital Service Costs TShs.
Karatu Consultation fee 500
Investigation: Brucellosis 1,500
Test for malaria 300
Test for typhoid 1,500
Treatment/drugs 4,900
Total cost 8,700






Dared a Cost for diagnosis and treatment 1,500
Hydom Cost for diagnosis and treatment 1,500



















3.4 Discussion and conclusion
More women were diagnosed as suffering from brucellosis than males in the year
2001, the difference was statistically significant (p<0.05). It is possible that women
who engage more in farm and home-based activities such as looking after animals,
milking and cleaning pose themselves to a greater risk of brucellosis than men.
Studies conducted in Spain and Egypt by Troy et al., (2005) and Hussein et al.,
(2005) respectively also showed similar results that brucellosis is much more
common in women than men. In the current study most of the brucellosis patients
were 16-30 years of age and fewer were at pre-school age, school-age or in old-age.
In the study area most of the individuals of 16-30 years of age are married and are
actively involved in different home or farm-based activities. These results suggest
that such activities might pose a greater risk to them than to other age groups that are
less involved with such activities.
More brucellosis patients were recorded in the beginning and towards the end of the
calendar year at a time when most parts of the study area had slight rains, farmers
were either preparing the land for planting or had already planted their crops. It is
possible at this time of the year there was more transmission of brucellosis or it is
possible that farmers had sold their crops and were better able to afford the costs of
treatment. More studies need to be conducted to establish the reasons for this seasonal
distribution of brucellosis patients.
The majority of practitioners thought brucellosis patients presented with non-specific
clinical features that resemble malaria and typhoid, but it was a common practice for
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them to investigate for malaria and typhoid first because they thought malaria and
typhoid were much more prevalent than brucellosis. The practice of not testing
routinely for brucellosis is likely to cause a delay in diagnosis and treatment of
brucellosis.
All the practitioners interviewed mentioned the criteria for investigating and hence
diagnosing brucellosis as a history of fever, joint pain, headache, general body
malaise, fatigue and a positive test for brucellosis. This agrees with literature
(Onyemelukwe, 1989; Sadat-Ali et al., 1991; Al-Shamahy and Wright, 2001;Tsolia
et al., 2002; Chadda et al., 2004; Fallatah et al., 2005; Mantur et al., 2004; Galukande
et al., 2005 ; Andriopoulos et al., 2006 and Kokoglu et al., 2006) showing that
practitioners generally had the correct knowledge on the presentation and diagnosis
of brucellosis.
Different hospitals were found to use different antigens and techniques to test for
brucellosis such as ChronolabK containing B. abortus, Merox® with B. melitensis and
Biosystem® with B. melitensis and B. abortus antigens. As the sensitivities and
specificities of these antigenic tests are not known, there is a possibility that
brucellosis is misdiagnosed in the area.
It was evident that no standardized treatment protocol for brucellosis existed in the
study districts. Even drugs that are used for the treatment of tuberculosis such as
streptomycin and rifampicin were found to be used at different doses and for different
durations. It was also observed that due to a short supply of drugs, practitioners
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prescribed different types of drugs, some in combination and some alone at different
doses, depending on their availability. This practice could predispose to the
emergence of drug resistant strains not only of Brucella but also tuberculosis and
other bacterial pathogens (Al-Hajjaj et al.t 2001; Al Dahouk et al., 2005; Bayindir et
al., 2003). According to the Ministry of Health, the standard treatment guideline and
the National Essential Drugs List for Tanzania (NEDLIT) produced in 1998, requires
that a combination of either doxycycline or tetracycline for four weeks and
streptomycin injection for the first two weeks should be used for the treatment of
brucellosis. This was not practiced in the study area.
Brucellosis patients used an average of 5771 TShs. for consultation, investigation and
treatment of brucellosis. This excludes the costs of transportation to and from the
hospital and the costs of family members escorting them (see chapter 8). It is possible
that the majority of farmers who depend on subsistence farming for their livelihood
would not afford if several members of a household were to suffer from brucellosis in
a year. Apart from morbidity, brucellosis is therefore likely to have a significant
socio-economic impact on the poor farmers in the study area.
There is an urgent need for evaluation of brucellosis treatment regimes and diagnostic
tools in Tanzania with an aim of establishing and hence adopting standardized
treatment and diagnostic protocols. This would improve the diagnosis and treatment
outcome and prevent emergence of drug resistant strains of Brucella, Mycobacteria
and other bacterial pathogens. The government and hospitals should ensure that the
recommended drugs and reagents for the tests are available throughout the year.
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There is a need to carry out a study that would establish to what extent brucellosis is a
problem, not only to the hospital-going population, but also in the communities in
Arusha and Manyara regions. Other areas into which further research is required
include risk factors for brucellosis, health seeking behavior and clinical features of
brucellosis patients.
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Objectives: To determine the seroprevalence of human brucellosis in Arusha and Manyara
regions. The study also aimed to determine the relationship between infection in humans and in
livestock and the relationship between the serostatus of human brucellosis and clinical
manifestations of the disease.
Methodology: A cross-sectional survey was conducted between May 2002 and July 2003 in the
districts of Karatu and Ngorongoro in Arusha region and Mbulu, Babati and Hanang in Manyara
region. Villages, tencell units and households for blood sampling were obtained by multistage
cluster sampling. Samples of blood collected were tested for brucellosis using the RBPT in the
field and at the SUA and using the c-ELlSA test at the VLA. For all the RBPT positives, clinical
features were recorded. Open and closed ended questionnaires to establish the knowledge, attitude
and practice of the people towards brucellosis and other zoonotic diseases were also administered.
Results: Based on the RBPT results, the seroprevalence of brucellosis was 4.8% in the field and
6.4 % at the SUA, and using the c-ELISA test conducted at the VLA which was the gold standard
test the seroprevalence of brucellosis was 7.7%. The majority of Rose-Bengal positive individuals
(56.5%) were asymptomatic. Of those with clinical features, fever, joint pain and backache were
the most common. There was a significant association between prevalence of brucellosis in
humans and the prevalence of brucellosis in goats at district level (p<0.05).
Discussion and conclusion: There could be a considerable number of brucellosis cases in
Arusha and Manyara regions that do not present to hospital due to various reasons.
Estimation of the burden caused by brucellosis should also take into account members of the
community that meet the diagnosis criteria. Community members should be made aware of
the danger posed by goats in transmitting brucellosis particularly during handling fluids
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from goats such as blood and during assisting parturition. Care should be taken in choosing
the type of serological test to be performed in prevalence studies as some tests might not
give the true brucellosis prevalence.
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4.2 Introduction
Zoonotic diseases have a major impact on the health and economic prosperity of the developing
world (Smits and Cutler, 2004). Brucellosis is one of the most important bacterial zoonoses
worldwide caused by bacteria of the genus Brucella (Young, 1995a). Brucella is responsible for
enormous economic losses as well as considerable human morbidity and mortality in endemic
areas (Boschiroli et al., 2001). The losses are much more evident in developing countries where
disease control strategies do not exist, or have collapsed. Poor farming systems have also
contributed to difficulties in the control of animal movement and disease monitoring (Schelling
et al., 2003; McDermot and Arimi, 2002).
Humans contract brucellosis mainly from domestic animals including cattle, sheep and dogs,
but further complications arise through wild animal reservoirs which may also carry and
transmit the disease (Godfroid, 2002). Transmission from infected livestock to man can either
be direct through contact with infected material, or indirect through consumption of animal
produce. In man, the disease may affect almost any organ such as musculo-skeletal organs, the
heart, lungs, liver, brain, spleen and kidneys, which, if not treated early may lead to severe and
prolonged disability (Corbel, 1997). B. melitensis is the most common species infecting man
and is probably the most virulent, followed by B. suis and B. abortus (Domenech et al., 1983).
Brucellosis caused by B. melitensis in humans is therefore more prolonged and more severe and
debilitating than brucellosis caused by B. abortus or B. suis (Domenech et al., 1983). In
animals B. melitensis infection occurs more commonly in small ruminants such goats and sheep
whereas B. abortus occurs more commonly in cattle (Corbel et al., 1984; Crawford et al.,
1990).
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Brucellosis remains a major problem in many parts of the world, notably in the Mediterranean
region, western Asia, and parts of Africa and Latin America (Corbel, 1997). Even in some
countries of Western Europe where it has been eradicated, there is still a constant threat of
reintroduction via livestock trading (Whatmore et al., 2005). In a cross-sectional study that was
conducted in two provinces of Anatolia, Turkey, the seroprevalence of brucellosis in humans
ranged from 2.9 to 8.5% using the Rose Bengal test. Adherence to traditional farming practices
and lifestyle and a preference for fresh dairy products were found to contribute to the high
seroprevalence of brucellosis in the two provinces (Rose et al., 2006). In a random survey
conducted in Punjab (India), the overall prevalence of brucellosis in humans using ELISA was
11.23% (Dhand et al., 2005).
Brucellosis has been reported from almost all countries in Africa (Refai, 2002). It is prevalent
in all major livestock production systems in sub-Saharan Africa, yet it is often unrecognised
through lack of awareness by both veterinarians and human health staff and the absence of
accessible laboratory diagnostic facilities (McDermott and Arimi, 2002). This has resulted in
the disease being largely neglected with little control and prevention in many parts of the
continent (McDermott and Arimi, 2002). Worldwide, the incidence of brucellosis is highest in
pastoral production systems where large numbers of animals mix, and is lowest for confined
farms. This has made the control of brucellosis more problematic in pastoral or migratory
populations, which in Africa is practiced by a significant proportion of the agricultural
population (Schelling et al., 2003).
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Although brucellosis was first confirmed in Tanzania in 1928 (Kitaly, 1984), very few studies on
brucellosis have focused on the burden of the disease in the traditional sector that makes up more
than 97% of the national total herd. The majority of the studies have been conducted in dairy
farms and ranches (Mahlau, 1967; Kitaly, 1984; Minga and Balemba, 1990; Jiwa et al., 1996;
Weinhaulp et al., 2000), where the disease was suspected, and only a few studies used random
methodology to sample the study population. In addition, studies on brucellosis have mainly been
carried out by veterinary professionals. In humans, most of community-based studies conducted
in Tanzania have focused on malaria (Omombu et al., 2004; Bodker et al., 2006; Wang et al.,
2006; Kachur et al., 2006) and HIV (Matee et al., 2006; Somi et al., 2006; Nielsen et al., 2006;
Kwesigabo et al., 2005), which have been regarded as of greater public health importance. In
Tanzania many zoonotic diseases such as brucellosis have generally been regarded as not posing
a serious threat to human health. It is not surprising therefore to see that to date, no studies have
been conducted to determine the distribution and characteristics of human brucellosis in
Tanzania.
The current study aims to determine the seroprevalence of human brucellosis in Arusha and
Manyara regions and to examine the relationship between brucellosis seropositivity and farming
systems. The study also aims to determine the relationship between brucellosis in humans and in
livestock and to examine the relationship between serostatus and clinical manifestation of
brucellosis.
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4.3 Materials and methods
4.3.1 Study area and methodology
The study area and the methodology involved have been described in detail in the second
chapter of this work. A brief account of the methodology is described.
The study was conducted between May 2002 and July 2003. In the household cross-sectional
survey a multistage cluster sampling was conducted from the village level, the ten-cell leader unit
and finally to the household level. Random tables were used in the random selection. The
sampling frame comprised all of the 285 villages in the study area. From the sample, 32 villages
comprising 20 pastoral and 12 agropastoral villages were randomly selected.
At the household level all members of the households were encouraged to be tested for
brucellosis and for livestock the number of each species to be sampled was determined
according to the sample size needed to detect infection in a herd, using 99% confidence and
power of 80% and prevalence of 5% (Thrusfield, 2001). Questionnaire data collection on the
knowledge, attitude and practice of the people towards brucellosis and other zoonoses was then
undertaken. Respondents were members of households and information was obtained by
posing a question after which household members gave responses after discussion. In some
households, translators had to be used to ease communication between the investigator and
respondents.
Human and livestock blood sampling and testing with the RBPT was conducted in the field (see
section 2.4.5) and feedback of human results conveyed to those tested, and those of livestock
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conveyed to the head of the household on the same day. In both cases, confidentiality was
observed. Serum samples were stored for the RBPT and the c-ELISA test at the SUA and the c-
ELISA test at the VLA.
For all the RBPT positive individuals, history of any symptoms was recorded and physical
examination for any clinical features of a disease was undertaken. For the c-ELISA positive
individuals it was not possible to record their clinical picture as samples had to be taken to the
VLA, UK for testing and there was a delay in getting the feedback of results. During storage and
shipment, some samples leaked and some were lost. This explains the differences in the number
of samples tested in the field, at the SUA and at the VLA.
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Plate 4. 2: The RBPT in the field
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4.3.2 Data analysis
All data were entered on Microsoft Office Excel 2003 spreadsheets (Microsoft Corporation,
Redmond, Washington, USA). Using the VLA c-ELISA result as a binary response variable,
logistic regression analysis was conducted to analyse the association between brucellosis
seropositivity and sex, age and farming systems. Test statistics with a p-value of <0.05 were
considered significant. In the analysis of the relationship between the prevalence of brucellosis in
humans and in livestock at the household, the village and the district levels, the prevalence of
brucellosis was calculated from the total number of c-ELISA positives divided by the total
number of all those tested using the VLA c-ELISA test at that particular level and the result was
multiplied by 100 to obtain a percentage.
The prevalence of brucellosis in the study area was calculated from the total number of all
seropositives (by the RBPT or by the c-ELISA test) divided by the total number of all tested in





A total of 106 randomly selected households in 29 villages were visited in Karatu, Mbulu,
Hanang, Babati and Ngorongoro districts between May 2002 and July 2003. Of these, 12
households were from Babati, 14 from Hanang, 38 from Karatu, 18 from Mbulu and 24 from
Ngorongoro districts. Fourteen household leaders did not consent to participate with the study
activities, hence other households were selected randomly as replacements. In total, 476
individuals from the above households were tested for brucellosis (Table 4.1). Of those tested,
249 (50.4%) were male and 236 (49.6%) were female (Table 4.2).
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Table 4. 1: Villages visited and individuals tested


































Table 4. 2: Sex distribution of individuals tested for brucellosis
District
Sex Babati Hanang Karatu Mbulu Ngorongoro Total
Female 28 (50%) 23 (46%) 89 (48%) 45 (48%) 51 (57%) 236 (49%)
Male 28 (50%) 27 (54%) 98 (52%) 48 (52%) 39 (43%) 240 (51%)
Total 56 50 187 93 90 476
4.4.2 Results of the field RBPT
Of the 476 individuals tested for brucellosis using the RBPT in the field, 23 (4.8%) were
seropositive. Fifteen of these (8.0%) were from Karatu district, four (4.4%) from Ngorongoro,
two (4.0%) were from Hanang, and two (4.4%) were from Mbulu. None of the individual tested
in Babati district gave a positive result (Table 4.3).

















Total 56 50 187 93 90 476
4.4.3 Results of the RPBT and the c-ELISA test conducted at the SUA laboratory
At the SUA laboratory, only 280 samples weie tested using the c-ELISA test. Of these, 18 (6.4
%) tested positive. The RBPT was performed on 427 samples and of these 3.7% tested positive
for brucellosis (Table 4.4)
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Table 4. 4: Results of the c-ELISA test and the RBPT at the SUA laboratory
District
c-ELISA Babati Hanang Karatu Mbulu Ngorongoro Total
Negative 48 (100%) 47(95.9%) 167(91.3) 0(0%) 0(0%) 262(93.6%)
Positive 0(0%) 2(4.1%) 16(8.7%) 0(0%) 0(0%) 18(6.4%)
Total 48 49 183 0 0 280
Laboratory
RBPT
Negative 47(97.9%) 49(98%) 174(95.1%) 69(97.2%) 72(96%) 411(96.3%)
Positive 1(2.1%) 1(2%) 9(4.9%) 2(2.8%) 3(4%) 16(3.7%)
Total 48 50 183 71 75 427
4.4.4 Results of the c-ELISA test at the VLA
Thirty three samples (7.7%) of 395 human samples collected in the fourteen month period tested
positive for the c-ELISA test at the VLA. Ngorongoro district recorded the highest proportion of
seropositives. None of the samples from Babati was seropositive (Table 4.5). The majority of
seropositive individuals belonged to the age group 16-30 years of age (Table 4.6). The locations
of the c-ELISA positives and negatives are shown in Figure 4.1.
Table 4. 5: Results of the c-ELISA test at the VLA
c-ELISA
results















Total 56 46 175 91 60 428
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Figure 4. 1: Map of Arusha and Manyara regions showing the locations of households
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Table 4. 6: Age and sex distribution of individuals who tested positive with the c-
ELISA test conducted at the VLA.
Age groups Female Male Total Percentage
1-15 2 1 3 9.09
16-30 8 7 15 45.45
31-45 4 5 9 27.27
46-60 2 2 4 12.12
>60 1 1 2 6.06
Total 17 16 33 100.00
4.4.5 Brucellosis in pastoral and agropastoral areas
Of the 395 individuals who were tested with the c-ELISA test at the VLA, 15.4% (8/52) were
seropositive in pastoral areas and 7.3% (25/343) were seropositive in agropastoral areas (Table
4.7).
Table 4. 7: Brucellosis in pastoral and agropastoral areas
District Predominant VLA c-ELISA results
farming system Positive Negative
Babati Agropastoral 0 (0 %) 56
Karatu Agropastoral 20(11.4%) 155
Mbulu Agropastoral 3 (3.2%) 88
Hanang Agropastoral 2 (4.3%) 44
Total in agropastoral 25 (7.3%) 343
Ngorongoro Pastoral 8 (15.4%) 52
Total in pastoral 8 (15.4%) 52
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4.4.6 Test of association between brucellosis seropositivity and sex, age and
farming system.
Using the VLA c-ELISA results as a binary response variable, a logistic regression
analysis was conducted to test for association between brucellosis seropositivity and sex,
age and farming system. Results showed that there was no significant association
between brucellosis seropositivity and age, sex and farming system (Table 4.9). When
age was aggregated into two age groups with children 15 years and less and adults with
greater than 15 years of age, there was a significant number of those with greater than 15
years (Table 4.8).
Table 4. 8: Analysis for association between brucellosis seropositivity and sex, age
and farming system
Variable Coefficients p-value OR 95% confidence interval
Upper Lower
Age 0.00 0.90 1.00 0.98 1.02
(Continuous)
Sex 0.15 0.65 1.17 0.60 2.26
Farming 0.01 0.77 1.01 0.49 2.11
system
Age (cut-off 0.12 0.001 3.4 1.23 6.24
point 15 years)
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4.4.7 Clinical features observed in the RBPT and the c-ELISA positive individuals
Of the 23 individuals who tested positive with the RBPT during the cross-sectional survey, only 10
(43.5%) had clinical features suggestive of brucellosis. The most common clinical features in the
RBPT positive individuals were fever, joint pain, backache, headache and general body malaise. Of
those who tested positive with the RBPT, 10 (43.5%) individuals also tested positive with the c-
ELISA test performed at the VLA. Out of these, five (50%) had clinical features suggestive of
brucellosis (Table 4.9).
Table 4. 9: Clinical features observed in the RBPT and the c-ELISA positive individuals
Symptom RBPT positives Percentage c-ELISA positives Percentage c-
with symptoms RBPT positives with symptoms ELISA positives
with symptoms with symptoms
Fever 9 39.0 4 40
Joint pain 8 34.0 4 40
Backache 6 26.0 2 20
Headache 5 22.0 4 40
General body malaise 3 13.0
Chest pain 2 9.0 2 20
General body weakness 2 9.0
Loss of appetite 1 4.5
Cough 1 4.5
Adenitis 1 4.5
Abdominal discomfort 1 4.5 1 10
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4.4.8 The relationship between the prevalence of brucellosis in livestock and in humans
at household, village and districts levels
The relationship between prevalence of brucellosis in livestock and in humans was analysed at
household, village and district levels. VLA c-ELISA results were used in the analysis. The following
is a summary of statistics for regression analysis carried out at different levels.
4.4.8.1 Relationship between the prevalence of brucellosis in livestock and in humans at
the household level
At the household level there was no significant association between the prevalence of brucellosis in
livestock and in humans (F-statistic=0.03, df=l, p-value =0.87) (Figure 4.2).
Figure 4. 2: Relationship between the prevalence of brucellosis in livestock and in humans
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4.4.8.2 Relationship between the prevalence of brucellosis in livestock and in humans at
the village level
At the village level there was no significant association between the prevalence of brucellosis in
livestock and in humans (F-statistic=1.09, df=l, p-value = 0.31) (Figure 4.3).
Figure 4. 3: Relationship between the prevalence of brucellosis in livestock and in humans
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4.4.8.3 Relationship between the prevalence of brucellosis in cattle and in humans at the
village level
At the village level there was no significant association between the prevalence of brucellosis in
cattle and in humans (F-statistic=0.28, df=l, p-value=0.6) (Figure 4.4).
Figure 4. 4: Relationship between the prevalence of brucellosis in cattle and in humans at
the village level
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4.4.8.4 Relationship between the prevalence of brucellosis in humans and in goats at
the village level
There was no significant associaton between the prevalence of brucellosis in goats and the
prevalence of brucellosis in humans at the village level (F-statistic=l .36, df=l, p-
value=0.25) (Figure 4.5).
Figure 4. 5: Relationship between the prevalence of brucellosis in goats and in humans
at the village level
Prevelence in goats (%)
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4.4.8.5 Relationship between the prevalence of brucellosis in sheep and the prevalence
of brucellosis in humans at the village level
At the village level there was no significant association between the prevalence of
brucellosis in sheep and the prevalence of brucellosis in humans (F-statistic=0.02, df=l, p-
value=0.88) (Figure 4.6).
Figure 4. 6: Relationship between the prevalence of brucellosis in sheep and the
prevalence of brucellosis in humans at the village level
20 30
Prevalence in sheep (%)
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4.4.8.6 Relationship between the prevalence of brucellosis in livestock and prevalence
of brucellosis in humans at the district level
At the district level there was no significant association between the prevalence of
brucellosis in livestock and in humans (F-statistic=0.09, df=l, p-value=0.78) (Figure 4.7).
Figure 4. 7: Relationship between the prevalence of brucellosis in livestock and in
humans at district level
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4.4.8.7 Relationship between the prevalence of brucellosis in cattle and the prevalence
of brucellosis in humans at the district level
There was no significant association between the prevalence of brucellosis in cattle and in
humans at the district level (F-statistic=4.89, df=l, p-value=0.11) (Figure 4.8).
Figure 4. 8: Relationship between the prevalence of brucellosis in cattle and in humans
at the district level
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4.4.8.8 Relationship between the prevalence of brucellosis in goats and in humans at
the district level
At the district level there was a significant association between the prevalence of brucellosis
in goats and the prevalence of brucellosis in humans (F-statistic=l 1.44, df=l, p-value=0.04)
(Figure 4.9).
Figure 4. 9: Relationship between the prevalence of brucellosis in goats and the
prevalence of brucellosis in humans at the district level
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4.4.8.9 Relationship between the prevalence of brucellosis in sheep and the prevalence
of brucellosis in humans at the district level
At the district level the association between prevalence of brucellosis in sheep and the
prevalence of brucellosis in humans was not statistically significant (F-statistic=6.53, df=l,
p-value=0.08) (Figure 4.10).
Figure 4. 10: Relationship between the prevalence of brucellosis in sheep and the
prevalence of brucellosis in humans at the district level
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4.5 Discussion
Seropositivity was found to be higher in individuals of above 15 years of age than those below
15 years of age. The results were similar to those obtained in Yemen by Al-Shamahy and
Wright (2001), in which seropositivity was found to be more common in adults than in
children. The cut-off point of 15 years was used to distinguish between school children and
adults who are fully involved with home and farm based activities. Seropositivity was higher
in the age group 16-30 years, and was low in the very elderly (>60 years). Younger age groups
carry more YLL and YLD than the aged who are approaching the end of their life span (see
section 8.3.3). Since DALYs is the sum of YLL and YLD (Murray and Lopez, 1994), the age
pattern of brucellosis cases is likely to give higher DALY. As most of the cases are in the
productive age, the burden caused by brucellosis is likely to have also an impact on the
economies of the households of the affected and Tanzania as a whole.
Of the 23 individuals who tested positive with the RBPT in the field, only 10 (43.4%)
individuals had clinical features suggestive of brucellosis. Of these, five (21.7%) individuals
were c-ELISA positive and had symptoms suggestive of brucellosis. Most of the
asymptomatic c- ELISA positive individuals were likely to be in the subclinical stage or were
in the incubation period. The majority of the individuals in subclinical stage or incubation
period eventually develop the acute clinical disease. It is also possible that some of the RBPT
positives individuals were not actually due to Brucella but rather due to cross-reaction with
other bacteria such as Yersinia or Salmonella (Staak et al., 2000; Gourdon, 1999) which cause
mild or no clinical disease in humans.
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The most common clinical features in seropositive individuals were fever followed by joint
pain and backache. Similar findings were obtained in other studies (Tsolia et al., 2002; Mantur
et al., 2004; Fallatah et al., 2005; Kokoglu et al., 2006) where fever and joint pain were cited
as the most common clinical feature of brucellosis. Others include back pain (Sadat-Ali et al.,
1991; Chadda et al., 2004; Galukande et al., 2005), malaise, headache, drenching sweat,
spleen and liver enlargement (Onyemelukwe, 1989; Al-Shamahy and Wright, 2001;
Andriopoulos et al., 2006). However, additional trace-backs and thorough physical
examination of the c-ELISA positives are required to provide a better clinical picture of
brucellosis cases in the study area.
The c-ELISA test and the RBPT were used in different settings to provide information on the
prevalence of brucellosis. Based on the RBPT, the seroprevalence of brucellosis was 4.8% in
the field, and 6.4 % at the SUA and based on the c-ELISA test performed at the SUA and the
VLA, the seroprevalences of brucellosis were 3.7% and 7.7% respectively. The differences in
the results may be attributed to the differences in the sensitivities and specificities of the tests
and the personnel involved in testing. The c-ELISA test conducted at the VLA was the gold
standard test in the study. The seroprevalence of brucellosis based on the VLA c-ELISA
results was therefore taken as the true seroprevalence and was compared with other
seroprevalence results. All other tests showed lower seroprevalence compared to the VLA c-
ELISA seroprevalence results. The discrepancies in the results obtained indicated that care
should be taken when choosing the type of test to be used for prevalence studies as some tests
might not give the true picture of the disease. It is important that a test is evaluated first before
using it in prevalence studies. Analysis and discussion on brucellosis diagnostic tests are
described in chapter 7 of this thesis.
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The prevalence of brucellosis in humans did not show a significant association with the
prevalence of livestock at the household level. This finding agrees with what was established
during the case-control study (see chapter 6), in which no association was established between
brucellosis cases and their own livestock. There was a significant association between the
prevalence of brucellosis in humans and prevalence of brucellosis in goats at the district level.
Goats within the district were therefore more strongly associated with brucellosis than cows
and sheep at household and village levels. In the univariate analysis of risk factors for
brucellosis (see chapter 6), brucellosis was found to be significantly associated with a
household where a goat had aborted. Since milk from goats is not widely consumed in the
study area, the transmission of brucellosis in the study area is most likely by contact with
infected goats during assisting parturition. The finding could also be an indication that B.
melitensis which is most commonly found in small ruminants such as goats and sheep is the
main cause of brucellosis in the study area. Although in a concurrent study conducted by
Shirima et al., (2005) in Arusha and Manyara regions, B. melitensis was isolated, a large
number of samples did not show any growth due to problems encountered during shipment
and storage. There is a need of another study that would provide a full picture of species
common in the study area.
In the current study brucellosis seropositivity was found to be higher in pastoral areas than in
agropastoral areas but the difference was not statistically significant. In a study conducted in
Chad by McDermont and Arimi (2002), brucellosis seropositivity was found to be higher in
pastoralist communities than in other communities. However, the methodology used in the
current study was not strictly random. In some households, the heads of households decided on
who should be screened and in other households those who considered themselves to be
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unwell presented to be screened for brucellosis. Children were scared of being bled, some ran
away and some did not cooperate during the exercise making it difficult to screen them for
brucellosis. This could have contributed to the difference in the findings of the studies.
4.6 Conclusion
There could be a considerable number of brucellosis cases in Arusha and Manyara regions that
do not present to hospital due to various reasons. Using data from hospitals alone could
therefore give an underestimation of the burden caused by brucellosis. Estimation of the
burden caused by diseases such as brucellosis should also take into account members of the
community that meet the diagnosis criteria. Community members should be made aware of the
danger posed by goats in transmitting brucellosis particularly during handling fluids from
goats such as blood and during assisting parturition. Future research should investigate the
species of Brucella prevalent in Arusha and Manyara regions. Care should be taken in
choosing the type of serological test to be performed in prevalence studies as some tests have
shown to give false brucellosis prevalence.
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5. Health-seeking behaviour and clinical characteristics of human
brucellosis cases in Arusha and Manyara regions, Tanzania
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5.1 Summary
Objectives: The aim of the study was to establish the clinical characteristics of human
brucellosis cases in Arusha and Manyara regions and determine whether clinical criteria
for diagnosis can be identified using the clinical features. The study also aimed to
establish the health-seeking behaviour of brucellosis cases, to investigate the frequency
of other conditions that may be confused with brucellosis, to determine treatment
outcomes of brucellosis cases and to collect relevant data for assessing the burden
caused by brucellosis.
Methodology: Socio-demographic, clinical and laboratory data were collected from
patients who reported to selected hospitals between June 2002 and April 2003. All
patients with conditions suspicious of brucellosis on the basis of preliminary clinical
examination and history were enrolled into the study as brucellosis suspects. Blood
samples were taken and tested at the hospitals using the hospital serological test, the
supplied RJBPT, and later the RBPT at the SUA and the c-ELISA test at the VLA. A
follow-up of 49 cases was made to assess treatment outcome and nine cases for
duration of Brucella antibody response.
Results: On the basis of hospital serological tests, brucellosis was diagnosed in 14.4%
(n=l 153) cases. Of the remainder, 26.4% were diagnosed and treated for malaria, 17.3
% for typhoid, 16.7 % for joint complaints, 6.3 % for other bacterial infections, 1.3%
amoeba, 0.3 % tuberculosis and the remaining 17.3% were treated for other diseases
such as worm infestation, diabetes, psychiatric disorders, low and high blood pressure,
and other gastrointestinal complaints such as ulcers. Of the suspects 6.2% (n=l 586),
tested positive for the c-ETISA test, and were defined as brucellosis cases. The
incidence of brucellosis was 11.2 cases /100,000 people per annum. Joint pain,
headache, backache, fever and fatigue were the main clinical features described by the
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confirmed c-ELISA positive patients, but these were also most commonly reported by
the c-ELISA negative patients initially suspected as having brucellosis. It was therefore
difficult to use clinical features for the definitive diagnosis of brucellosis. Different
practitioners were found to prescribe different regimes for the treatment of brucellosis
some of which are not recommended for the treatment of brucellosis and treatment
outcome was poor. Patients with brucellosis delayed going to hospital with a median
delay time of 90 days, and with 20% of the cases presenting to hospitals more than a
year after the onset of symptoms. Distance to the hospital, keeping animals and
knowledge of brucellosis were significantly associated with patient delay to present to
hospital. Antibodies to Brucella were found to persist for a period of over 12 months
after treatment for brucellosis. People engaging in business were much more common
among the brucellosis cases than among suspects with other flu-like diseases.
Conclusion: More efforts need to be directed towards improving the diagnosis and
treatment of brucellosis to reduce prolonged human suffering from brucellosis in Arusha
and Manyara regions. This should include the evaluation and adoption of standardized
diagnostic and treatment protocols. Health education should also stress the importance of
early presentation to hospitals for prompt treatment. Practitioners should be made aware
of the implications of persistent antibodies on the diagnosis and treatment of brucellosis
in an area where other febrile conditions with similar clinical features co-exist. Future
research work on brucellosis should try to work on thorough clinical examination and
severity of clinical features brucellosis cases present with.
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5.2 Introduction
Brucellosis is caused by gram-negative bacilli, of the genus Brucella (Brucella
abortus, B. suis, B. melitensis and B. canis) (Young, 2000a). Clinical features include
fever, fatigue, headache, sweating, joint pain, loss of appetite, muscular pain, lumber
pain, weight loss, hepatomegaly, splenomegaly and arthritis. The multiple and non¬
specific features of brucellosis contribute to difficulties in the diagnosis of brucellosis
in areas where diseases with similar clinical features such as malaria, tuberculosis,
typhoid and joint diseases co-exist (Colmenero, et al., 1996; Young, 2000a).
In many sub-Sahara African countries, febrile or flu-like conditions with similar
manifestations occur commonly and have significantly contributed to difficulties in
the diagnoses of such diseases as brucellosis, typhoid, malaria, amoeba and
tuberculosis (Mutanda, 1998; Maichomo et al., 1998). In Narok, Kenya, 12% of flu¬
like patients were diagnosed using the RBPT as brucellosis patients and 40% typhoid
(Maichomo et al., 2000). In Kampala, Uganda, of patients with joint pain, general
malaise, and/or constant headache, 73% were found to be suffering from malaria and
13.3% from brucellosis (Mutanda, 1998).
As it is difficult to diagnose brucellosis clinically, its diagnosis relies on laboratory
investigations (Schwabe, 1984; Maichomo et al., 2000). However, most of the
hospital laboratories in rural sub-Saharan Africa have limited capacity for the
diagnosis of brucellosis. Brucellosis is commonly diagnosed after failure to respond
to malaria, typhoid or tuberculosis treatments (Oomen and Waghela, 1974; Muriuki
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et al., 1997). In Tanzania, it was observed that serological diagnosis was only
conducted in districts or designated district hospitals (Chapter 2). In Kenya, local
clinics were conducting the RBPT, but additional tests such as the SAT were only
conducted in central veterinary or medical testing facilities (Muriuki et al., 1997;
Maichomo et al., 2000). Most of these facilities however are not easily accessible to
the majority of people in rural areas of Africa due to their geographical location and
poor infrastructure.
Although generally speaking, any member of the public is at risk of getting
brucellosis through consumption of poorly prepared dairy products in the form of
meat, milk, cheese and butter, certain occupations such as veterinarians, butchers,
abattoir workers, meat inspectors, farmers and those working in meat packing and
dairy processing industries are known to be at a greater risk (McDermott and Arimi,
2002; Smits and Cutler, 2004). In South Africa for example, brucellosis caused five
out of seven occupational infections of abattoir workers (Mauff, 1980). In Ethiopia,
brucellosis contributed to the same proportion of occupational infection amongst
veterinarians and farm workers (Seboxa, 1982). Although the number of cases that
were examined was few, the results shed some light on brucellosis as an occupational
hazard and challenge further research on brucellosis as an occupational hazard.
Brucellosis caused by B. melitensis is the most important clinically apparent disease
in humans and is the one usually associated with occupational exposure or
consumption of poorly prepared dairy products (Corbel, 1997), followed by infection
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with B. abortus and by B. suis (Domenech et al., 1983). Because of its greater
severity, infections with B. melitensis are generally considered more likely to be
diagnosed than infection with other Brucella species.
Health-seeking behaviour of patients suffering from infectious and non-infectious diseases
in many parts of Africa have been analysed. These include those suffering from
tuberculosis (Wandwalo et al., 2000; Odusanya and Babafemi, 2004; Yimer et al., 2005;
Kiwuwa et al., 2005), sleeping sickness (Odiit et al., 2004), rabies (Kaare, 2006) and non¬
infectious diseases (Mwende et al., 2005). Factors that determine when patients get hospital
treatment vary from the patients' own reasons to those due to health providers. Patient
factors include expectations that the symptoms might improve, visit to local traditional
healer and self medication from a nearby drug shop or private clinic. Other factors include
distance to the nearest health facility and socio-economic status. Some households are far
from hospitals and poor infrastructure make accessibility to health care difficult. In areas
where there is transportation, affordability of the costs of transport made patients unable to
present to hospitals in time. Factors related to health provider included poor referral
system, high work load and diagnostic difficulties (Wandwalo et al., 2000; Odusanya and
Babafemi, 2004; Yimer et al., 2005; Kiwuwa et al., 2005; Mwende et al., 2005). The
present study aims to investigate the duration and nature of clinical features of human
brucellosis, to determine whether they can be used to establish diagnostic criteria for
brucellosis and to examine the health-seeking behaviour, treatment outcome, and frequency
of other conditions that may be confused with brucellosis. Data for estimations of burden
caused by brucellosis were also collected during this study (see chapter 8).
5.3 Materials and methods
5.3.1 Study area, suspects and cases enrolment
The study was conducted in the northern regions of Arusha and Manyara, Tanzania,
comprising the districts of Mbulu, Ngorongoro, Babati, Karatu and Hanang. Details of
hospitals involved, their location and the methodology for data collection have been
discussed in chapter 2. Briefly, the study group was drawn from patients presenting to the
hospitals, between June 2002 and April 2003.
Plate 5. 1: A health centre in Simanjiro with patients waiting for investigation
and treatment
All patients who presented to the hospitals with any of the clinical features including fever,
headache, joint pain, malaise, backache, fatigue and loss of appetite were enrolled into the
study as suspected brucellosis cases or suspects. Detailed data on clinical history, clinical
features, impact of disease, location of household and potential risk factors (such as
occupation, age, sex) were collected by the practitioners and blood sampling for the RBPT
(see section 2.4.5.1) and hospital tests were conducted. All patients with positive
serological results for brucellosis conducted at the hospitals were named as 'brucellosis
seropositives' to distinguish them from 'suspected brucellosis patients' and all patients
with any two or more of fever, headache, joint pain, waist pain, backache, malaise, fatigue
and tested positive with the c-ELISA test at the VLA (see section 2.4.5.2) were defined as
brucellosis cases. Nine cases that received treatment for brucellosis were followed-up to
investigate the persistence of antibodies to Brucella. The objective of the exercise was to
determine how long cases will continue to test positive for brucellosis.
5.3.2 Incidence of brucellosis
The incidence of brucellosis in the study area was calculated from the total number of new
confirmed cases of brucellosis recorded during the study period divided by the total
population at risk in the study area. The study area was assumed to have a population of
1,054,238 people during the study period (Population and housing census, 2002). To get an
annual estimate of incidence of brucellosis a cross-multiplication was done and later a
factor of 100,000 was used to ease interpretation of incidence obtained.
5.3.3 Distance to the nearest hospital
The G1S coordinates of the households and of the hospitals were recorded from a hand-held
Garmin® GPS machine. All coordinates were then transferred to Excel 2003 spreadsheets
(Microsoft Corporation, Redmond, Washington, USA) and the distance between the
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hospitals and the households calculated in kilometers using ArcGIS 9 software (ESRI,
Redlands, California).
5.3.4 Patient delay
Patient delay was the time interval between the development of first symptoms of
brucellosis to the time presented to hospital. Thirty days since the onset of first symptoms
was taken as the cut-off point during which any patient with brucellosis symptoms was
supposed to have presented to hospital for diagnosis and treatment (Colmenero et al.,
1996). The outcome variable was therefore binary with all cases who presented to hospital
30 days or more after the onset of the first symptoms defined as delayed going to hospital
and those who presented earlier than 30 days not delayed.
5.3.5 Data analysis
Data were entered on Excel 2003 spreadsheets (Microsoft Corporation, Redmond,
Washington, USA) and analyzed using Minitab version 1.4 (Minitab Inc. 2000, Release
14 for Windows, State College, Pennsylvania). Chi-square tests were used to analyze
all data and Fisher's exact test was used where 2x2 tabular results were obtained with
any expected counts of less than 5. A p-value of <0.05 was considered statistically
significant. In multivariate analysis, Minitab version 1.4 was used to run logistic
regression analysis. A backward stepwise method was used to find the best suite of
variables (model simplification). The least significant variables were considered first
for removal. Any variables that caused an insignificant increase in deviance on removal
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from the model was left out of the model and the variable that caused a significant
increase in deviance on removal was retained in the model.
5.4 Results
5.4.1 Brucellosis suspects
Of the 2230 patients who presented at the hospitals with clinical features consistent with
brucellosis (brucellosis suspects), detailed clinical data were available from 1153 patients.
5.4.2 Brucellosis cases
Of the 1586 samples that were collected from suspected brucellosis patients over a
ten-month period and sent to Weybridge for the c-ELISA test, 98 (6.2%) tested
positive for brucellosis. These 98 cases were considered to be confirmed positive
cases, resulting in an annual incidence of brucellosis of 11.2 cases /100,000. The sex
and age distribution of cases is shown in Table 5.1.
Table 5. 1: Sex and age distribution of confirmed brucellosis cases
Age groups Males Females Total Percentage (%)
1-15 12 2 14 14.3
16-30 1 1 15 26 31.6
31-45 12 19 31 26.6
46-60 9 7 16 16.3
>60 9 2 11 11.2
Total 53 45 98 100.0
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Among all patients who presented to the study hospitals, the highest proportion of brucellosis
cases was found in Hanang district 13.6% (46/336) followed by Ngorongoro district 11.3%
(18/159). The remaining districts recorded 6.7% (7/103) cases Mbulu, Karatu 5.5% (6/109)
cases, and Babati 2.3% (21/888) cases (Table 5.2).
Table 5. 2: Distribution of brucellosis cases in districts and farming systems
Predominant Number of cases Number of all suspects Percentage (%)
District Farming system
Babati Agropastoral 21 885 2.4
Karatu Agropastoral 6 106 5.7
Hanang Agropastoral 46 338 13.6
Mbulu Agropastoral 7 102 6.9
Total
Agropastoral 80 1431 5.6
Ngorongoro Pastoral 18 163 11.3
Total pastoral 18 163 11.0
5.4.3 Test for the association between brucellosis and age, sex, farming system
and different occupational groups
5.4.3.1 Univariate analysis
Using the VLA c-ELISA results as a binary response variable, logistic regression
analysis was done to analyse the relationship between brucellosis and age, sex,
farming system and different occupational groups. All variables with p-value less
than 0.05 were include in the multivariate analysis (Table 5.3).
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Table 5. 3: Univariate analysis of association between brucellosis and age, sex,
farming system and different occupation categories
Variable Coefficients P-value OR 95% confidence interval
Lower Upper
Age 0.00 0.88 1 0.98 1.02
Sex
(Male vs female)
0.53 0.06 1.71 0.96 3.04
Pastoral/agropastoral
farming system 0.77 0.04 2.17 1.02 4.644
F.mployed -0.31 0.59 0.73 0.22 2.39
Farming -0.06 0.82 0.94 0.53 1.67
Housewife 0.16 0.73 1.18 0.45 3.05
Business 1.49 <0.01 4.48 1.45 13.874
Student 0.73 0.11 2.08 0.85 5.09
Teacher -1.31 0.19 0.27 0.04 1.98
t - Variables included in the multivariate analysis.
5.4.3.2 Multivariate analysis of association between brucellosis, farming system and
people engaging in business
In the multivariate analysis brucellosis was found to be associated with pastoral farming
system and with people engaging in business (F=9.24, df=l, p<0.01) (Table 5.4).
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Table 5. 4: Multivariate analysis of association between brucellosis, farming
system and people engaging in business
Variable Coefficients P-value OR 95% confidence interval
Lower Upper
Pastoral/agropastoral 1.62 0.02 5.07 1.62 15.83
farming system
Business 0.85 <0.01 2.36 1.10 5.08
5.4.4 Patient delay and treatment delay
Data on health-seeking behaviour were available for 49 brucellosis cases. Of these, 11 (23%)
went to hospital within one month after the onset of symptoms, 10 (20%) between one and
three months, 12 (25%) between three and six months, six (12%) between six months and
one year and 10 (20%) sought treatment more than a year after the onset of symptoms
(Figure 5.1). Using the cut-off point of 30 days as the time that a case was supposed to go to
hospital, the median patient delay time was 90 days (mean, 157. 3 days). Health system delay
was a result of false negative results causing a failure to diagnose 22 (54%) cases of
brucellosis on their first visits to hospitals.
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Figure 5.1: The time cases presented to hospitals
14
Less than a 1 month to Three Six months More than a
month three months months to to one year year
six month
Interval between time symptoms developed to time cases
went to hospital
5.4.5 Factors responsible for patient delays
Using ArcGIS, the mean distance between the households of cases and hospitals was
determined as 8.3 km, (median, 7.1 km). Univariate analysis showed that age of the case,
distance to hospital, economic status, whether the household keeps livestock and
knowledge of brucellosis were significantly associated with patient delay in presentation to
hospitals (Table 5.5). Patient delay was found to be most associated with distance to the
nearest hospital, knowledge of brucellosis and if the household of a case keeps livestock
(likelihood ratio p-value 0.03) (Table 5.6).
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Table 5. 5: Univariate analysis of factors responsible for patient delay
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Gender 0.69 0.43 2 0.86 4.67 0.09
Age 0.02 0.01 1.02 1.01 1.04 O.OOlt
Knowledge of
brucellosis
1.50 0.78 4.50 0.97 20.83 0.03t
Level of
education
















brucellosis 1.09 0.82 3 0.61 14.86 0.15
t - Variables included in multivariate analysis
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Table 5. 6: Final model of multivariate analysis of causes of patient delay
Variable Coefficients Std. P-value Odds 95% confidence interval
error ratio Lower Upper
Distance to
hospital 0.03 0.07 0.00 2.23 0.89 3.18
If keeps
livestock 1.23 1.11 0.04 3.42 0.39 30.02
Knowledge of
brucellosis 0.28 1.09 0.02 1.32 0.15 11.34
5.4.6 Site of first treatment
The majority of brucellosis cases 43 (87.7%) gave a history of going to hospital as the first
point of care, five (10.2%) purchased drugs from a nearby drug shop before going to hospital
and one patient (2%) went to a local traditional healer first.
5.4.7 Clinical features experienced by suspects and cases
For comparative purposes, confirmed brucellosis cases were analyzed separately from all
suspects to identify different characteristics of the cases that may help distinguish them from
other febrile or flu-like conditions. Of the suspects (excluding brucellosis cases), 88.9%
(n=1059) had joint pain, 82.1% backache and 65.8% headache. Other clinical features
included fever 59.1%, fatigue 57.0%, chest pain 36.2%, abdominal pain 35.9% and loss of
appetite 24.3%.
Of the cases, 43 (88.9 %) reported a history ofjoint pain, 41 (91.1%) backache, 38 (77.6%)
headache, 36 (73.5%) fever, 26 (53.1%) fatigue, 17 (34.7%) loss of appetite, 15 (30.6%)
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chest pain and abdominal pain was recorded from 14 (28.6%) cases. The summary of the
results above and p-values for the number of suspects and cases with a particular symptom
are included in Table 5.7.
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Table 5. 7: Clinical feature experienced by confirmed brucellosis cases and
brucellosis suspects, who were subsequently diagnosed as being seronegative and
hence did not have brucellosis.
Symptom No. of Percentage Number Percentage /2testp-
suspects with symptom of cases With symptoms value
Joint pain 816 88.3 43 88.9 0.91
Back pain 754 82.1 41 91.1 0.09
Headache 696 65.8 38 77.6 0.41
Fever 626 59.1 36 73.5 0.11
Fatigue 604 57.0 26 53.1 0.86
Chest pain 383 36.2 15 30.6 0.19
Abdominal pain 380 35.9 14 28.6 0.22
Loss of appetite 257 24.3 17 34.7 0.49
Respiratory
symptoms
242 22.9 9 18.4 0.95
Neurological
symptoms
116 10.9 9 18.4 0.30
Diarrhoea 107 10.1 3 6.1 0.60t
Lymphnode
Enlargement
50 4.7 5 10.1 0.18t
Skin diseases 47 4.4 3 6.1 0.75t
Palpitations 2 0.2 0 0.0 0.481'
t - Fisher's exact test p-value
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5.4.8 Differential diagnoses
Information on differential diagnoses was important in assessing the judgment of the
practitioners as regards to diseases included for investigation i.e. to see which disease
conditions were considered for diagnosis and which ones were not. Data on differential
diagnoses was obtained from 1004 brucellosis suspects. These were divided into first, second
and third differential diagnoses depending on what the practitioners thought were the most
probable diagnoses in descending order (Appendix II). In the first category, malaria 435
(43.3%) was recorded by most practitioners as the first (most likely) diagnosis, followed by
brucellosis 321(31.9%), typhoid 114(11.3%), arthritis 101(10.1%), urinary tract infection
9(8.9%), bronchitis 4(3.9%) (Table 5.8). Of the 321 suspected brucellosis patients whose first
differential diagnosis was brucellosis, only 16 (3.98%) were confirmed as brucellosis cases.
Table 5. 8: Differential diagnoses of patients with clinical features consistent








Malaria 43.3% Typhoid 35.0% Brucellosis 50%
Brucellosis 31.9% Brucellosis 33.6% Arthritis 14.2%
Typhoid 11.3% Malaria 16.7% Malaria 10.7%








Bronchitis 3.9% TB 0.1% Amoeba 1.9%
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5.4.9 Hospital diagnoses of the cases presenting to the hospital with clinical
features consistent with brucellosis (brucellosis suspects)
Of the 1153 suspects who were seen by practitioners, 304 (26.4%) were diagnosed and
treated for malaria, 199 (17.3%) for typhoid, 192 (16.6%) for joint diseases which included
back pain and waist pain and 166 (14.4%) were treated for brucellosis (referred to here as
hospital brucellosis seropositives).
Suspects with other bacterial infections such as those involving the urinary tract,
respiratory tract (excluding tuberculosis), gastrointestinal tract were 73(6.3%), amoebiasis
15(1.3%) and all forms of tuberculosis that was diagnosed in 4(0.34%) suspects. The
remaining 200 (17.3%) were treated for other disease conditions such as worm infestation,
diabetes, psychiatric disorders, low and high blood pressure other gastrointestinal
complaints such as ulcers (Figure 5.2).
Figure 5. 2: Hospital diagnoses of the cases presenting to hospital with clinical




Of the 281 suspects who were diagnosed at the hospitals using the supplied Rose Bengal
antigen and antigens used by the hospitals (referred to here as hospital brucellosis
seropositives) and then treated as suffering from brucellosis, 238 (84.7%) tested negative
with the c-ELISA test indicating that they were actually not suffering from brucellosis as a
result of false positive diagnosis. On the other hand, of 997 suspects who were not
diagnosed as suffering from brucellosis at the hospitals and were treated for other disease
conditions, 40 (4%) tested positive with the c-ELISA test indicating that they were actually
suffering from brucellosis (false negatives).
5.4.11 Progression of clinical features and treatment outcome
A follow-up of 41 cases was made to assess their treatment outcomes and the progression
of their clinical features. The results showed that 19 (46%) patients were diagnosed and
treated for brucellosis at the hospitals, while 22 (54%) were not diagnosed as suffering
from brucellosis at the hospitals due to false negative results. False negative brucellosis
patients comprised 17.1% patients who were treated for malaria, 15.2% for joint pain, 9.5%
for typhoid, 4.9% for other bacterial diseases and 7.3% for non bacterial diseases such as
gastric ulceration and worm infestation. All the cases that were treated for diseases other
than brucellosis continued to have clinical features such as headache, joint pain, backache
and general body malaise which are consistent with brucellosis.
Of the confirmed cases that were diagnosed and treated for brucellosis, 15.8% (3/19) did
not show any signs of improvement after completion of brucellosis treatment, 10 (52.6%)
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showed some improvements while the remaining 6 (31.6%) made a complete recovery
from brucellosis (Figure 5.3). Two cases (66.7%) that did not improve received
doxycycline tablets alone and one (33.3%) received doxycycline and cotrimoxazole. Four
cases (40%) that showed some improvement received doxycycline alone, three (30%)
received doxycycline and cotrimoxazole, one (10%) received floxacillin, one (10%)
received streptomycin and doxycycline and one (10%) received streptomycin and
cotrimoxazole (Table 5.9).














Table 5. 9: Brucellosis treatment regimes and outcome of treatment
Regime Number of cases Percentage
Cases that did not show any sign of improvement
Doxycycline 2 66.7
Doxycycline and cotrimoxazole 1 33.3
Cases that showed some signs of improvement
Doxycycline 4 40.0
Doxycycline and cotrimoxazole 3 30.0
Floxacillin 1 10.0
Streptomycin and doxycycline 1 10.0
Streptomycin and cotrimoxazole 1 10.0
Cases that completely recovered from brucellosis
Doxycycline 2 33.3
Doxycycline and cotrimoxazole 2 33.3
Streptomycin and cotrimoxazole 1 16.7
Streptomycin and doxycycline 1 16.7
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5.4.12 Duration of brucellosis clinical features and number of days cases spent
in hospital as in-patients
The duration of brucellosis clinical features and the number of days that patients stayed in
hospital as inpatients is discussed in chapter eight of this thesis.
5.4.13 Determination of persistence of antibodies to Brucella using the RBPT
A follow-up of nine brucellosis cases that received treatment for brucellosis was conducted
to investigate the duration of antibodies to Brucella after treatment in relation to clinical
features. Any with remission of clinical features, established by interview and physical
examination, was considered to have recovered from brucellosis. Results showed that 6
(66.7%) cases continued to test positive on the last day of follow-up (Table 5.10). Only one
patient (11.1%) completely recovered from brucellosis, the remaining 8 (88.9%), showed
some improvement but still had some of the original clinical features.
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Table 5. 10: Results of follow-up of elinical features and serostatus using the RBPT.
Id. No. Village Date of 1st test Date of 2"1' Date of 3rd T reatment Duration of
results and results and results and received antibodies
clinical features clinical features clinical
features
581 Oldonyo 14/3/03 17/08/03 10/1/04 Doxycycline >10 months
Wasso +ve +ve +ve (duration unknown)
Cough, anorexia Symptoms free General
Joint pain, fever weakness
584 Oldonyo 14/3/03 17/08/03 10/1/04 Doxycycline for 4 >10 months
Wasso +ve +ve +ve weeks and
Joint pain, fever, Headache, joint Intermittent cotrimoxazole for 6
Backache pain,malaise fever weeks
652 Masakta 15/10/02 10/09/03 20/2/04 Doxycycline 6 >16 months
+ve +ve +ve weeks
General Flu, low grade General body
malaise,backache, fevers malaise,
Joint pain weakness
K4 Mang'ola 15/8/02 18/09/03 Doxycycline 6 <13 months
+ve -ve weeks
Loss of appetite, Abdominal
fever, joint pain distension
775 Basutu 11/2/03 7/09/03 19/1/04 Streptomycin 4 >11 months
+ve +ve +ve weeks and
Headache, Joint pain, Joint pain Doxycycline 4
Backache, fever fever, headache weeks
joint pain
809 Jorodom 15/6/02 9/09/03 22/2/2004 Doxycycline for 6 <15 months
+ve -ve -ve weeks and Local
Headache, joint Symptoms free Joint pain, herbs
pain, backache, weakness
fever
863 Oloipir 12/01/03 15/8/03 10/02/04 Doxycycline for 4 >13 months
+ve +ve +ve weeks and
General malaise General Much better, cotrimoxazole for 6
and pain, wasted malaise with weakness, joint weeks
some pain
improvement
800 Gitting 5/07/02 7/09/03 19/2/04 Cotrimoxazole and <14 months
+ve +ve -ve Streptomycin for 4
Fever, backache, General body Symptoms free weeks
malaise, fatigue, malaise and
joint pain backache
950 Endasaki 14/4/03 9/09/03 18/2/04 Streptomycin 4 >10 months
+ve +ve +ve weeks and
Fever, joint pain, Symptoms free Had a bout of Cotrimoxazole for 6




There were proportionally more cases of brucellosis recorded in hospitals located in pastoral than
in hospitals located in the agropastoral areas. During cross-sectional survey, it was established
that seropositivity was higher in the pastoral than in the agropastoral system although the
difference was not statistically significant. Such factors as movement with livestock, animal
husbandry and consumption habits of animal products among the people living in the pastoral
system are likely to contribute to more cases in the pastoral systems (Schelling et al., 2003). As
the occurrence of the disease in humans is largely dependent on the animal reservoir (McDermot
and Arimi, 2002) control strategies for brucellosis should be given priority to pastoral areas.
Only 23% of the cases started to seek treatment within a month since the onset of symptoms.
More striking however, was the fact that 20% of the cases stayed for a period of over a year
without seeking any treatment. Distance to the nearest hospital, keeping livestock and
knowledge of brucellosis were significantly associated with delay to present to hospital.
Cases that stay far from the hospitals were found to have a higher chance of delaying going
to hospital than those staying close to hospitals. In the study area many households stay far
from health facilities and the infrastructures are still poor. Delay to present to hospital is
therefore associated with how accessible the hospitals are. Cases keeping livestock were
also found to delay going to hospital. Probably it was not possible to leave their livestock
with nobody to attend and go to hospital. They only presented to hospital when symptoms
worsened. Cases with the knowledge of how brucellosis is transmitted and manifests also
delayed going to hospital. It is possible they think brucellosis has mild acute clinical features
and fatality is rare and only when the symptoms get worse do they seek medication.
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The majority of cases first sought treatment at a hospital and a few either treated themselves
at home by buying medicine from a nearby drug shop (10.2%) or attended a local traditional
healer (2%). In the study area, a purely private health system has not been fully established,
so the majority of patients go to public hospitals which are run by government or religious
groups (missionary hospitals). It was therefore unlikely for cases to be delayed by
commercially oriented health providers such as those found in urban areas. Studies
conducted on the causes for tuberculosis patients delay to go to hospitals, established that
patients spent longer periods seeking treatment from traditional healers or at commercial
hospitals where most of their financial resources were used without getting proper treatment
(Wandwalo et al., 2000).
Brucellosis still poses a significant diagnostic challenge in the study area. The clinical features
that brucellosis cases presented with were found to be similar to those recorded from suspects
with other febrile conditions, with joint pain, backache, headache, fever, and fatigue being the
most common features. None of the clinical features was found to be statistically more common
in either of the groups than the other. Co-existence of such diseases in the study area therefore,
makes it difficult to use clinical features to reach the definitive diagnosis of brucellosis.
Practitioners in the study area should therefore consider testing routinely for brucellosis all
patients presenting with non-specific clinical features such as joint pain, headache, backache,
fever, fatigue and malaise. Similar conclusion was reached by Canova et al., (1993) in a study
conducted in Yugoslavia. Brucellosis patients were found to present with nonspecific
manifestations which caused diagnostic delays. It was suggested that high index of suspicion is
important in all patients presenting with multiple nonspecific features for early diagnosis of
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brucellosis in rural areas where dairy products are commonly used and brucellosis has been
reported.
The finding that there were more people engaging in business among the cases than among the
suspects suggests that practitioners should give brucellosis a high index of suspicion when a
person doing business presents to hospital with non-specific flu-like clinical features. Data on the
types of businesses cases were doing were not collected so it was difficult to establish how the
type of business they were doing could have put them at risk. However, in the study area, people
engaging in business meet in market places and in auctions where they consume among other
things meat and milk. In auctions, animals are slaughtered and the meat cut into portions for
selling or roasting. It possible that handling and consumption habits of animal products amongst
the people engaging in business expose them to the risk of getting brucellosis. The majority of
individuals in the study area are farmers. It is possible even teachers, students, those doing
business are farmers of some kind as well, this explains why farming did not appear as a risk
occupation in the analysis. Occupationally at risk people such as meat inspectors, butchers,
abattoir workers and veterinarians who are known to be more at risk of brucellosis (Serra et al.,
2000; Thakur and Thapliyal, 2002; Karimi et al., 2003; Reid, 2005) were not recorded in either of
the groups. It is possible that they are very few in the study area and none of them fell sick during
the study period or they are more aware of diseases such as brucellosis, so they protect themselves
against them.
As a result of false negative results, 22 (54%) brucellosis cases were not diagnosed as suffering
from brucellosis on their first visit to hospitals, they were treated for other diseases hence they
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continued to suffer from brucellosis. The findings agree with Muriuki et al., (1997) and Oomen
and Waghela (1974), who found that brucellosis cases are normally diagnosed after failure to
respond to treatment for malaria and typhoid. Apart from poor diagnostic tools, practitioners have
always been underestimating the threat posed by brucellosis. Patients presenting with non-specific
clinical features are not tested for brucellosis routinely. In the current study, 31.9% of the suspects
were considered for brucellosis investigation as the first differential diagnosis. Out of these only
3.9% were confirmed as brucellosis cases. However, the results that brucellosis was second to
malaria in terms of consideration for investigation could have been caused by the Hawthorne
effect (Roethlisberger and Dickson, 1939, cited by Holden, 2001). It was evident in the
preliminary hospital survey (see chapter 3) that brucellosis is not routinely tested for in patients
presenting to hospitals with non-specific symptoms. The fact that the study was conducted by the
brucellosis study team could have influenced the judgment of the practitioners.
Although brucellosis false seropositivity was higher (84.7%) than false negativity, it did not seem
to pose a significant therapeutic problem for other flu-like conditions. Other flu-like conditions
such as malaria and typhoid were found to be tested routinely on patients first presentations to
hospitals. Since false positives received a combination of antibiotics and pain killers with an
intention of treating brucellosis, they tended to get a relief of symptoms for the flu-like conditions
they were suffering from. Hence, except for patients suffering from tuberculosis and amoeba,
most of brucellosis false positives received treatment for their conditions without a definitive
diagnosis.
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Of the 19 cases that were diagnosed correctly and received treatment for brucellosis, only six
(31.6%) had a complete recovery and three (15.8%) did not show any sign of improvement. The
persistence of clinical features in cases could mean failure to respond to treatment, re-infection,
relapse or co-existence of untreated other flu-like conditions. In a study conducted by Ariza et al.,
(1995) the choice of less effective antibiotics was found to be among the factors causing relapse
of brucellosis. Since Brucella localize within the host's reticulo-endothelial cells, a site relatively
inaccessible to antibiotics (Khan et al., 1989; Hall, 1990), proper combination of antibiotics for
longer periods is required to improve the outcome and prevent relapses (Ariza et al., 1985).
Practitioners in the hospitals involved with the study did not adhere to recommended brucellosis
treatment regimes, this could have caused the high rate of treatment failure.
Based on the available data, it was difficult to ascertain the eff cacy of different brucellosis
treatment regimens. Practitioners did not use specific standardized treatment regimens for
brucellosis, only available drugs were prescribed. As a result, for 19 cases that received treatment
for brucellosis, fve treatment regimens were used some of which are not recommended for
brucellosis treatment. A better planned clinical trial needs to be carried out with more number of
cases assigned specific treatment regimens and treatment groups followed-up at fixed time
intervals for assessment.
Antibodies to Brucella were found to persists for more than 12 months after treatment. Similar
findings were established in South Africa by Mauff (1980) who found that antibodies to Brucella
could persist for a period of up to 12-24 months after cure and posed diagnostic difficulties for
brucellosis and other flu-like conditions. It is likely that some cases of malaria, typhoid,
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tuberculosis or other joint diseases are unnecessarily diagnosed and treated for brucellosis
because of persistent antibodies to Brucella. Clinicians should be aware that seropositivity to
Brucella spp using current hospital diagnostic tests is insufficient evidence to provide a confirmed
diagnosis of brucellosis and that other differential diagnoses should be excluded.
In the present study thorough examination of the cases to rule out organ involvement such as
the heart, liver, spleen and lungs and any neurological involvement which have been shown to
be common in human brucellosis (Charters, 1980; Fallatah et al., 2005; Troy et al., 2005), were
not conducted. In addition, the assessment of the severity of clinical features with which
brucellosis cases presented to hospitals was not recorded. Some of brucellosis clinical features
could have been missed by this omission. Future research work should take into account the
severity and pathognomonic features of brucellosis so as to get a full picture of brucellosis
cases in Tanzania. Further examination using extra facilities such as ultra sound, X-ray and
extra blood tests such as full blood picture and organs function tests could be performed.
Because most of these tests are not performed in the rural hospitals, arrangements could be
made for them to be performed elsewhere for scientific and epidemiological knowledge.
5.6 Conclusion
More efforts need to be put on improving the diagnosis and treatment of brucellosis as failure to
diagnose and treat brucellosis contributed to prolonged human suffering. This should include
adoption of standardized diagnostic and treatment protocols for brucellosis. Evaluation of
different tests with an intention of coming up with the tests with high sensitivities and specificity
and a well planned clinical trial of different brucellosis drug therapies need to be conducted.
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Among other important issues, health education to the public should also include emphasis on
patients to go to hospital early when chronic clinical features and complications have not
developed as late presentation may carry poor prognosis even after treatment. Practitioners should
also be made aware of the implications of persistent antibodies to Brucella on diagnosis and
treatment in an area where other febrile conditions of similar clinical features co-exist.
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Objective: To determine the risk factors for transmission of brucellosis to humans in
Tanzania.
Study design: A matched case-control study.
Methodology: Any person with a positive result by the c-ELISA test for brucellosis, and
presenting to the selected hospitals with at least two clinical features suggestive of brucellosis
such as headache, fever which is recurrent or continuous, sweating, joint pain, joint swelling,
general body malaise or backache, was defined as a case. For every case in a district, a
corresponding control was traced and matched by sex using multistage sampling. Other
criteria for inclusion as a control included that the matched individual had a negative c-ELISA
test result and would present to hospital if sick. Using risk sets as a matching variable, and
cases and controls as outcome variables, models were fitted to test their significance and the
likelihood ratio was used to identify risk factors for human brucellosis.
Results: Multivariable analysis showed that brucellosis was associated with assisting cattle,
sheep or goat during abortion. It was shown that the closer the distance between households,
the higher the risk of brucellosis. People who were of Christian religion were found to have a
higher risk of brucellosis compared to other religions. No association was established
between human brucellosis and brucellosis serostatus of their own livestock. In humans,
there was no association between human brucellosis and HIV serostatus.
Conclusion: Protecting humans against contact with fluids and tissues during assisted
parturition of livestock may be an important means of reducing the risk of transferring
brucellosis from livestock to humans. The possibility of contracting brucellosis from
neighbors or other herds should also be considered. These can be achieved through
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health education to the communities where brucellosis is common. There was no
association between HIV serostatus and brucellosis cases, indicating that brucellosis is
not more likely to occur in patients immune compromised by HIV in the study areas.
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6.2 Introduction
Brucellosis is a zoonosis of veterinary, public health and economic significance in most
developing countries (WHO, 1997). Human brucellosis is a severely debilitating
disease that requires prolonged treatment with a combination of antibiotics leaving
permanent and disabling sequelae, and results in considerable medical expenses in
addition to loss of income due to loss ofworking hours (Corbel, 1997; Smits and
Cutler, 2004; Solera et al., 1997). In livestock, brucellosis results in reduced
productivity, abortions and weak offspring and is a major impediment for trade and
export. Almost all domestic species can be affected. Thus, its prevention, control and
eradication are a major challenge for public health programmes (Corbel, 1997; Smits
and Cutler, 2004). The disease has been eradicated in a number of countries, including
the UK, since 1980-81. Even in these countries, human infections are still encountered
as the occasional case arising from endemic areas (WHO, 1997).
Where brucellosis exists in sheep and goats, it causes the greatest incidence of infection
in humans (WHO, 1997). Most human cases involving field strains ofBrucella species
can be traced to domestic food animals, and the prevalence of disease in humans
reflects its occurrence in livestock reservoirs. Commonly, B. abortus and B. suis
infections are associated with certain occupational groups, including farm workers,
veterinarians, and meat-packing employees (Young, 1983). Transmission through
consumption of contaminated dairy products is the route that has been well documented
in many parts of the world (Busch and Parker, 1972). Unpasteurized milk and
processed dairy foods from infected animals have been considered a source of infection
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for the general population, and infected carcasses as a source of infection for workers in
the meat-packing industry.
Veterinarians may acquire brucellosis from assisting births in infected livestock, as
well as through inadvertent exposure to vaccines. Veterinarians, laboratory staff, and
workers based in meat plants were found to be at increased risk of exposure in Ireland
and Spain (Reid, 2005; Bouza et al., 2005). In Burundi, the prevalence of positive
serology was found to be significantly higher in professionally at risk people than in
people consuming contaminated food (Laroche et al., 1987). Airborne transmission
of bacteria to humans has also been documented in clinical laboratories and abattoirs
(Buchanan et al., 1974). Human-to-human transmission through sexual intercourse
has been reported by Ruben et al., (1991).
Contact with products of conception has been shown to be an important factor in the
transmission of brucellosis to humans (Young, 1983). In Kyrgyzstan, brucellosis was
shown to be associated with exposure to aborted farm animals in the household and
consumption of home-made milk products obtained from bazaars or neighbors (Kozukeev
et al., 2006). Touching calves or placentas that were infected with the Brucella species was
found to be associated with brucellosis transmission during cattle birth in Korea (Lim et al.,
2005). Similar findings were obtained in Greece, Chad and Saudi Arabia (Cooper, 1992;
Bikas et al., 2003; Schelling et al., 2003) where products of conception, especially the
placenta were found to be a risk factor for brucellosis transmission.
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The Tanzanian economy depends largely on agriculture, of which livestock forms an
integral part (Ministry ofAgriculture and Cooperatives, 1995a). As the economic future of
the country lies mainly in agricultural development, diseases with considerable effect on
livestock productivity and human health such as brucellosis should not be ignored (Stark
and Protz, 1973). The objective of this study is to explore factors that are responsible for
transmission of brucellosis to humans in Arusha and Manyara regions and identify the most
plausible ways to minimize the transmission of the disease from animals and their products
based on the established risk factors. This will hopefully decrease the burden caused by
brucellosis.
6.3 Materials and methods
6.3.1 Study area
Details of the study area and the methodology used have been discussed in chapter 2 of this
work. A brief account is given.
6.3.2 Study design
This was designed as a matched case-control study. All patients who presented to the
selected hospitals between July 2002 and June 2003 with clinical features suggestive of
brucellosis were recorded and investigated.
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6.3.3 Selection of cases and controls and blood sampling
Any person with a positive serological result by the c-ELISA test conducted at the VLA, and
showing at least two of the following clinical features: headache, fever which is recurrent or
continuous, sweating, joint pain, joint swelling, general body malaise or backache, was
defined as a case. For every case, a community-based control was selected. A control was an
individual in the same district as the case, having a negative brucellosis serological result by
the c-ELISA test, matched by sex and coming from a hospital-going household.
Blood sampling and testing for brucellosis in both humans and livestock was conducted
using the RBPT (Davies, 1971) section 2.4.5.1 in the field and at the SUA, the c-ELISA test
for brucellosis (Perret, et al., 2001) section 2.4.5.2 at the VLA and testing using Vironostica
Uniform II Plus O, at Muhimbili University College of Health Sciences in Dar es Salaam
were conducted. A questionnaire on potential risk factors was also administered during the
follow-up period (Appendix I).
6.3.4 Data analysis
A conditional logistic regression was performed to analyse case-control data using Egret for
Windows version 2.0 (Cytel Software Corporation, Cambridge Massachusetts). The
univariable relationships between all independent variables and brucellosis were estimated by
including them individually in a model with brucellosis serological result as the dependent
variable. Forty-four risk sets were obtained from the cases and controls studied. Using risk
sets as a matching variable, and cases and controls as outcome variables, a number of models
were fitted to test their significance as risk factors for a brucellosis positive serological result.
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Due spillage and small amount of sample collected, only 66 samples from cases and controls
were available for HIV testing. The univariate analysis using HIV results was therefore carried
out separately using Epi-info 6 and the results were interpreted separately without being included
in the multivariate analysis. All the 95% confidence intervals were calculated using Epi Info 6
software (CDC, Antanta, Georgia).
Multivariable models were created by a backward stepwise procedure using Egret for
windows. Variables that had a p value of <_0.2 from the univariable analysis were considered
for inclusion in the final models. Values were retained if on their removal there was a
significant increase of the residual deviance of the model with likelihood ratio statistics (LRS)
of p>0.05 and they were removed from the model if they caused an insignificant increase or
decrease in the residual deviance with LRS of p < 0.05.
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6.4 Results
6.4.1 Cases and controls
Of the 98 cases identified in hospitals, only 44 were available for follow-up (Table 6.1). Of
the 44 cases, 25 were males and 19 were females. Four cases died before a follow-up was
conducted; these included two patients from Hanang district, one from Karatu district and
one from Ngorongoro district. A total of 55 controls were followed-up (Table 6.1) during the
study period, of these 29 were males and 26 females. The mean age for the cases was 36.4
and for controls 36.3 with standard deviations of 17.8 and 17.3 respectively. The locations of
the cases and controls followed are as shown in Figure 6.1.
Table 6. 1: Cases and controls followed-up
Babati Hanang Karatu Mbulu Ngorongoro Total
Case 11 24 1 1 6 44
Control 12 34 1 1 8 55
Total 23 58 2 2 14 99
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Figure 6. 1: Map of north-eastern Tanzania showing locations of cases, controls








Univariable relationships between independent variables and a brucellosis cases result are
shown in Table 6.2. The likelihood of becoming a brucellosis case increased with any
animal abortion, history of household member suffering from brucellosis and decreasing
distance to the nearest neighbour irrespective of neighbour's serostatus.
The likelihood of brucellosis also increased with Christian religion, households where a
goat had aborted, involvement in preparing meat, involvement in assisting aborting
livestock and a middle socio-economic status.
148
Table 6. 2: Univariable relationships between independent variables and brucellosis cases
Variable Coefficient Standard p-value Odds ratio 95% Confidence LRS p-






-0.01 0.004 0.02 0.99 0.98 0.99 0.007




1.72 0.79 0.03 5.61 1.19 26.28 0.01
Abortion of any
animal
1.27 0.46 0.006 3.55 1.43 8.80 0.003
Goat aborted 1.07 0.44 0.01 2.90 1.23 6.86 0.009
Involved in
assisting abortion
1.49 0.65 0.02 4.46 1.25 15.92 0.009
Prepared any
meat
0.96 0.48 0.04 2.62 1.02 6.74 0.03
Economic status-
Low
0.80 0.71 0.26 2.24 0.55 9.05
Economic status-
Middle
2.51 0.95 0.008 12.31 1.92 78.79
Economic status-
High
0.16 1.06 0.88 1.17 0.15 9.39 0.008
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6.4.3 Multivariable analysis
Three variables were included in the final model (Table 6.3). Brucellosis was
significantly associated with involvement in assisting with abortion, with proximity to the
nearest neighbor and with the Christian religion (likelihood ratio statistics p< 0.001).
Table 6. 3: Multivariable relationship between independent variables and brucellosis






-0.02 0.01 0.01 0.98 0.97 0.99
Involved in
assisting abortion
2.06 0.84 0.01 7.86 1.51 40.87
Christian religion 1.94 0.98 0.03 3.03 2.11 18.44
6.4.4 Result of HIV testing
Only 66 samples were available for HIV testing using Vironostica Uniform 11 Plus O
(bioMerieux bv, Boxtel, The Netherlands), including 37 controls and 29 cases (Table
6.4). Of the samples tested, two cases tested positive for HIV and three controls (3.1%,
95% CI, 0.2-17.9) tested positive for HIV (OR, 0.84, 95% C I, 0.13-5.39).
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Table 6. 4: HIV ELISA results of human cases and controls
ELISA
Positive Negative Total
Case 2 27 29
Control -)J 34 37
Total 5 61 66
Plate 6. 1: Assisting an aborting animal was found to be a risk factor for transmission of
brucellosis to humans




Brucellosis in humans was found to be associated with assisting aborting livestock. An
abortion storm in a herd of livestock is among the common features of brucellosis in
livestock (Schelling et al., 2003). During abortion, large numbers of Brucellae are
released which may, in turn, cause the infection to other animals in the herd (Manthei
and Carter, 1950). The univariate analysis, showed that brucellosis was associated with
a household where a goat had aborted, however it was not shown whether assisting
goats during abortion was associated with brucellosis. The findings agree with Young
(1983) who found that persons usually become infected with Brucella through direct
contact with infected animals or their products. Place of residence, professional
occupation with animals, and human's trauma during animal delivery were found to be
important risk factors for brucellosis transmission to humans in Greece (Bikas et al.,
2003).
Contact with placenta of livestock was found to be highly associated with brucellosis
transmission in a study conducted in Chad (Schel 1 ing et al., 2003). In Saudi Arabia,
assisting animals during parturition was found to be an important risk factor for
brucellosis transmission, but no significant risk associated with other direct
(unspecified) animal contact was observed (Cooper, 1992). Though there was no
classification of outcome of parturition i.e. normal or abortion, or whether the placenta
belonged to a live normal delivery or aborted material the studies point to the fact that
products of conception are important risk factor for brucellosis transmission.
153
Distance between households was found to be significantly associated with brucellosis
transmission. The shorter the distance between the households the greater was the chance
of contracting brucellosis, irrespective of the serostatus of the neighbours. In most
African communities, neighbors assist each other in conducting different activities. These
range from home-based to farm-based duties. Assisting neighbour's animals during
parturition, sharing of food stuffs such as milk and other dairy products is also not
uncommon in communities visited in Arusha and Manyara regions. It is likely that some
of the cases acquired brucellosis either while assisting neighbors' animals during abortion
or during preparing meat.
The association between brucellosis and people belonging to Christian religion was rather
unexpected in this study. There are many practices however that could be linked with the
religious group in Arusha and Manyara regions that need be taken into consideration or
need further investigation as far as the risks of contracting brucellosis are concerned.
Issues like animal husbandry, the number of livestock kept, the location, interaction
between livestock and humans and taboos associated with certain religious groups could
be important factors for comparison in the study area. For example, in the study area,
Muslims either do not keep animals or keep a few of them. It is also known that Muslims
do not consume meat from an animal they do not know how it was slaughtered which
means that Muslims would not consume meat in auctions or market places as much as the
Christians.
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Brucellosis in humans is a chronic disease with multiple presentations some ofwhich are
non-specific and could mask HIV in HIV endemic areas. In the current study there was
no positive association between HIV and brucellosis in the study area (OR=0.84). This
could be due to the low prevalence ofHIV in the area or the number of samples tested
was too few to allow conclusions to be drawn about the relationship between the
serostatus of brucellosis in livestock and that in humans. The findings are similar to the
study conducted in Kenya by Paul et al., (1995) in which it was established that there was
no association between Brucella antibody status and HIV status hence Brucella serology
may be helpful in the diagnosis of patients with non-specific symptoms in East Africa,
regardless ofHIV status. A study carried out in Spain by Moreno et al., in 1998
established that HIV infection does not seem to increase the incidence of brucellosis.
Since most cases occur in asymptomatic patients with relatively normal immunity, the
epidemiology, clinical presentation, diagnosis, response to therapy, and outcome are
similar to those observed in non-HIV infected people.
In other parts of Africa brucellosis transmission was associated with a wide range of
other risk factors, but all are animals to humans directly through contact or animal
products to humans through consumption. In Nigeria the highest prevalence (20%) of
brucellosis was observed among cattle handlers followed, in decreasing order of
prevalence by goat rearers (10%), mixed sheep and cattle rearers (9%), mixed sheep and
goat rearers (8%), and 4% among each of sheep rearers and non-rearers of animals (Baba
el al., 2001). The social habit of eating raw meat, e.g. raw liver or other offal with spices
(Marrara or umfitfit) was found to be an important epidemiological factor in contracting
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the disease in central Sudan, the majority of the patients were found to have a combined
infection of both Brucella abortus and Brucella mellitensis (Mohd, 1989). The present
study and others conducted in sub-Saharan Africa indicate that transmission of
brucellosis to humans is primarily from livestock reservoirs. Thus, the risk to humans is a
function of the risk in livestock and human-livestock effective contact rate (McDermott
and Arimi, 2002; Baba et al., 2001).
6.6 Conclusion
Health education on ways to prevent brucellosis transmission through contact while
assisting animal delivery should be provided in animal keeping communities. Though it
may be difficult for each and every farmer to obtain gloves to use while attending to
livestock that are about to give birth, simple plastic bags that are easily and cheaply
available in the rural settings could be used to prevent the direct contact between humans
and the products of conception that have been shown to harbour Brucella species. During
grazing far from home, pieces of clothes can be used to reduce contact with products of
conception as well. Health education on possibilities of getting infection from
neighbour's animals or consumption of dairy products from a neighbour should be taken
into account as well. Dairy products such as milk and meat should be properly handled,
thoroughly cooked or boiled to prevent the transmission of not only brucellosis but also
other zoonoses such as tuberculosis.
As no association between brucellosis and HIV was established, the Brucella sero
diagnosis could be an important diagnosis for febrile illness even in areas where HIV is
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thought to be prevalent in Arusha and Manyara regions. Each disease condition should be
treated on its merit. Patients presenting with clinical features suggestive of relapsing
brucellosis should however be investigated for HIV.
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7. Evaluation of diagnostic tests for human brucellosis in Arusha
and Manyara regions, Tanzania
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7.1 Summary
Objectives: To evaluate the diagnostic tests for brucellosis in Arusha and Manyara
regions.
Methodology: Samples for evaluation of diagnostic tests were obtained from the cross-
sectional study and hospital clinical study. In the cross-sectitonal survey, subjects for
blood sampling were obtained by multi-stage cluster sampling to household level. At the
randomly selected households, all family members who agreed to participate with the
study were tested for brucellosis using the RBPT. In the clinical study, all brucellosis
suspects were tested for brucellosis using antigen purchased by the hospital and Rose
Bengal antigen supplied by the project. The RBPT was also performed at the SUA
laboratory. Samples were shipped to the VLA for the c-ELISA test which was
considered the gold standard test.
Results: The sensitivity and specificity of the RBPT in the cross-sectional survey were
39.4% and 98.8% respectively, at the laboratory, 38.7% and 96.8% respectively and at
the hospitals, 44.3% and 89.5% respectively. All the other tests performed at the
hospitals had sensitivities less than 76%, with Eurocell A® having the highest (75%).
The specificities of the tests performed at the hospitals were also low with Eurocell A®
having the highest (90%). There was a poor agreement between the RBPT performed at
the SUA, the RBPT performed in cross-sectional survey and tests performed at the
hospitals.
Discussion and conclusion: The antigens used for the diagnosis of brucellosis showed
very low sensitivity. The results indicated that brucellosis is likely to be under-diagnosed
in Arusha and Manyara regions. The storage of samples during transportation, errors
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during testing and labelling and strain variation could also have contributed to the very
low sensitivity results. The specificity of the RBPT was high but the specificities of
antigens used at the hospitals were generally low. The diagnosis of brucellosis needs to
be improved in Arusha and Manyara regions. There is a need to have a standardized
protocol for diagnosis of brucellosis which should include the control of a number of
antigens used and regular quality assurance surveillance. Zonal specialized laboratories
might assist to improve brucellosis case detection.
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7.2 Introduction
Many human diseases are under-diagnosed in Africa because of limited diagnostic
capacity and coverage of the health services. The problem of under-diagnosis is more
common among the poor people as a result of their uneven geographical distribution, and
inherent difficulties in diagnosing diseases in rural and peri-urban areas (Schwabe, 1984).
As a consequence, the under-diagnosis of such diseases as zoonotic diseases has greatly
contributed to their under-reporting in developing countries, in particular, sub-Sahara
African countries. A good example is shown by the official figures of incidences of
rabies, brucellosis and trypanosomiasis in developing countries, they represent only a
fraction of the actual disease burdens in these countries (Cleaveland, et al., 2002; WHO
1998b; Cattand et al., 2001).
Clinical features of brucellosis in humans are similar to malaria and typhoid (Mutanda,
1998; Muruiki et al., 1997), it is therefore possible that some cases of brucellosis are
recorded as malaria or typhoid where these diseases coexist. Diagnostic difficulties are
also encountered with human African trypanosomiasis (HAT) and tuberculosis. HAT is
difficult to diagnose because the parasites are not always evident in blood, and screening
tests often generate a high proportion of false positives. In the case of tuberculosis, few
hospitals have the diagnostic capacity to distinguish bovine tuberculosis from the more
common form of human tuberculosis (DF1D, 2005), because of a number of reasons
including logistic, culture facilities and expertise. These difficulties have contributed to
the general lack of epidemiological information on zoonotic disease in sub-Saharan
Africa (Anon, 1963; Holden, 1999; Perry et al., 2002).
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The diagnosis of brucellosis is based on the clinical features and the results of laboratory,
tests (FAO/WHO, 1985). Since many other diseases with similar clinical features occur
commonly amongst the poor, the diagnosis of brucellosis in such communities depends
on laboratory investigation. The definitive diagnosis of brucellosis could be made by
culture and isolation of the causative organisms, but the procedure requires special media
and it takes several weeks of inoculation and has low sensitivity in acute cases (Gotuzzo
et al., 1986; Christie, 1987; Araj et al., 1990). The SAT is used in sero-prevalence
studies, and has been used in sero-diagnosis of bovine brucellosis in Tanzania (Mahlau
and Hammond 1962; Staack and Protz, 1973). However, this technique has two
disadvantages: first, cross reactions occur with bacteria related to the genus Brucella such
as Afipia, Francissela, Vibrio and Yersinia species and second, positive results occur in
exposed populations and following cure (Goicochea et al., 1996; Drancourt et al., 1997).
Although more sensitive tests are available, SAT is still useful in providing data sufficient
to differentiate active from inactive disease when other factors such as clinical history and
follow-up sera are considered (Young, 1991). The use of agglutination reaction, as the
sole technique for the diagnosis of brucellosis, should be considered carefully in endemic
areas in the context of patients who are exposed repeatedly to Brucella or have a history
of brucellosis (Ruiz-Mesa et al., 2005). Other tests used for diagnosis of brucellosis
include, the Complement Fixation Test (CFT) (Alton et al., 1975), Fluoroscent
Polarization Assay (FPA) (Nielsen et al., 2000), EL1SA (Lucero et al., 1999),
162
radioimmunoassay (Parratt et al., 1977), the indirect immunofluorescence assay
(Colmenero et al., 1989), and the 2-mercaptoethanol test (Reddin et al., 1965).
Several studies have been conducted to evaluate the sensitivity of agglutination tests as a
tool for diagnosis of brucellosis (Young, 1991; Oomen and Waghela 1974; Colmenero et
al., 1989). In a study conducted by Mert et al., (2003), the sensitivity of SAT was found to
be 100% and in another study conducted by Memish et al., (2002) the sensitivity of SAT
was found to be 96.65%. In Turkey, a study conducted by Ciftci et al., (2005) showed the
sensitivity of the RBPT to be 100%, and 94.3% for STA. In Spain, Gall and Nielsen (2004)
demonstrated the overall sensitivity of the RBPT as 92.9%. In a few studies however, such
as that conducted by Sirmatel et al., (2001), low sensitivities of standard tube agglutination
and Rose Bengal tests (83.7%, and 67.9% respectively) were obtained.
The specificity of the agglutination tests has been shown by many studies to be high. In a
study conducted in Spain by Gall and Nielsen (2004), the overall specificities of the RBPT
for groups of patients with history of brucellosis, regular exposure to brucellosis and those
treated for brucellosis were 94.3%, 91.7% and 76.9%, respectively, with positive likelihood
ratios of 16.5, 10.4 and 4.2. Memish et al., (2002), and Mert et al., (2003) demonstrated the
specificity of standard agglutination test to be 100%. The high specificity results of
agglutination tests are a good indicator for diagnosis of brucellosis where many diseases
with similar clinical features and those eliciting similar antigenic response co-exist.
However, as stated earlier in this chapter, the use of agglutination reaction, as the sole
technique for the diagnosis of brucellosis, should be considered carefully in endemic areas
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where patients are exposed repeatedly to Brucella or have a history of brucellosis. A
thorough clinical history needs be taken and at times follow-up sera should be considered.
Agreement between agglutination tests and other tests has also been studied in different
parts of the world. Maichomo et al., (1998), conducted a study on the agreement between
the RBPT performed at three hospitals in Narok, Kenya. He was able to establish that the
performance of the RBPT was good, but staff performing the tests needed more training as
the agreement between the RBPT, the SAT and the CFT was poor. Oomen and Waghela
(1974) and Morgan et al, (1969) also established a good correlation between the RBPT and
the SAT with low false positive and false negative rates. They concluded that the RBPT
and the SAT were reliable tests for the diagnosis of human brucellosis especially in areas
where laboratory facilities are not available.
The retrospective hospital study and the cross-sectional survey that were conducted in
Arusha and Manyara regions between May 2002 and July 2003 provided an opportunity to
know the types of tests used at the hospitals in Arusha and Manyara regions for diagnosis
of brucellosis and to establish the prevalence of brucellosis in Arusha and Manyara regions
using different tests (see chapter 3). In the retrospective hospital survey, hospitals were
found to use different tests and during the cross-sectional survey it was established that
prevalence of brucellosis was 4.8% based on the field RBPT, 6.4 % based on the RBPT
performed at the SUA, and by using the c-ELISA test performed at the VLA the prevalence
of brucellosis was 8.3% (see chapter 4). However, the performance of the tests used need to
be evaluated so that we can know the validity of the results.
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This study therefore intends to determine the validity of brucellosis diagnostic tools used
at the hospitals in Arusha and Manyara regions and also to determine the validity of the
RBPT as a diagnostic tool for brucellosis in the field and hospitals. The aim is to improve
the diagnosis of brucellosis and allow prompt treatment. It is our hope that this will
alleviate the burden caused by brucellosis to the people living in mainly rural areas of
Tanzania.
7.3 Materials and methods
7.3.1 Study area
The study area and the hospitals involved with the study have been discussed in the
second chapter of this work.
7.3.2 Study design and sampling
Serological data for evaluation of diagnostic tests were obtained from the cross-sectional
study and the hospital clinical study. In the cross-sectional study, subjects for blood
sampling were obtained by multi-stage cluster sampling discussed in chapter 2. In the
clinical study, all patients presenting with clinical features suggestive of brucellosis
(brucellosis suspects) were tested for brucellosis using antigen purchased by the hospital
and the RBPT supplied by the project. Further analyses performed included the RBPT and
the c-ELISA at the SUA and the c-ELISA test at the VLA.
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Samples collected from suspects in hospitals were processed and tested for brucellosis at
the hospitals using both the RBPT and local hospital tests in current use for diagnosis of
brucellosis (Table 3. 5). The remaining aliquot was stored at -20°C for further analysis at
the SUA and the VLA as described above. Details of the RBPT and the c-ELlSA test
conducted have been described in chapter 2 of this thesis.
7.3.3 Analysis
Samples collected and tested in the cross-sectional survey, at the laboratory in SUA and
at hospitals were subjected to the c-ELlSA test at the VLA. This test was taken as a gold
standard. The test results were entered and analyzed in Excel spread sheets. Diagnostic
sensitivities (Se), specificities (Sp), positive and negative predictive values (Ppv, Npv
respectively) were calculated as described by Thrusfield (2001). The Youden's index
(YI) was calculated as: Se +Sp - 1 (Youden, 1950). The accuracy (Index of validity)
and likelihood ratios calculations based on a method described by Sackett et al., (1991)
as: Accuracy = (True positives+true negatives)/Total tested)* 100, the positive likelihood
ratio = (1-Se)/Sp and the negative likelihood ratio = Se/(1-Sp). Cohen's Kappa
agreement test (Cohen, 1960) was used to determine the agreement between the tests.
Epi info 6 (CDC, Antanta, Georgia) was used to calculated the 95% confidence
intervals.
To examine the trend of Se and Sp at different cut-off points, and to calculate the best
cut-off point, the Receiver Operating Characteristic (ROC) curve was drawn using Win
Episcope software (CL1VE, Learning Technology Section, College of Medicine and
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Veterinary Medicine, University of Edinburgh). The cut-off point that provided the
maximum Se and Sp was determined by the largest area under the curve. The method
used to calculate the area under the curve was the one described by Hanley and McNeil
(1982).
7.4 Results
7.4.1 Evaluation of the RBPT as a screening test for brucellosis in the cross-
sectional survey
The diagnostic sensitivity and specificity of the RBPT were 39.4% (95% CI, 21.8%-61.1 %)
and 98.8% (95% CI, 97.2%-99.8%) respectively. The positive and negative predictive values
were 76.9% (95% CI, 46%-93.8%) and 95.7% (95% CI, 92.8-97.5%) and the Youden's index
was 0.39 (Table 7.1).





Total Se Sp Ppv Npv YI




21.8-61.1 97.2-99.8 46.0-93.8 92.8-97.5
Total 33 391 424
7.4.2 The performance of the RBPT for diagnosis of brucellosis in a laboratory
setting
The performance of the RBPT as a laboratory test for diagnosis of brucellosis was
conducted through analyses at the laboratory in SUA. The principal investigator and
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laboratory staff at the SUA were involved in the testing. The diagnostic Se and Sp of the
RBPT at the SUA laboratory was 38.7% and 96.8% respectively (95% CI, 29.5%-48.7%
and 95.8%-97.6% respectively) and the Youden's index was 0.36 (Table 7.2)
Table 7. 2: Performance of the RBPT as a laboratory test for brucellosis
c-ELlSA +ve c-ELISA-ve Total Se Sp Ppv Npv Yl
RBPT +ve 41 53 94 38J 963 4T6 963 036
RBPT-ve 65 1591 1656
95% CI 29.5-48.7 95.8-97.6 33.5-54.2 95-96.9
Total 106 1644 1750
7.4.3 Performance of the RBPT as a diagnostic test for brucellosis in hospital
settings
The Rose Bengal antigen was supplied by the VLA to hospitals, and hospital laboratory
staffwere trained on how to test serum samples by the plate agglutination method
(RBPT). The diagnostic Se and Sp of the test as performed in hospitals was 44.3% and
89.5% (95% CI, 34.4-54.8 and 87.8- 91 respectively), Youden's index was 0.34 (Table
7.3).
Table 7. 3: Performance of the RBPT in hospitals
c-ELlSA +ve c-ELISA -ve Total Se Sp Ppv Npv YI
RBPT +ve 43 159 202 44.3 89.5 21.3 96.2 0.34
RBPT -ve 54 1356 1410
95% C I 34.4-54.8 87.8-91.0 16-27.7 95.0-97.1
Total 97 1515 1612
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7.4.4 Performance of antigens used in hospitals
All the antigens used at the hospitals were evaluated. The overall performance of the tests
combined and of individual tests was performed. The overall diagnostic Se and Se of the
combined tests were 47.7% and 82.1%, with Youden's index of 0.29 (Table 7.4).
Table 7. 4: Performance of antigens used in hospitals
Test c-ELISA+ve c-ELISA -ve Total Se Sp Ppv Npv YI
Hospital tests +ve 44 268 312 47.7 82.1 14.1 96.2 0.29
Hospital tests -ve 49 1227 1276
95% C I 37-57.9 80-84 10.5-18.6 94.9-97.1
Total 93 1495 1588
Chronolab +ve 34 188 222 45.9 83.6 15.3 96 0.29
Chronolab -ve 40 957 997
95% C I 34.4-57.9 81.3-85.7 11-20.9 94.5-97.1
Total 74 1145 1219
Murex +ve 1 30 31 50 56.5 3.2 97.5 0.07
Murex -ve 1 39 40
95% C I 2.7-97.3 44.1-68.2 0.2-18.5 85.3-99.9
Total 2 69 71
Nairobi RBPT +ve 3 43 46 50 74.3 6.5 97.6 0.24
Nairobi RBPT -ve 3 124 127
95% C I 13.9-86.1 66.8-80.6 1.7-18.9 92.7-99.4
Total 6 167 173
Eurocel A +ve 6 7 13 75 90 46.2 96.9 0.65
Eurocel A -ve 2 63 65
95% C I 35.6-95.5 79.9-99.5 20.4-73.9 88.4-99.5
Total 8 70 78
7.4.5 Sensitivity and specificity of the RBPT at different cut-off points of the c-
ELISA test percentage optical density.
The Se and Sp of RBPT conducted in the cross-sectional survey were calculated at
different cut-off points of percentage of the c-ELISA test Optical Density (OD), so as to
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examine the effect of cut-off point on Se and Sp (Table 7.5). Using Win Episcope
2(CLIVE, Learning Technology Section, College ofMedicine and Veterinary Medicine,
University of Edinburgh), a ROC curve (Figure 7.1) was drawn and the cut-off point
with the best results of both Se and Sp was calculated by using the method by Hanley
and McNeil (1982). The area under the ROC curve was calculated as 66.5% (95% CI,
65.0%-67.9%). At this cut-off point the Se and Sp of the RBPT in the cross-sectional
survey were 37.14% and 98.97% respectively.
Table 7. 5: Se and Sp of the RBPT at different cut-off points of percentage of the c-
ELISA test OD


























Figure 7. 1: Receiver Operating Characteristic (ROC) curve for the values of Se
and Sp at different cut-off points.
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7.4.6 Accuracy (Index of validity), positive and negative likelihood ratios of the
tests
The RBPT performed at the SUA laboratory had the highest accuracy and likelihood ratio of
a positive test (0.95 and 69.50 respectively) compared to other tests, followed by the RBPT
performed in the cross-sectional survey, and Eurocel A&. Murex® had the lowest accuracy
and likelihood ratio of positive test (Table 7.6)
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Table 7. 6: Accuracy, positive and negative test likelihood ratios of the tests








RBPT laboratory 0.95 69.50 0.59
RBPT hospital 0.86 4.22 0.60
Chronolab® 0.81 2.70 0.60
Murex® 0.56 1.10 0.80
Nairobi RBPT 0.70 1.95 0.67
Eurocel A® 0.88 7.50 0.28
7.4.7 Agreement of the tests
Cohen's Kappa agreement test (Cohen, 1960) was used to assess the agreement between the
RBPT performed at the SUA and all the other tests (The RBPT performed in the field and all the
tests performed at the hospitals) (Table 7.7).
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The RBPT used at the hospital and in the field, and the hospital antigens, showed low diagnostic
sensitivities. Based on the results, it is most likely that brucellosis is underdiagnosed in Arusha
and Manyara regions. The RBPT supplied by the VLA had the diagnostic sensitivities of 39.4%
in the cross-sectional survey, 38.7% at the SUA laboratory and 44.3% in hospitals. The different
antigens used by the hospitals were no better with the most sensitive being Eurocel A® used by
Wasso hospital in Ngorongoro district which gave a sensitivity of 75%. The results indicated that
the antigens were actually poor in the diagnosis of brucellosis. This was supported by the low
likelihood ratio of positive tests results, with the RBPT conducted at the SUA laboratory having
the highest value (69.5) followed by the RBPT in cross-sectional survey (12.09).
The tests showed high specificities with the RBPT performed in the cross-sectional the highest
(98.9%) followed by the RBPT performed at the SUA laboratory (96.8%) and Eurocel A® (90%).
The other antigens used at the hospitals had specificities ranging from 56.5% (Murex®) to 83.5%
(Chronolab11). The results were supported by the likelihood ratio of negative tests results which
were below 1, with Eurocel A® having the lowest ratio (0.28).
There was poor agreement between the tests performed at different settings and the RBPT
performed at the SUA. The RBPT performed in cross-sectional survey had the highest value of
agreement (56.7%) and Eurocel A"8, the lowest (0.08%). Besides the fact that Eurocel A® had the
highest sensitivity and specificity amongst the tests performed at the hospitals, there was a poor
agreement between it and the RBPT performed at the SUA. The results indicated that in addition
to the antigens themselves a local technical problem could have influenced the test results.
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The results of the RBPT were rather unexpected and differed from the results of studies done
elsewhere (Young, 1991; Sirmatel et al., 2001; Mert et al., 2003; Gall and Nielsen, 2004; Ciftci
et al., 2005) in which the sensitivity of the RBPT was observed to be high. The low
sensitivities of the antigens in cross-sectional survey, hospitals and in laboratory settings make
them unsuitable for use in the diagnosis of brucellosis in Tanzania. The poor agreement of the
tests showed a possibility of shortfalls in sample handling or testing techniques. Several other
factors might have contributed to the poor performance of the tests such as freeze, thaw cycle
between the tests and the strain variation. On the other hand the c-ELlSA test is not by itself
100% sensitive; this might also have an influence on the low sensitivities of the tests.
Changing the cut-off point of the c-ELlSA test did not seem to have a profound influence on
the diagnostic specificity. Lowering the cut-off point for example to 30, apart from decreasing
the number of cases detected by 48.8%, it increased the sensitivity of the test to only 64.7%
(64.3% increase) which is still low for a test to be considered valuable for brucellosis
diagnosis. Increasing the cut-off point on the other hand, decreased the sensitivity of the test
still further. At the cut-off point of the c-ELISA test OD of 66.7% (from ROC curve), the
sensitivity of the RBPT decreased at the expense of specificity which increased by 0.01%. The
results vindicated the cut-off point of 60% because other cut-off points did not give higher
sensitivity and specificity results.
7.6 Conclusion
The sensitivities of the antigens evaluated were too low to support them as reliable tests for
diagnosis of brucellosis in the study area. A number of factors could have contributed to the
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poor performance of the tests. These include Brucella strain variation in the study area, the
storage of the samples during transportation and errors during testing. There is a need to carry
out more variations of the tests with improved conditions and a study to establish the types of
strains common in the study area. This might help in improvement or modification of the
antigens used.
Staff involved should take extra care in handling specimens for testing so as to maintain their
optimal ability to form agglutination during testing. The staff should try to abide by tests'
procedures such as use of clear background, stick to test-specific times during testing and proper
storage of reagents. If conditions allow, there is a need to conduct regular quality assurance
surveys of diagnostic tools for brucellosis. This will ensure that proper laboratory procedures
such as proper storage and sample handling are followed.
The number of antigens used for testing brucellosis in the study area, is an issue of particular
concern. There is a need to monitor and standardise the protocols and guidelines for diagnosis of
brucellosis in Tanzania if the Ministry of Health is to be serious with brucellosis case detection.
Advanced tests such as the c-ELISA test are not cost-effective for conducting routine brucellosis
testing in the study area. It is therefore unlikely that hospitals in the study area could afford
acquisition of tests such as the c-ELISA test for routine testing of brucellosis. It is however
possible to establish zonal laboratories in areas where brucellosis is thought to be common,
where samples of difficult or chronic cases could be analysed, with such confirmatory tests as the
c-ELISA test. This would also minimize the problems encountered during shipment of samples
over a long distance.
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Estimating the burden caused by brucellosis in Tanzania
8.1 Summary
Objectives: To assess the burden of brucellosis in Tanzania in terms of Disability
Adjusted Life Years (DALY) and direct and indirect costs to the health provider and to
the patient.
Methodology: The study applied the World Health Organization (WHO) and the World
Bank (WB) recommended DALY to estimate the burden of disease caused by brucellosis
in Tanzania. Data for DALY estimations were obtained from the cross-sectional survey
and cases established during the prospective hospital survey in Arusha and Manyara
regions. Socio-demographic characteristics, economic status, clinical history, and data on
costs of treatment were obtained from the cases by using questionnaires administered by
the principal investigator of the study and from hospital records. The results obtained
were extrapolated to the whole country and compared to DALY estimates caused by
other diseases.
Results: By using disability weights of 0.2, discounting and duration of brucellosis of
4.5 years, 3,645 - 3,709 DALY burden were estimated to be caused by brucellosis based
on hospital data, and by using disability weight of 0.2, discounting and duration of one
year, 92,080 - 121,550 worth of DALY were estimated to be caused by brucellosis based
on data from the cross-sectional survey. The majority of cases continued to show clinical
features of brucellosis for a period of over two years, and out of these, five days were
spent as inpatients. During the period of two years, the productive force of the cases was
lowered. Each household used a total of US $ 90.65 (92, 826 TShs.) to care for a single
case of brucellosis per year and each health provider used a total of US $ 858 (878,592
TShs.) per year to care for cases of brucellosis.
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Discussion and conclusion: Brucellosis contributes to poverty and suffering
particularly to the poor in the rural areas of Tanzania and yet it is neglected. The burden
caused by brucellosis based on hospital data was found to be more than thirty times less
than the burden estimated from cross-sectional data. It is therefore important to consider
calculating DALY using data based on the general community, particularly in
developing countries where few cases present to hospital and when the disease runs a
chronic course. Data collecting and recording systems in Tanzania should be updated so
that diseases such as brucellosis can be notified at the district, regional and national
levels for a better epidemiological picture of diseases that would potentially be under-
reported and neglected. More attention needs to be directed towards control of
brucellosis in Tanzania. However, the control measures should also take into account the
cost effectiveness of intervention strategy as Tanzania is a poor country that requires care
in the allocation of resources.
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8.2 Introduction
The DALY is a quantitative indicator of burden of disease that reflects the total amount
of life lost, to all causes, from premature mortality or from some degree of disability
during a period of time (World Bank, 1993). Other metrics for burden of disease include
analyses of direct monetary costs of medical care, and the indirect costs related to lost
wages and productivity (USA Department of Health, 2000; Murray, 2002). The DALY
was designed as a measurement unit for the Global Burden of Disease (GBD) study to be
used for two tasks: first, as a unit for measuring the magnitude of premature death and
non-fatal health outcomes attributable to causes, including diseases and injuries, poor
water supply, tobacco use or socio-economic inequality (Murray and Lopez, 1996); and
second, as a measure for cost-effectiveness analyses of interventions that could reduce
the burden of the causes and socio-economic determinants listed above. The
development of DALY was intended to make the ethical dimensions of quantifying
health more transparent (Murray and Lopez, 1996).
The World Health Organization (WHO) has consistently indicated the continent of
Africa as the place that deserves much more attention for future health investment
(WHO, 2002). The majority of the world's burden of disease is in sub-Saharan Africa
(Figure 8.1). In 2001 for example, an estimated 24.4% of the global burden of disease
was borne by Africa, home to only 10.7% of the global population (WHO, 2002). The
greater part of the DALY for sub-Saharan Africa is caused by high mortality in early
childhood from a number of infectious diseases. It is estimated that malaria alone
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contributes to a loss of 36.8 million DALY, of which 34 million are in Africa alone
(WHO, 2002).
Figure 8. 1: DALY per 1000 population by region broken down into years lost
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Many zoonoses occur in Africa, in particular, the sub-Saharan area. However, it has been
difficult to appreciate the size of the burden posed by the zoonotic diseases in sub-
Saharan African countries at a continental and national level (Cattand et al., 2001). The
number of cases reported to the WHO by the individual countries either represents a
small proportion of cases or cases are not reported at all. In Zimbabwe for example, one
of the very few national burden of disease estimations was conducted by Chapman et al.,
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(2006). Results showed that none of the zoonotic diseases featured as the cause of
disease burden in Zimbabwe. This is provides evidence that zoonotic diseases are under¬
diagnosed or neglected and hence not accounted as among the major cause of disease
burden in the continent.
Many factors have been put forward as contributing to this general lack of data on
zoonoses. These include diagnostic difficulties, limited surveillance coverage,
geographical distribution of those mostly affected and the general lack of knowledge of
the threat posed by zoonoses (WHO, 1998b; Cleaveland et al., 2002; Cattand et al.,
2001). Brucellosis is a well known disease in many countries, but official figures
produced by individual countries and international institutions do not fully reflect the
actual number of people infected each year, and the true incidence has been estimated to
be between 10 and 25 times higher than reported figures indicate (WHO, 1997).
Disease burden and economic growth are intimately related. Zoonoses have a significant
impact on the economic development of the poor people in developing countries (Perry
et al., 2001; Shaw, 2004). The losses caused by zoonotic diseases are both directly due to
morbidity, mortality to both humans and livestock, and to reduction of fertility, milk
yield and ability for animals to work as traction animals, and indirectly such as due to the
costs of ineffective control measures, limiting production opportunities, and influencing
the choices made by livestock keepers and farmers (Perry et al., 2001; Shaw, 2004).
Brucella is one of the world's major zoonotic pathogens, and is responsible for enormous
economic losses as well as considerable human morbidity in endemic areas (Boschiroli
182
et al., 2001) with a high prevalence in the Mediterranean countries (Lulu et al., 1988;
WHO, 1990). It is also present in Asia, sub-Saharan Africa and Latin America (Abu
Shaqra, 2000; Domingo, 2000; Mikolon et al., 1998). Clinical manifestations of
brucellosis in humans include joint pain, backache, headache, fatigue and loss of appetite
(see chapter 5). Other common features include drenching sweats, spleen and liver
enlargement in advanced stage (Corbel, 1989b; Madkour, 1989). The young and middle-
aged adults who are the most productive force, are the ones mostly affected, with a low
incidence among infants and elderly patients (Lulu et al., 1988) see chapter 2 and chapter
4. Transmission is through direct contact with infected animals or their products.
Unpasteurized milk and processed dairy foods from infected animals are the major
source of infection for the general population (Corbel, 1989a). Acute brucellosis may
occur after an incubation period of 2 -3 weeks, and chronic form up to one or two years,
during which the patient may be severely debilitated (Young, 1995b). The case-fatality
rate of untreated brucellosis is 2% or less and is caused mainly by endocarditis (Jacobs et
al., 1990).
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Plate 8. 1: Weak and grossly emaciated brucellosis case (Picture by Tim Fison)
The benefits of zoonotic diseases control need to account for dual benefits to public
health and livestock sectors. A study conducted in Mongolia by Roth et al.,(2003) to
estimate the economic benefits, cost-effectiveness, and distribution of benefit of
improving human health, found that a total of 49.027 DALY could be averted by mass
vaccination of animals against brucellosis. Estimated intervention costs were US$ 8.3
million, and the overall benefit was US$ 26.6 million. If the costs of vaccination of
livestock against brucellosis were allocated to all sectors in proportion to the benefits, the
intervention might be profitable and cost effective for the agricultural and health sectors.
184
Plate 8. 2: In chronic form, brucellosis manifests as a severe debilitating condition
Brucellosis was first reported in Tanzania in livestock in the then Tanganyika in 1928. In
humans brucellosis was first reported in 1935 by Evans (1935). Livestock surveys
carried out in Tanzania at different times have shown prevalence of brucellosis varying
from 2%-97% (Mahlau, 1967; Kitaly, 1984; Mingaand Balemba, 1990; Jiwa et al.,
1996; Weinhaulp et al., 2000). However, studies to assess the burden caused by
brucellosis to humans in-terms of DALY loss and the costs of treatment have not been
conducted. The current study aims to estimate the burden of brucellosis in I anzania in
terms of DALY losses and costs of treatment to both the patient and the health provider.
This was the first study of its kind to be conducted in Tanzania. It is hoped that the
estimation of the burden caused by brucellosis will stimulate the estimation of the burden
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of other diseases using DALY instead of using only mortality and morbidity. This will
create an enabling environment for easier health policy formulation.
8.3 Methodology
8.3.1 Study area
Detailed information on the study area and hospitals involved with the study, have been
described in the second chapter of this report. A brief account of methodology applied
specifically to this chapter is described.
8.3.2 Data collection
Data for DALY estimations were obtained from the cross-sectional survey and the
prospective hospital survey in Arusha and Manyara regions. Methodology used for case
recruitment both in the cross- sectional and in the prospective hospital survey have been
described in sections 2.4.1 and 2.5.1 respectively of this thesis. Socio-demographic
characteristics, economic status, clinical history, and data on cost of treatment were
obtained from the cases by using open-ended questionnaires administered by the
principal investigator of the study (Appendix III). Data on human population size in the
study areas were obtained from national population and housing census conducted in
2002 (Tanzania population and housing census, 2002) and from district and regional
councils. Data on standard life expectancy was obtained from Standard Model West
level 26 (Murray, 1994).
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In Tanzania both the patient and the health provider share the costs of treatment in what
is termed as the "cost sharing system". Extra costs (indirect costs) are however incurred
by patients for transport, meals and at times accommodation for the patient and any
accompanying person/s, during the course of treatment. In the current study, data on
patients' direct and indirect costs of treatment were obtained from both case follow-up
and hospital records.
8.3.3 DALY parameters
8.3.3.1 Disability weights (D):
Disability weight (D) is the degree of incapacity. D has six classes defined with weight 0
as perfect health and 1 as death (Murray, 1994) (Table 8.1). DALY was calculated using
class 2 (weight 0.2) which has also been used by other studies (Roth et al., 2003).
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Table 8. 1: Definition of disability weighting used in DALY calculation
Class Description Weight
1 Limited ability to perform at least one activity in of the following areas: 0.096
Recreation, education, procreation or occupation
2 Limited ability to perform most activities in one of the following areas: 0.220
Recreation, education, procreation or occupation
3 Limited ability to perform activities in two or more of the following: 0.400
Recreation, education, procreation or occupation
4 Limited ability to perform most activities in all of the following areas: 0.600
Preparation, shopping or housework
5 Needs assistance with instrumental activities of daily living such as meal 0.810
Preparation, shopping or housework
6 Needs assistance with instrumental activities of daily living such as eating, 0.920
personal hygiene or toilet use
8.3.3.2 Age weights:
This is the parameter that shows the relative importance of healthy life at different ages.
The parameter rises up to 25 years and then starts to decline (Figure 8.2). In the present
study DALY was calculated with and without age weighting function. Age weighting
function was calculated from the formula: Age weighting = (Cxe^).
Where:
• C = Constant equal to 0.16243.
• fi = Constant equal to 0.04.
• v = Age.
• e = Constant equal to 2.71.
188
Figure 8. 2: Variation of relative weight (Relative importance of life) with age
Graph by Burden of Disease unit, Harvard University
8.3.3.3 Time preference:
This is the value of health gains today compared to the value attached to the health gains
in the future. Using the discount rate of 3%. the discounting function was calculated as:
(e-r<x-a>).
Where:
• r = Discount rate, fixed at 0.03
• x = Age.
• e= Constant equal to 2.71
• a = Onset year.
8.3.3.4 Duration of time lost due to a death at each age or Years of Life Lost due
to premature death (YLL):
This is the years of life lost due to premature death. YLL is calculated as (Cxe'ls)(e-tx'a>).
Standard life expectancy at birth is taken as 82 for females and 80 for males (according
to model life-table West level 26) (Murray, 1994) based on Japanese female and male
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life expectancies respectively. The current study used the model life-table West level 26
to allow comparisons with other studies on DALY conducted (Murray and Lopez, 1996).
8.3.3.5 Duration of brucellosis:
The duration of brucellosis clinical features was taken as 4.5 years. This was the time
established by (Beklemischew, 1968) and has been used in other studies (Roth et al,
2003).
8.3.3.6 Years of Life Lost due to disability (YLD)
This is the years of life lost due to a non-fatal condition, it is calculated from the
formula, YLD = I *D*L
Where:
• I = number of incident cases
• D = disability weight
• L = average duration of the case until remission or death (years).
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8.3.4 Assumptions made during calculation of DALY for the whole of
Tanzania
To extrapolate the burden of brucellosis for the whole of Tanzania from data
collected in Arusha and Manyara regions, the following assumptions were made:
• Brucellosis is common in all regions with people keeping livestock. Regions such
as Mtwara, Lindi and the islands of Zanzibar and Pemba where livestock are not
commonly kept were excluded from the study.
• Brucellosis is common in rural areas that make up 75% of the Tanzanian
population (World Bank, 2002). In rural areas there is a close relationship
between humans and livestock and activities such as assisting parturition are
common. The total population involved in DALY calculation was therefore 75%
of the total population of Tanzania excluding Mtwara, Lindi and the islands of
Zanzibar and Pemba. This was calculated as 24,392,862 people.
• Although in the current study brucellosis was found to be more common in
pastoral than in agropastoral areas, the pastoral community compose a very small
proportion of livestock keepers in the whole of Tanzania. The incidence of
brucellosis was therefore assumed to be the same in both pastoral and
agropastoral areas.
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• As the number of brucellosis cases reporting to hospitals represent only a fraction
of those suffering from the disease in the community, DALY were calculated
using data obtained during cross-sectional and during hospital surveys for
comparison purposes.
8.3.5 Calculation of DALY
The total DALY score was calculated by using the formula:
DALY(x)= (D)(Cxep)(e-r(x-a))+(Cxet3)(e-r<x-a>), which is equal to YLD+ YLL. The
number of incidence cases of brucellosis established and deaths due to brucellosis in
Arusha and Manyara regions were extrapolated to the whole of Tanzania based on
assumptions listed on section 8.3.4.
8.3.6 Estimating the burden of brucellosis in terms of direct and indirect costs
to the patient/household and to the health provider
The costs of treatment were taken as the average of the total cost incurred by all the
patients. In the current study it was evident that some brucellosis patients attended
traditional healers prior to going to hospital and some attended several different hospitals
for investigation and treatment and were prescribed a number of drugs. These costs were
not included in the calculations, as it was difficult to establish the exact costs that cases
incurred. All the mean costs, which were taken as costs per case, were calculated as the
total costs divided by the number of cases. The costs incurred by each hospital were
calculated as the total costs incurred by all hospitals divided by the number of hospitals.
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Plate 8. 3: Health facilities are overstretched to accommodate the number of patients requiring
investigation and treatment for brucellosis
The annual income per household of agropastoral families was calculated from annual
sales of crops (if it is assumed none was left for household consumption) divided by the
number of households. One bag of maize was 12,000 TShs., of beans 40,000 TShs., of
millet 15,000 TShs. and of sunflower 40,000 (data from markets in the study area as of




8.4.1 Common febrile conditions in the study area
Of 1,153 patients who were seen by practitioners in the hospitals, 304 (26.37%) were
diagnosed and treated for malaria and 192 (16.65%) treated for joint pain categorised
as arthritis. Pain such as back and waist pain were also included in this category.
Typhoid fever ranked third with 199 (17.26%) patients while 166 (14.40%) patients
were treated for brucellosis. Detailed information about other febrile /flu-like
conditions have been described in chapter 5 of this work.
8.4.2 Brucellosis cases and incidences for DALY calculation
Of 428 individuals who were tested with the c-ELISA test at the VLA during the
cross-sectional survey, 33 tested positive. These were extrapolated to 467,340
brucellosis cases in the whole of Tanzania. As no fatality was recorded during the
cross-sectional survey, YLL was not calculated. During the hospital survey, 98
brucellosis cases were established and out of these five cases died of brucellosis.
All five deaths were males of greater than 50 years of age. This was extrapolated to
2,721 cases and 139 male deaths per annum due to brucellosis in the whole of
Tanzania.
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8.4.3 YLL, YLD and DALY for Tanzania
By using disability weights of 0.2, discounting and duration of brucellosis of 4.5 years,
3,645 - 3,709 DALY burden were estimated to be caused by brucellosis based on
hospital data, and by using disability weight of 0.2, discounting and duration of one
year, 92,080 - 121,550 worth ofDALY were estimated to be caused by brucelloasis
based on data from cross-sectional survey. The summary of parameters used,
calculation involved and results for YLL, YLD and total DALY are in tables 8.2-8.8.
195



























































YLLs-earofLifestdutoprematureeathwithoutgw igh ing YLLa-earsofLifestdutoprem tureeathwigew ighting




































































































































































































































































































































































































































































































































8.4.4 Burden of brucellosis in terms of direct and indirect costs to the patient and
to the health provider
Data on household expenditures for brucellosis cases, and clinical history were available for
41 brucellosis cases. All the cases used a total of US $ 725.68 (743,100 TShs.)^ for transport,
investigation and treatment, an average of US $ 17.70 (18, 124 TShs.) per case per-single
presentation to hospital. Most patients had to get food from nearby hotels, or alternatively they
bought cooking ingredients from nearby shops instead of getting these from home, thus each
patient was estimated to use half a dollar for meals everyday.
Extra costs for transport of accompanying persons amounted to US $ 100.91 (102,319 TShs.),
an average of US $ 2.26 per person/household (2,496 TShs.). Each household therefore
incurred a total of US $ 22.66 (23,203 TShs.) for treatment and transport of a single case and
other costs required by a person accompanying a case to hospital. As on average cases
presented to hospitals four times in a year, the total costs incurred by each household to care
for a single case of brucellosis amounted to US $ 90.65 (92, 826 TShs.). The costs for meals
for persons accompanying the patients were not included as most of them spent nights within
hospital premises and some with relatives or friends living close to the hospitals. The
breakdown of the estimates is shown in Table 8.9.
* The exchange rate was US $ 1 for 1024 Tanzanian shillings
*
US $ = United States Dollar
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Total in US $
single presentation
Total in US S
four presentations
Costs for all
cases 725.68 102.50 100.91 929.09 3716.36
Costs per case 17.68 2.50 2.46 22.66 90.64
Health providers incurred the costs of bedding, electricity, water, salaries for staff and a part of
medication for patients. This was estimated at US $ 3.5 per day per patient in a rural setting (in
Uganda it was US $ 2.5; Odiit, 2003)§. For all 98 cases that were diagnosed during the course of
study, health facilities used a total of US $ 1,715 (1,756,160 TShs.). If the cost was to be shared
equally among the eight hospitals, each hospital used US $ 214.50 (219,648 TShs.) per year to
cater for brucellosis cases alone. As it was indicated earlier in the analysis, these were the costs
of a single presentation to hospital. As cases attended to hospitals on four occasions within a
year, each hospital used a total of US $ 858 (878,592 TShs.) per year to cater for brucellosis
cases alone (Table 8.10).
* Tariffs are higher in Tanzania than in Uganda, estimated costs in Tanzania were made higher than in
Uganda by US $ 1.
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Table 8. 10: Costs incurred by health provider
Total costs by all hospitals Total costs per hospital Total costs per hospital per
per year for single per year, single year, four presentations
presentation presentation
US $ 1,715 US $214.50 US $ 858
In total, all brucellosis cases gave a history of symptoms of 29.602 days (722 days per case).
All the cases gave a history of limited daily work performance such as farming, cooking and
attending to animals while they were sick. Out of these days, a total of 204 days were spent in
hospital as inpatients (5 days per patient).
Plate 8. 4: Most of brucellosis cases are poor farmers in rural areas.
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The mean expenditure per annum for school, health (including of brucellosis), food and other
requirements was US $ 394.48 (403,951.50 TShs.) and the annual income of agropastoral
families generated from sales of crops was estimated at US $ 363 (371,354 TShs.) per
household, the Gross National Product (GNI) of Tanzania is US $ 340 (World Bank, 2006)
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8.5 Discussion
Africa has the largest share of the world's burden of diseases (WHO, 2002). Estimation of burden
caused by diseases is therefore an essential strategy toward rational health planning. Prioritization of
different interventions, to a large extent, depends on the burden of the disease and cost effectiveness
of the intervention strategies, both of which can be estimated by using DALY (World Bank, 1993;
Murray et al., 2002; Murray and Lopez 1996). The present study established that the disease burden
caused by brucellosis in Tanzania is enormous and yet it is neglected. Brucellosis contributes to
poverty and suffering particularly to members of animal keeping communities in the rural Tanzania.
Based on hospital data 3,645 - 3,709 DALY burden were estimated to be caused by brucellosis and
based on cross-sectional data 92,080 - 121,550 worth of DALY were estimated to be caused by
brucelloasis. In poor countries where health services are not easily accessible to many people, a
significant number of diseased individuals are likely to be in the community. As brucellosis cases
presenting to hospital represent just a fraction of real number of cases in the community it is
important to consider calculating DALY using data that is based on all cases that are in the
community, particularly for diseases that take a chronic course like brucellosis.
Data on DALY parameters for other diseases show that zoonotic tuberculosis caused by
Mycobacteria bovis caused 9,739 DALY loss, rabies 42,669, Mycobacteria tuberculosis (due to
human to human transmission) resulted in 730,891 DALY burden in the year 2000 (Coleman et al.,
2004). Data on the burden caused by other diseases in terms ofDALY was scarcely available making
it difficult to make comparisons with many other diseases in Tanzania. The differences in rabies,
brucellosis and tuberculosis DALY values is attributed to the incidence/prevalence of the diseases,
fatality rate, the disability caused (presented as disability weight) and the age mostly affected. Other
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factors that may attribute to the differences in DALY values include the methodology involved and
the sample studied. Younger ages carry more YLL and YLD and hence more DALY than adults
(Murray and Lopez, 1994). In Soroti, Uganda, DALY losses due to T.b. Rhodesiense sleeping
sickness was estimated at 124 in 1999 (Odiit et al., 2005). The DALY results were low because the
sampling frame comprised of only a few health facilities in one area. There was a need to extrapolate
the results to the country level.
On average brucellosis cases continued to have clinical features for a period of over two years, and
of these, five days were spent as inpatients. This period is two and a half years less than the period
observed in Russia by Beklemischew (1968) and which has been used in other studies (Roth et al.,
2003). During the period of sickness, cases gave a history of limited capacity to perform farm and
home-based works and the employed recorded several days of absences. Students, who contributed
12% of all cases (see chapter 5), had irregular school attendances which could have an impact on
their academic performances. Cases visited health facilities about 4 times within a year of illness
instead of participating in production activities and it was even worse when the case was the
household bread-winner.
Every case used about US $ 90.6 (92,826 TShs.) in a year to treat brucellosis. This amount is a heavy
burden to poor extended households that have many other issues to deal with, and whose incomes
depend on subsistence farming. The GNI of Tanzania is US $ 340 (World Bank, 2006) and for
agropastoral families the annual earnings from crops selling was US $ 363. Using US $ 91 to treat a
single case of brucellosis per year in an area with a burden ofmany other diseases, worsens the
economies of the households in the study area still further. The non-specific manifestations of
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brucellosis and their resemblance to other endemic diseases, such as malaria and typhoid in the study
area made early diagnosis of brucellosis difficult. Extra costs for investigations and treatments were
incurred by the cases and health providers to rule out other diseases that present like brucellosis. In
addition to drugs for treating malaria, typhoid, and brucellosis, pain killers such as paracetamol,
Ibuprofen, diclofenac and vitamins supplements were also found to be prescribed. Each hospital used
a total of US $ 858 (878,592 TShs.) per year to cater for brucellosis cases which is a heavy burden to
the already overstretched and under-funded health provider.
8.6 Conclusion
Brucellosis contributes to poverty and great suffering to people in Tanzania but yet it is
underestimated and ignored. The study challenges public health specialists, in particular those
involved with health planning, to take great care when estimating the burden caused by diseases. It is
likely that some diseases are underestimated and neglected due to the nature of their clinical features
and accessibility to healthcare for the people most affected. It is therefore important to consider
estimating the DALY burden caused by diseases using data collected from the community rather than
data from health facilities alone.
Brucellosis causes a significant loss of resources to those affected, their households and health
providers hence still further worsening the economies of poor people and increasing the burden on
the already underfunded health sector. Due attention needs to be directed towards control of
brucellosis with appropriate intervention strategies focused on the areas mostly affected by the
disease. This should include among other strategies, health education on ways brucellosis is
209
transmitted and improved diagnosis. However, any control measures implemented should also take
into account their cost effectiveness as Tanzania is a poor country that requires great care in
allocation of resources. Data collecting and recording systems in Tanzania should be updated so that
diseases such as brucellosis can be notified at the district, regional and national levels for better
epidemiological information on diseases that would potentially be under-reported and neglected.
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9. Knowledge of causes, clinical featuress and diagnosis of common
zoonotic diseases among medical practitioners in Tanzania
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9.1 Summary
Objectives: To assess the knowledge of medical practitioners of the common
zoonoses in Tanzania
Study design: Cross-sectional survey.
Methodology: An open-ended questionnaire was administered to medical practitioners in
selected health facilities within urban and rural areas in Tanzania between April and May
2005. Knowledge of medical practitioners of transmission, clinical features and diagnosis of
anthrax, rabies, brucellosis, trypanosomiasis, echinococcosis and bovine tuberculosis in
humans in urban and rural areas was analysed.
Results: Medical practitioners in rural hospitals had poor knowledge of transmission of
sleeping sickness to humans (p<0.04) and clinical features of anthrax and rabies in humans
(p< 0.05 and p-value < 0.01 respectively) compared to the practitioners in urban hospitals. In
both areas the practitioners had poor knowledge on how echinococcosis is transmitted to
humans, clinical featues of echinococcosis in humans, and diagnosis of bovine tuberculosis
in humans.
Conclusion: Knowledge of medical practitioners of zoonotic diseases is likely to contribute
to the under-reporting of zoonotic diseases in Tanzania. Refresher courses on zoonoses or
more emphasis on zoonotic diseases in teaching curricula of medical practitioners should be
implemented in Tanzania to improve the diagnosis of zoonotic diseases. There is also a need
for a greater veterinary and medical collaboration in sharing of knowledge important for
identification and control of zoonotic diseases.
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9.2 Introduction
Zoonotic diseases are diseases that can be transmitted between humans and vertebrate
animals (WHO, 1959, Palmer et al., 1998). A total of 61% (n=868) of all human
diseases are actually zoonotic and 75% of emerging human pathogens are zoonotic
(Taylor et al., 2001). The ability of pathogens to infect a wide range of hosts is a risk
factor for disease emergence in humans (Taylor et al., 2001) and animals (Cleaveland
et al., 2001). Several emerging human diseases have been cited as transmitted
between humans and vertebrate animals (Institute of Medicine, 1992; Morse, 1995;
Murphy 1998; Palmer et al., 1998), but its only now that zoonoses have been
demonstrated by quantitative analysis as risk factors for disease emergence (Taylor et
al., 2001). Both domestic and wild animals have been shown to be important
reservoirs of zoonotic diseases (Kilonzo and Komba, 1993; Haydon et al., 2002).
Zoonoses form part of infectious diseases which account for 29 out of the 96 causes
of human morbidity and mortality listed by the World Health Organization and World
Bank (Murray and Lopez 1996). The connections between animal and human
diseases are now generally understood, but individuals as well as societies remain
slow to act on this knowledge (Hardy, 2003). This could be due to insufficient
systematic continuing education and opportunities to acquire new knowledge on
zoonoses for those working in health facilities (Asano et al., 2003). The physician
who attends an ill veterinarian or zookeeper will immediately suspect a wide array of
other diseases; likewise a pediatrician who attends the child who recently received a
puppy for his birthday will not suspect an animal transmitted disease. Medical
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professionals have not been giving due consideration of animals as carriers of
diseases that can be transmitted to humans (Goskienski, 1983). This has resulted in
poor quality of epidemiological data on different zoonoses and their control measures
on animal and human populations in especially sub-Saharan Africa (Holden, 1999;
Perry et al., 2002).
Within sub-Saharan Africa, many zoonoses are poorly controlled in both livestock
and human populations (WHO, 1994). In Africa, bovine tuberculosis, brucellosis,
anthrax, sleeping sickness, and rabies are still widespread (Meslin et al., 1992; Barret,
2006). In a study conducted in northern Tanzania in 2002, nineteen diseases were
recorded as zoonoses by household members with rabies, tuberculosis, anthrax and
brucellosis the top four zoonotic diseases in pastoral, agro-pastoral and smallholder
dairy farming systems (Shirima et al., 2003). Although the majority of households
practiced at least one risk activity for transmission of zoonotic diseases there was
general lack of knowledge about the diseases. This coupled with poor animal
husbandry could be important factors for disease transmission in the areas (Mfinanga
et al., 2003, Shirima, et al., 2003).
Although human brucellosis is a modifiable disease in many countries, official
figures do not fully reflect the number of people infected each year and the true
incidence has been estimated to be between 10 and 25 times higher than what
reported figures indicate (WHO, 1997). Cases very often remain
unrecognized because of inaccurate diagnosis, and are thus treated as other diseases
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as "fever of unknown origin" (WHO, 1997). In Uganda, it was noted that despite the
reported increase in the number of individuals infected with T.b. gambiense species in
the 1990s, WHO estimated that the figures represent only 10-15% of the actual
number of infected individuals (Cattand et al., 2001). Apart from poor knowledge of
zoonoses, poor referral systems, limited surveillance coverage, difficulty and delay in
diagnosis by the health facilities have been contributing to the under-reporting of
zoonotic diseases. Patients on the other hand have been seeking alternative services
such as those offered by traditional healers and hence delay to present to health
facilities or failing to present at all, making data on their diseases not available for
epidemiological records (Wandwalo et al., 2000; Cattand et al., 2001; Odiit et al.,
2004; Mfinanga et al., 2005).
As targeted education has been demonstrated to be an important factor in improved
diagnosis of diseases (Jorge et al., 2005), assessing the level of knowledge of
zoonotic diseases of medical practitioners could be an important step in identifying
target receptors for public health education in Tanzania. Knowledge of animal
reservoirs and their relationship to human disease causation enabled the identification
ofmany zoonotic diseases outbreaks in the world such as Rift Valley fever in Kenya
and Somalia (WHO press release, 1998a), Nipah virus in Malaysia and Singapore
(Chua et al., 2002), West Nile virus in USA (Lanciotti et al., 1999) and Hendra virus
in Australia (Westbury, 2000). No study however, has been conducted in Tanzania to
evaluate the knowledge of health personnel responsible for the diagnosis and
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treatment of zoonotic diseases. Here we evaluate the knowledge ofmedical
practitioners as a factor for the diagnosis of zoonotic diseases in Tanzania.
9.3 Materials and methods
9.3.1 Types of health facilities in Tanzania
All public health facilities in Tanzania are administered by the Ministry of Health,
including privately owned health facilities such as those run by churches. Referral
hospitals manage cases refered from regional, district, ordinary hospitals, health
centres and dispensaries.
Diagnosis and treatment of patients is the responsibility of a range of health personnel
including medical officers, assistant medical officers, and clinical officers (medical
assistants). Medical officers have training to degree level while assistant medical
officers and clinical officers have training to diploma and certificate levels
respectively. For the purpose of this study, all these categories of staff have been
referred to as medical practitioners or practitioners.
9.3.2 The study area
The study was carried out in the districts ofNgorongoro, Karatu and Arusha in
Arusha region, Mbulu, Babati and Simanjiro in Manyara region and Moshi in
Kilimajaro regions in north-eastern Tanzania, and Dodoma urban in Dodoma region
in central Tanzania (Figure 9.1). Health facilities involved included Mount Meru,
216
Karatu Lutheran and Endulen hospitals in Arusha region and Dareda missionary,
Mbulu district, Babati district hospital and Simanjiro health centre in Manyara region.
Others included Makole health centre and Dodoma regional hospital in Dodoma
region and Mawenzi hospital in Kilimanjaro region (Figure 9.2). All the regions
studied have the majority of people practicing animal husbandry (Ministry of
Agriculture and Cooperatives, 1995a). Arusha and Manyara regions have subsistence
farmers practicing both agro-pastoral and pastoral farming systems whereas farmers
in Kilimanjaro and Dodoma regions practice mainly agro-pastoral system.
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Figure 9. 1: Map of Tanzania showing study area
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Figure 9. 2: Study area with hospitals involved
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9.3.3 Study design and sampling
The study was designated as a cross-sectional survey and was conducted between April
and May 2005. It focuses on areas in Tanzania containing a high proportion of livestock-
keepers (Ministry of Agriculture and Cooperatives, 1995b, Tanzania population and
housing census, 2002) within the central belt and northern Tanzania. Logistic and time
constraints prevented access to regions in the southern highlands. A list of all medical
facilities within the regions was compiled and assigned as urban or rural on the basis of
Tanzania government regional administrative divisions. Four hospitals were selected at
random from urban and six from rural communities within the six regions.
9.3.4 Data collection
An open-ended questionnaire was developed to assess knowledge of the causes, clinical
features and diagnosis of anthrax, bovine tuberculosis, trypanosomiasis, rabies,
hydatidosis and brucellosis (Appendix V). Field testing of the questionnaire was
conducted at Wasso hospital in Ngorongoro district which was not included in the study.
The focus of the questionnaire was on medical practitioner's knowledge considered
important for the diagnosis of zoonotic diseases. On transmission, the emphasis was on
knowledge of animal reservoirs and transmission routes and on clinical features,
questions were asked about classical and pathognomonic features of zoonoses in humans
and finally data were collected on knowledge of diagnostic protocols for zoonoses.
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9.3.5 Data analysis
All the responses were assessed in relation to the information provided by text books of
zoonoses (Hubert et al., 1975; Martin and Hugh-Jones, 1995) and were assigned as:
"True" if the response was the same or closely similar to the documented, "False" if it
was not and "Partial" if the respondent had some correct knowledge of a particular aspect
of a zoonotic disease and incorrect on the other aspect. All the practitioners present on
the first day of the visit and who agreed to participate with the study were enrolled. Two
medical practitioners dropped out of the study citing time constraint. Time to fill in the
questionnaire was allocated according to average time recorded during pre-testing (20
minutes). This was done to minimize sharing of knowledge and referring to text books
that could have interfered with the analysis.
Medical practitioners were classified into levels of training as medical officers, assistant
medical officers and clinical officers and then assigned into urban and rural areas
according to the location of health facilities. Frequency data were analysed using
likelihood ratio chi-square in Minitab version 14 (Minitab Inc. 2000, Release 14 for
Windows, State College, Pennsylvania) to compare knowledge of transmission, clinical
features and diagnosis of the zoonotic diseases of the practitioners in the two settings.
For each analysis, likelihood ratio chi-square p-value of less than 0.05 was considered to
be significant. Fisher's exact lest was used where expected results were less than 5.
Analysis was initially conducted in two phases. In the first phase responses from medical
officers and assistant medical officers were combined and compared with responces from
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clinical officers. In this phase, two analyses were conducted. In the first analysis all the
"Partial" responses were included as "True" responses and in the second analysis
"Partial" responses were omitted and hence only "True" and "False" responses were
included in the analysis. In the second phase, medical practitioners were divided into
rural and urban and compared with respect to knowledge of different aspects of
zoonoses. As above, analysis was conducted with "Partial" responses as "True"
responses and repeated when omitted.
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9.4 Results
In total, 4 medical officers, 6 assistant medical officers and 27 clinical officers agreed to
participate (Table 9.1). Based on the location of the hospitals seventeen medical practitioners
were classified as working in rural hospitals and 20 in urban hospitals.
Table 9. 1: Medical practitioners involved in the study and hospitals
Hospital Farming
system
Assistant Medical Officers Clinical Officers Medical Officers Total
Babati Agropastoral 4 4
Dareda Agropastoral 2 2
Dodoma Agropastoral 2 2 2 6
Endulen Pastoral 1 3 4
Karatu Agropastoral 2 2
Mawenzi Agropastoral 2 2 4
Makole Agropastoral 5 5
Mbulu Agropastoral 1 2 -}J
Mount Meru Agropastoral 2 3 5
Simanjiro Pastoral 2 2
Total 6 27 4 37
When level of training was considered in the analysis, there was no significant difference
between the two groups of medical officers combined with assistant medical officers versus
clinical officers in any aspect of knowledge of zoonotic diseases, showing that level of
training was not a factor in determining the type of response. Analysis was therefore
conducted basing on comparison of responses from medical practitioners in urban and rural
hospitals with "Partial" knowledge responses omitted.
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9.4.1 Knowledge of practitioners of transmission of zoonotic diseases
"True" responses with respect to transmission of rabies were recorded in a high proportion of
practitioners in rural and urban areas (93.75%, 95% CI=69.77- 99.84, n=19 and 94.74%,
95% CI=73.97-99.86, n=19 respectively) with no significant difference between them
(Fisher's exact test, p=l). Significantly more practitioners in urban hospitals appeared to
have the correct knowledge of how sleeping sickness is transmitted compared to their rural
counterparts (x2=4.2, df=l, p<0.05). In both urban and rural health facilities, only a few
practitioners were observed to have the right knowledge of the transmission of
echinococcosis (44.44%, 95% CI=21.5-69.2, n= 18 and 23.53%, 95% CI=6.8-49.8, n=17
respectively), with no significant difference between urban and rural sites (%2 =1.6, df=l,
p>0.05) (Table 9.2).
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Table 9. 2: Knowledge of practitioners of transmission of common zoonotic
diseases to humans.



















9 69.23 4 30.77 15 93.75 1 6.25 0.14*
Transmission
brucellosis
12 92.31 1 7.69 10 66.67 5 33.33 0.17*
Transmission
rabies
15 93.75 1 6.25 18 94.74 1 5.26 1*
Transmission
trypanosomiasis
7 46.67 8 53.33 16 80.00 4 20.00 0.04
Transmission
bovine TB
11 84.62 2 15.38 15 88.24 2 11.76 1 *
Transmission
echinococcosis
4 23.53 13 76.47 8 44.44 10 55.56 0.19
* Fisher's exact test p value
9.4.2 Knowledge of practitioners of clinical features of zoonotic diseases in
humans
There was a significant difference between the knowledge of practitioners in the rural and
urban hospitals on clinical features of anthrax and rabies. More practitioners in urban
hospitals were found to have the correct knowledge of clinical features of anthrax and
rabies compared to the practitioners in the rural hospitals (%2=4.6, df=l, p < 0.05 and x2
=6.991, df = 1, p-value <0.01 respectively). In both urban and rural hospitals a few
practitioners were observed to have the right knowledge of clinical features of
echinococcosis (33.33%, 95% CI=11.82-61.61, n=15 and 47.06 %, 95% CI=22.98-72.2,
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n= 17 respectively), with no significant difference between them (%2 = 0.6, df=l, p>0.05)
(Table 9.3).
Table 9. 3: Knowledge of practitioners on clinical features of zoonotic diseases in
humans



















5 35.71 9 64.29 12 75.00 4 25.00 0.03
Clinical features
brucellosis
10 66.67 5 33.33 8 50.00 8 50.00 0.35
Clinical features
rabies
7 43.75 9 56.25 17 85.00 3 15.00 0.008
Clinical features
trypanosomiasis




7 53.85 6 46.15 3 25.00 9 75.00 0.23*
Clinical features
echinococcosis
5 33.33 10 66.67 8 47.06 9 52.94 0.43
* Fisher's exact test p value
9.4.3 Knowledge of practitioners of diagnosis of zoonotic diseases in humans
In both rural and urban hospitals, a few practitioners had the correct knowledge of type of
samples and investigations to be conducted to rule out bovine tuberculosis (33.33%, 95%
CI=4.3-77.7, n=6 and 47.06%, 95% 0=22.9-72.2, n=17 respectively) and the difference was
not statistically significant (%2= 1.8, d=l, p>0.05). There was no significant difference
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between the number of practitioners in rural and urban hospitals with correct knowledge of
diagnosis of other zoonotic diseases (Table 9.4).
Table 9. 4: Knowledge of urban and rural practitioners on diagnosis of zoonotic
diseases in Tanzania




No. gave % No. gave % No. gave % No. gave
correct wrong correct wrong




43.75 9 56.25 10 58.82 7 41.18 0.38
Diagnosis
brucellosis
13 86.67 13.33 56.25 43.75 0.11*
Diagnosis
rabies
33.33 10 66.67 60.00 40.00 0.14
Diagnosis
trypanosomiasis
12 75.00 25.00 16 84.21 15.79 0.68*
Diagnosis
bovine TB
33.33 66.67 8 47.06 52.94 0.66*
Diagnosis
echinococcosis
12 75.00 25.00 15 78.95 21.05 0.09
* Fisher's exact test p value
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9.5 Discussion
The diagnosis and hence reporting of diseases depend to a large extent on the level of
understanding of the disease. Accordingly, incomplete understanding of reservoirs of
diseases has hampered not only reporting but also the control of many diseases such as rabies
in Africa (Cleaveland et al., 1995; Bingham et al., 1999). The knowledge of animal reservoir
and transmission modes of zoonotic diseases have helped the identification ofmany zoonotic
disease outbreaks (WHO press release, 1998a, Lanciotti et al., 1999; Westbury, 2000; Chua
et al., 2002). But it has been noted that, often health personnel focus more on common or
endemic diseases and forget diseases such as those transmitted from animals (Goskienski,
1983). Where malaria is endemic diseases such as brucellosis and anthrax can easily be
missed because they have similar clinical features (WHO, 1997).
According to the population and housing census conducted in Tanzania in 2002, about
75% of the Tanzanian population live in rural areas keeping more livestock than their
urban counterparts (Ministry of Agriculture and Cooperatives, 1995b; Tanzania
population and housing census, 2002). One would therefore expect a higher burden and
more awareness of zoonotic disease in rural than in urban areas. In the current study
however it was found that practitioners in the rural area had poor knowledge on how
sleeping sickness is transmitted to humans (p<0.05) and clinical features of anthrax and
rabies (p<0.05 and p< 0.02 respectively). In both areas the practitioners had poor
knowledge on how echinococcosis is transmitted, how it presents, and how to investigate
bovine tuberculosis. Poor knowledge on any one of the aspects of the diseases could
result in the disease misdiagnosis. Knowing how the disease manifests without knowing
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how it is investigated likewise, knowing how diseases are diagnosed without knowing
clinical features can result in misdiagnosis as one wouldn't know which disease to
investigate.
Practitioners might be equipped with good history taking skills, but adequate knowledge of
how zoonotic diseases are transmitted will provide room for key and focused questions
leading to definitive diagnosis and hence treatment of zoonotic disease (Huff and Barry,
2003). It is possible that some zoonotic diseases are missed by the staff entrusted with the
duty of identifying them. This might be due to forgetting after years of concentrating on
diseases that are thought to be more common or the teaching curricula in institutions
concerned don't put due emphasis on zoonotic diseases. Some zoonotic diseases
investigated by the present study require advanced diagnostic techniques. Before more
weight is put on the acquisition of the sophisticated diagnostic techniques, efforts should be
made to equip the concerned staffwith adequate knowledge of zoonotic diseases to avoid a
waste of resources on equipments that will not be properly utilized.
9.6 Conclusion
The study suggests that lack of knowledge of medical practitioners of zoonotic diseases
could be a contributing factor to under-reporting of zoonotic diseases in Tanzania. Refresher
courses on zoonoses or more emphasis on zoonotic diseases in the teaching curriculum of
medical practitioners should be put in Tanzania as part of sensitization for improved
diagnosis of zoonotic diseases. This will not only enable medical practitioners in the proper
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diagnosis of zoonoses but will also provide them with up-todate knowledge on prevention of
the diseases in the community.
More collaboration between veterinary and medical personnel should be emphasized in
Tanzania. This should include sharing and exchange of knowledge on various diseases of
mutual interest. Working together between veterinary and medical professionals will
enable updating each other on knowledge of zoonoses of public health importance and
hence assist in identification and control of zoonotic diseases that are increasingly
becoming of importance in Tanzania.
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General discussion and conclusions
10.1 Introduction
Tanzania is among the sub-Sahara African countries that share the largest of the global burden
of diseases (WHO, 2002). However, most of the burden of diseases is carried by the poor
underprivileged people in the rural areas whose livelihoods depend on livestock (Perry et al.,
2002). It is estimated that livestock contribute to the livelihoods of at least 70% of the world's
rural poor (Miranda, 2005). The dependence of rural people on livestock for their livelihoods
has made them succumb to many of the zoonoses such as brucellosis making their quality of life
deteriorate still further (Perry et al., 2002; Coleman, 2002).
The current study was conducted in livestock keeping communities in Arusha and Manyara
regions in northern Tanzania. The households visited practice the traditional animal husbandry
which in Tanzania is undertaken by more than 97% of the national herd, and most of these are in
the northern part of the country (Ministry of Agriculture and Cooperatives (1995b). Among the
ethnic groups studied, the Maasai and Barbaigs practice the pastoralist or nomadic system in
which they move far with their livestock in search of pastures, while other ethnic groups such as
Iraq, Fyomi and Sonjo practiced agropastoral systems and do not move far with their livesock.
Studies conducted in different parts of the world, however, have indicated that pastoralist or
nomadic systems favour transmission of zoonotic diseases such as brucellosis, hydatidosis and
rabies (Magambo et al., 2006; Okoh, 1981; Schantz, 2006).
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This is the first large scale study to be conducted on brucellosis in Tanzania. The study
was unique because it used methodology where the study population was selected at
random and tried to address several key issues that have not been highlighted by any
other studies. Such issues include, the evaluation of diagnostic techniques for brucellosis,
health seeking behaviour and clinical characteristics of brucellosis, risk factors for
transmission of brucellosis to humans, and burden of disease using DALYs and direct
and indirect costs of caring for brucellosis cases. The expectations of the study is to
address these key issues and ultimately formulate the best ways to alleviate the burden of
brucellosis and other zoonoses to particularly the poor people in the rural areas whose
dependence on livestock has made them suffer more from zoonoses.
10.2 Socio-demographic characteristics of brucellosis cases
Gender was not found to be significantly associated with brucellosis. Most studies conducted
elsewhere, indicated males to be at a greater risk of getting brucellosis than females (Thakur and
Thapliyal, 2002; Salari et al., 2003; Beggan et al., 2005). In other studies however, higher
brucellosis seropositivity was found in females than in males (Troy et al., 2005; Hussein et al.,
2005). Differences in sexes of the members of sample population and different risk exposures in
different places with regard to sex could have contributed to the different results. In the current
study gender was not a risk factor for brucellosis.
Brucellosis seropositivity was found to be higher in individuals of above 15 years of age than
those of 15 years of age and below. In the study area most of the individuals of above 15 years
233
were actively involved in different home or farm-based activities. These results suggest that
these activities pose a greater risk to them than to other age groups that are less involved with
such activities. The age group 16-30 years was found to have a greater proportion of
seropositive individuals than any other age group. These results are similar to those obtained by
Lulu et al., (1988) in which a greater incidence of brucellosis was observed in the young and the
middle-aged, with a low incidence among infants and elderly patients. The age pattern of
brucellosis cases contributed significantly to the estimation of burden caused by brucellosis using
DALYs because younger age groups carry more YLD than the aged (Murray and Lopez, 1994).
As the majority of the individuals of the age group 16-30 years are the ones more involved in
production activities, brucellosis therefore is likely to cause enormous socio-economic losses at
household and national levels.
10.3 Brucellosis and farming systems
There were proportionally more cases of brucellosis recorded in hospitals located in pastoral
areas than in hospitals located in agropastoral areas. Although in the cross-sectional study
brucellosis seropositivity was found to be higher in pastoral areas than in agropastoral areas,
the difference was not statistically significant. In studies conducted by Schelling et al.,
(2003) and McDermot and Arimi, (2002) brucellosis seropositivity was found to be higher
amongst people practicing pastoral or nomadic systems. Difficulties in the control of animal
movement in pastoral or migratory populations have made the control of zoonoses extremely
problematic. In pastoral or migratory systems practiced by a significant proportion of
agricultural population in Africa, large numbers of animals mix and travel long distances
potentially contracting and transmitting zoonoses such as brucellosis. These animals may
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then subsequently transmit infection to humans. Interventions to prevent the transmission of
zoonoses such as brucellosis to humans should, therefore, consider giving priority to pastoral
areas which in Arusha and Manyara regions are inhabited by mainly the Maasai and the
Barbaigs.
10.4 Diagnostic difficulties
Hospitals in the study area were found to use many antigens for diagnosis of brucellosis.
However, all the antigens used at the hospitals and the RBPT supplied by the study team
showed low diagnostic sensitivities. Although many factors could have contributed to the
low sensitivities of the tests, the results raised a high index of suspicion on the validity of
many tests that are used in the diagnosis of not only brucellosis but also other diseases in
Tanzania. It is likely that many diagnostic tests do not meet the standards required for the
diagnosis of diseases and hence resulting in underdiagnosis of diseases. Adoption of
diagnostic tests with low sensitivities and specificities has great repercussions on the
wellbeing of the patients in terms of diagnosis, treatment, the costs involved, their social
consequences and the economy of the nation as a whole.
Clinical features of brucellosis were found to be similar to clinical features of other febrile
or flu-like conditions such as malaria, typhoid, diseases that affect joints, amoeba and
tuberculosis, making it difficult to use clinical features to reach definitive diagnosis of
brucellosis. The findings are supported by studies conducted in Kenya and Uganda
(Muriuki et al, 1997; Mutanda, 1998; Maichomo et al., 1998), where diagnostic
difficulties were also encountered due to the coexistence of such diseases. In the present
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study joint pain, backache, headache, fever and fatigue were the most common clinical
features in both brucellosis cases and patients suffering from other febrile or flu-like
conditions listed above. Co-existence of such diseases in the study area has also made early
diagnosis of brucellosis a difficult exercise. The study calls for a need to establish and
harmonise the guidelines for diagnosis of brucellosis in Tanzania. The Ministry of Health
and research institutions should be at the forefront of this exercise. More research into the
the diagnostic tests which use antigens with high sensitivities and specificities need to be
carried out. Meanwhile, while this is sorted out, antigen with the brand name Eurocel As
which showed a higher sensitivity than the rest of the tests could be used at the hospitals.
On the other hand zonal laboratories could be established in areas where brucellosis is
prevalent, or the existing referral hospitals' laboratories could be equipped with more
sensitive tests such as the c-ELISA test. The establishment of such laboratories should go
hand in hand with training of laboratory staff to man the equipment and perform quality
assurance tests. This would minimize the problems encountered during shipment of
samples a long distance for confirmation of diagnosis and also improve the diagnostic
capacity for brucellosis and other zoonoses in areas where it is prevalent
10.5 Risk factors for human brucellosis
Brucellosis in humans was found to be associated with assisting aborting livestock,
people belonging to the Christian religion and closeness of the nearest neighbour.
Contact with products of an aborting animal has been shown by many studies as a risk
factor for brucellosis transmission (Young, 1983; Kozukeev et al., 2006; Lim et al.,
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2005; Bikas et al., 2003; Schelling et al., 2003; Cooper, 1992). In most cases, the
placenta was more associated with brucellosis transmission than other products. In the
present study, there was a significant positive association between brucellosis
seropositivity in humans and in goats at the district level. This indicates that goats
within each district were more associated with brucellosis than goats owned by the
individual household. In the study area there a is tendency for people to assist each other
in different activities. It is a common practice for people within the same district to
assist each other's domestic animals during parturition or handling a new born. In
Mongolia, a study conducted by Zinsstag et al., (2005a) also showed that a significant
proportion of human brucellosis was small-ruminant derived. It is likely that one could
contract brucellosis from an animal that is not his. In the current study the prevalence of
brucellosis in cattle and in sheep also showed positive association with the prevalence of
brucellosis in humans at the village and the district levels but their association was not
statistically significant.
Religious background was found to be a risk factor for brucellosis with people
belonging to the Christian religion more at risk of getting brucellosis than any other
religious group. The sample studied did not allow the comparison between Christians
and other religious groups with respect to risk exposures. However, factors such as
animal husbandry, the number of livestock kept, the location, the interaction between
livestock and humans etc. amongst Christians as opposed to other groups (Muslims or
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atheists) need to be studied further. No other study has shown an association between
religious belief and risk of diseases.
10.6 The burden of disease caused by brucellosis
Brucellosis is known to cause chronic debilitation to humans if diagnosed late (Corbel,
1997). In the current study, diagnostic difficulties, accessibilty of health facilities, and
limited knowledge of practitioners of the zoonotic diseases might have contributed to the
late diagnosis of brucellosis cases. Ultimately there was prolonged human suffering from
brucellosis. On average cases continued to have brucellosis clinical features for a period of
over two years in the current study, out of these, five days as hospital inpatients. During the
period of two years, the productive force of the cases was lowered. Each household used a
total of US $ 90.65 (92, 826 TShs.) to care for a single case of brucellosis per year and each
health provider used a total ofUS $ 858 (878,592 TShs.) per year to care for cases of
brucellosis. Since the presence of infection in man reflects the infection in livestock
(Young, 1995a; Karimi et al., 2003; Mishal et al., 1999), humans have to incur the costs of
seeking treatment of the animals and bear reproduction and draught power losses as well.
All these add further burden to a poor farmer, particularly in rural areas and the health
sector that is underfunded.
Brucellosis contributes to poverty and suffering particularly to the people in rural areas
who make over 75% of the total population of Tanzania (World Bank, 2002). Based on
hospital data 3,637- 8,220 of DALY burden was estimated to be caused by brucellosis and
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based on data from the cross-sectional survey 687,861 ofDALY was estimated to be
caused by brucellosis. Previos studies conducetd in Tanzania showed that Mycobacteria
bovis caused 9,739 DALY loss, rabies 42,669 DALY burden, Mycobacteria tuberculosis
(due to human to human transmission) resulted in 730,891 DALY burden in the year 2000
(Coleman et al., 2004). From the data it is evident that the DALY burden caused by
brucellosis is not very different from the DALY burden caused by other diseases.
However brucellosis is underestimated and neglected.
10.7 Conclusion and recommendations
10.7.1 Community
Health education to the public should be the core of intervention strategies to prevent the
transmission of zoonoses such as brucellosis to humans. These should include emphasis on
patients to attend hospital early for diagnosis and treatment as late presentation makes
diagnosis and treatment difficult. As regards to brucellosis, health education on ways to
prevent brucellosis transmission through contact while assisting animal delivery is also
required.
The intervention to prevent transmission of brucellosis should give priority to pastoral areas
where higher seropositivitymf brucellosis was found and should highlight the importance of
goats as the main source ofBrucella infection in Arusha and Manyara regions.
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10.7.2 Practitioners
Medical practitioners' knowledge of zoonotic diseases is an important factor in the
diagnosis and management of zoonoses. Refresher courses on zoonoses or more emphasis
on zoonotic diseases in the teaching curriculum of medical practitioners should occur in
Tanzania for improved diagnosis of zoonoses.
It was shown that, as antibodies to Brucella can persist for a period of more than 12 months
after treatment, practitioners should be made aware of the implications of persistent
antibodies on diagnosis and treatment in an area where other febrile conditions of similar
clinical features co-exist. Thorough history taking to distinguish between the cured, re¬
infected, exposure to other febrile conditions and the stage of the disease should be
undertaken for proper diagnosis and treatment.
10.7.3 Government
Data recording is an area that needs to be updated and strengthened in Tanzania so that
zoonoses such as brucellosis can be notified at district, regional and national levels for
better epidemiological data. Currently many zoonoses are not recorded at regional and
national levels which is a major omission in data recording systems in Tanzania.
10.8 Future research focus
The current study identified important gaps that require further research. These included
studying the efficacy of different brucellosis treatment regimens, studying the Brucella
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strains common in areas where brucellosis is prevalent, and studying factors associated
with Christian religion that might be a risk for human brucellosis.
Estimation of burden caused by diseases is something of utmost importance in health
planning of a poor resource country like Tanzania. Estimation of a disease burden enables
prioritization of resource allocation and intervention strategies against diseases. It was
however noted that, not many disease burdens have been studied in Tanzania using the
WHO recommended DALYs. The study challenges the researchers and public health
professionals in Tanzania to work on this area based on their disease specialties. Unlike a
study conducted in Zimbabwe by Chapman et al., (2006), zoonoses should be given an
upper hand and the estimation should include the cases in the community as those
presenting to health facilities do not represent the actual number of those diseases.
Future research should also try to explore the benefits of different intervention strategies
which might be useful in the control of brucellosis in animal population inTanzania. Such
intervention strategies as mass vaccination of animals have proven to be beneficial in some
countries (Roth, 2003) if there is a proper allocation of resources and involvement of
various sectors dealing with human and animal health.
10.9 Collaborations
The study calls for a stronger collaboration between the veterinary and medical sectors. It
was noted that every sector has been taking care of its client, the veterinary sector the
animals and the medical the humans. In such cases, zoonoses have been left between the
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two sectors with little or no attention at all. Elsewhere such a collaboration has been
stressed in various areas of mutual interest (Coulibaly and Yameogo, 2000; Kahn et al.,
2006, Zinsstag et al., 2005b; Schelling et al., 2005). These include the clinical area, in
which the input from both professions would improve assessments of the risks posed by
all species of animals that are in close contact with humans. In public health, human and
animal disease surveillance systems would be strengthened in tracking and controlling
zoonoses and in research, the dynamics of different disease agents-host interactions can
be studied by professionals from both sectors for better prevention and control strategies
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CASE-CONTROL QUESTIONNAIRE ON BRUCELLOSIS
(UNDULANT FEVER) IN HUMANS
1. Background data
1.1 ID no {Match with tube numberfor cases, for controls should
be allocated)





1.7 Tribe of case/control
1.8 Religion
1.9 Occupation of case/control
1.10 Head of household
1.11 District Village




1.15 Relationship to the case/control
1.16 GPS coordinates of household S E
1.17 Distance to the nearest neighbour
1.18 Distance to the nearest health facility/GPS coordinates of health facility and it's
name
Name Distance
GPS coordinates S E
1.19 Distance to the village Centre (CCM office as a reference
Point) GPS coordinates S E
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2.0. Hospital going characteristics, questions 2.1-2.4 (For Controls)
2.1 Have you attended to hospital in the last 5 years? Yes/No
2.2 If yes, do you remember which hospital did you go, when and what was troubling
you?
2.3 If no, would you go to hospital now if you get prolonged headache, backache, etc?
Yes/No/NA
2.4 If no, where would you go and reasons
(NA)
2.5 Are there any family members who got sick but didn't go to hospital? Yes/No








2.7 Are there any family members who got sick in the same period and went to hospital?
Yes/No










2.9 Where did you go first after getting Sick?
2.10 If the above facility fails where do you opt for?
3.0 Awareness of Brucellosis
3.1 Have you heard of the disease called Brucellosis in humans? Yes/No
If yes, how it is transmitted/prevented?
4.0 Clinical information
4.1 Has any family member been diagnosed as suffering from Brucellosis /had fever,
headache, joint pain, backache? Yes/No.
If yes where were they diagnosed?
Name Status
(husband/son/etc.






Which of the following clinical signs did he/she note:
Coughing □ Headache | | Backache [ | Joint aches 1
Diarrhoes | | Fatigue | | Anorexia | | Fever
Recurrent Fever | | Skin disease | [ Other (describe)
5.0 Risk Factors
5.1 Do you keep animals? Yes/No
5.2 If yes, how many of the following:







5.3 Were there any abortions in the last one-year? Yes/No
5.4 If yes, how many abortions were there? N/A Cattle... Goats... Sheep...
Were you involved in disposing the aborted material or assisting the animal?
Yes/No/NA If yes, how many were you involved in?
Describe how many you were involved in? N/A
5.5 Was there any animal that had retained placenta Yes/No?
5.6 If yes, how many retained placenta were there? N/A
Cattle Goats Sheep ,
Were you involved in assisting to remove the membranes/disposing them?
Yes/No/NA If yes, how many were you involved in?
Describe
5.7. Did you assist animals during parturition? Yes/No
5.8 Have you resuscitated a weak born calf/goat/sheep? Yes/No, if yes, Describe how
5.9 Did you milk cattle? Yes /No
If yes, describe
5.10 How often did you assist in milk cattle? (NA)
Daily Occasionally (describe) Not applicable
5.11 Did you milk goats? (Yes/No)
If yes, describe
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5.12 How often did you assist in milking goats? (NA)
Daily Occasionally (describe) Not applicable
5.13 Did you herd cattle? Yes/No
If yes, how often did you herd cattle? (NA)
Daily Occasionally (describe) Not applicable
5.14 Did you heard goats/sheep? Yes/No
If yes, how often did you herd goats/sheep? (NA)
Daily Occasionally (describe) Not applicable
5.15 Were you taking anything when going for grazing? Food:
Yes/No/NA
Water (Yes/No), Soured milk (Yes/No), other (specify)
5.16 If no, how did you manage to stay long without eating/drinking? (NA)
5.17 Did you participate in plastering the walls? Yes/No
If yes, how many times/Frequency
Describe
5.18 Did you participate in manure handling? Yes/No
If yes, how many times/Frequency
Describe
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5.19 Did you drink cow's milk Yes/No
5.20 If yes, could describe the source and frequency in which you consumed cow's
milk? (NA)





Any additional information on milk drinking pattern and seasonality
5.21 Did you drink goat's milk Yes/No?









Any additional information on milk drinking pattern and seasonality
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5.23 How often did you consume? (Probe in instances where there is plenty ofmilk or
When there is scarcity offirewood if they really boil milk)












5.25 Did you participate in?





5.26 Did you eat Meat? Yes/No
5.27 If Yes, in which state did you eat?













5.29 Did you drink blood? Yes/No
5.30 If yes, where did you get blood you drank? (NA)
Where blood obtained Frequency/rank









5.3 1 How was blood prepared before you consumed? (NA)
Blood preparation (V/P/X)
Just take raw
Raw blood mixed with hot soup
Raw blood mixed with milk
Raw blood mixed with duodenal
Content, bile and offal chops like
river
Fried/cooked
Raw blood mixed with ruminal fluid
(used as medicine)
Others (Specify) e.g.
5.32 Do you remember consuming reproductive organs of animal in the last 1 year? Yes/No
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Mixed with other items and cooked




5.34 Did you eat aborted foetus/still birth? Yes/No
If yes, how many times
Were you involved in the preparation of this food? Yes/No/N/A
How many times were you involved in the preparation of this food?
5.35 Did you handle any aborted material from wildlife? Yes/No
If yes, how many times did you handle materials from
wildlife?
5.36 What wild animals have been coming close to your premises/house

























For all patients reporting symptoms consistent with brucellosis
Patient ID Number: Patient Name:
(to match number on serum sample)
Age: Sex: Village:
Balozi: District:
A. First Clinical Signs Date clinical signs first observed: —/—/
Which of the following clinical signs did the patient note:
Coughing Q Headache Q Backache Joint aches [
Diarrhoea □ Fatigue □ Anorexia □ Fever □
Recurrent Fever Q Skin disease r~J Other (describe)
B. Effect on everyday activities
What is the principal occupation of the patient?
What impact does the disease have on everyday activities?
Completely unable to work/go to school □ Reduced ability to work/go to □
school
No effectEE Other (describe) |
C. First treatment received Date of first treatment: —/—/•
Where did the patient first seek treatment? (Tick only one box)
At home EH Local healer EE Dispensary EE
Hospital (give name)





D. Presentation at hospital Date of first presentation at hospital: —/—/-
Did the patient suggest himself/herself that he/she may be suffering from brucellosis?
YES/NO
Observations recorded on clinical examination: Temperature °C
Fevei] | LympahdenitisQ] Joint pain Q] Back pain Q Respiratory signs [
Chest painQ Abdominal pain Q Neurological signs Q HeadacheQ
Other (describe)
Describe any observations in detail if
necessary
E. Diagnosis and Treatment
1. First differential diagnosis Diagnostic test(s) performed:
Date of test: —/—/
Treatment given: Date treatment started: —/—/ -
For how long
2. Second differential diagnosis Diagnostic test performed:
Date of test: —/—/
Treatment given: Date treatment started: -—/-—/
For how long
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3. Second differential diagnosis
Treatment given:
Diagnostic test(s) performed:
Date of test: —/—•/—•
Date treatment started: —/—/•
For how long
4. Third differential diagnosis Diagnostic test(s) performed:
Date of test: —/—/
Treatment given: Date treatment started: —/—/
For how long
Name of Clinician:
F. FOLLOW-UP (by Brucellosis Project staff)
Date of follow-up: —/—/ Was the home of the patient located? YES/NO
Was patient present? YES/NO If no, who is providing information about patient
Response to treatment:
How long did the patient stay in hospital?
Has the condition of the patient improved? YES/NO
If Yes:
When did the patient first notice signs of an improvement?
Has the patient now fully recovered? YES/NO
For how long did the patient take the medicine?
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IfNo:
Has the condition got worse than it was when first reporting to the hospital? YES/NO
Describe current symptoms:
Has the patient sought other treatment since the first hospital appointment? YES/NO
Where?
Describe treatment:
What has been the response to this treatment?
For allpatients:
Were there any adverse effects of the treatment? YES/NO If Yes, Describe




QUESTIONNAIRE FOR CLINICAL SURVEY
Brucellosis project






GPS Coordinates of the household E S
GPS Coordinates of the hospital E S
Name and level of the
facility
Date of follow-up If patient present Yes/No, if not around who is
providing information
Date clinical signs first observed
Signs and symptoms: Cough □ Headache□ Backache □ Joint pain □
Diarrhea □ Fatigue□ Anorexia □ Fever I 1 Recurrent fever I I
Skin disease 1 I Other I 1.
Occupation of the case/control.
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Date first treated Where treated
Time spent in going to hospital , time spent at the hospital






Name of person who went with you to hospital Sex Age
Who is he/she to you cost incurred for his/her transport
What was the diagnosis




Date of first presentation to hospital
If suggested to Clinician to be investigated for brucellosis, Yes/No, if yes why?
Time spent in going to hospital , time spent at the hospital
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Name of person who went with you to hospital Sex Age
Who is he/she to you cost incurred for his transport
Day you started treatment , what treatment was given
If has improved, Yes/No, if improved when started to experience
improvement
If fully recovered Yes/No
For how long did you take the medication?
If not fully recovered what are the symptoms
If patient sought further treatment, Yes/No, If yes where
When treated , What was the diagnosis
What was the treatment given
What was the response
Were there any adverse effects of any medication given above?
Yes/No If yes, explain the effects
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Tf any at home ever suffered from brucellosis Yes/No, if yes;
Name Status Age Sex Symptoms
Socio economic status of the case/control
Number of houses number of hurts it has
Number ofwives Number of
children
Look at the house and observe
Roofing
Walls












Amount used for food, clothing and
medication for animals and humans in a
month
Amount used for Education for children in
a year





Where do you get treatment for your animals
Community based animal health worker





Level of education reached
No formal
education
Primary Secondary College Other






















1. Anthrax, brucellosis, rabies, trypanosomiasis, echinococcus, cholera and bovine
tuberculosis are known to be common in your area, we would like to know your
comments on the following:
a) Briefly describe the way the following zoonoses are transmitted, stating the animal
































Tanzania Health Research Bulletin (2004), Vol. 6, No. 14
DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS OF BRUCELLOSIS IN
ARUSHA AND MANYARA REGIONS, TANZANIA
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Abstract: A review of hospital records and interview with district medical
officers and health staff in Karatu, Ngorongoro, Babati, Hanang and Mbulu
districts in Arusha and Manyara regions was conducted between July and
September 2002. A data analysis showed that hospitals use different antigens and
techniques to test for brucellosis. Some use titration method and others serum/rapid
agglutination tests. Chronolab with Brucella abortus antigen was the most
commonly used technique. Other antigens included Merox with B. melitensis and
Biosystem with B. melitensis and B. abortus antigens. Most of the hospitals that
employ titration method used titre of 1:80 and above to diagnose brucellosis. There
was a wide disparity in treatment regimens and costs between different health
facilities. Diagnosis and treatment of brucellosis need to be addressed urgently. To
do this, it is important that different treatment regimens and costs for brucellosis
are evaluated in order to determine the most efficacious and cost effective regimen.
It is also important that the government provide adequate drugs for the treatment of
the diseases to avoid irrational use of antibiotics that might predispose to
emergence of drug resistant strains. Evaluation of different diagnostic tests should
be done so as to establish the most sensitive and with reasonable specificity. In this
paper, the diagnostic, therapeutic and cost implications of brucellosis in two
regions of northern Tanzania have been discussed.
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BRUCELLOSIS IN ARUSHA AND MANYARA REGIONS, TANZANIA: A
CHALLENGE TO PUBLIC HEALTH
J Kunda 1 S. Cleaveland2, J. Fitspatrick4, Nigel French5, D. Kambarage3, G.
Shirima4, R. Kazwala3
Summary
Setting: Karatu, Ngorongoro, Babati, Mbulu and Hanang districts in Arusha and Manyara regions, Tanzania.
Methodology: A retrospective study was conducted in Karatu, Ngorongoro, Babati, Hanang and Mbulu districts in Arusha and
Manyara regions between July and September 2002. Review of Hospital records and interview with district medical officers, hospital
Incharge and clinicians were conducted.
Results: Out 170,345 patients who attended hospitals in Babati, Dareda, Karatu, Hydom, Katesh, Wasso, Endulen and Mbulu
hospitals in the year 2001, 619(0.36%) were diagnosed as having brucellosis. It was found out that women suffer from brucellosis
more than males. Out of 619 cases of brucellosis reported in the year 2001, 432 (69.8%) were females and 187(30.2 %) were males.
Most of the patients were of the age between 16-35 (46.3%) i.e. after school age compared to the middle aged 36-50 (30.4%). Few
cases were found in the pre school age (<7 years), school age (7-15) and old age (>50 years)
Conclusion There is a need to carry out a study that will establish the burden caused by brucellosis in the area. This should also
include investigating the relationship between infection in animals and that in humans. There is also a need to investigate the burden
of the disease to the community as well and not only to those who attend hospitals . Factors that favor acquisition of brucellosis to
animals and subsequent transmission to humans must be explored and pointed out clearly so that the communities can be made aware
of and hence minimize the chances for transmission of brucellosis
Introduction
Brucellosis is an acute or chronically contagious disease of animals and humans, caused by species of the
genus Brucella (Brucella abortus, B suis, B. melitensis, B. ovis, B. neotomae). The disease has different
names; mediterranean fever, malta fever and undulant fever have been assigned to humans (Corbel, 1989).
Although brucellosis can be found worldwide, it is more common in countries that do not have good
standardized and effective public health and domestic animal health progs. Areas currently listed as high
risk are the Mediterranean Basin (Portugal, Spain, Southern
Correspondence to:
J Kunda, Box 65001, Mtihimbili National Hospital,
National Institute for Medical Research, Muhimbili Research Station
Centre for Tropical Veterinary Medicine, University of Edinburgh, Scotland
J Sokoine University of Agriculture, Morogoro
Dept. of Veterinary Clinical Studies, University ofGlasgow, Scotland, University of Liverpool, leahurst, England
France, Italy, Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia, Africa,
the Caribbean, and the Middle East. Un pasteurized cheeses, sometimes called "village cheeses," from
these areas may represent a particular risk for tourists (World bank, 1985).
The incidence of brucellosis caused by B. melitensis in sheep, goats and humans is still a very significant
problem in Macedonia and Greece. In Greece, cattle are also affected either by B. melitensis or B. abortus.
The disease is an endemic problem in some regions of Yugoslavia and includes B suis biovar 2 in pigs
and in Croatia, B.melitensis in sheep, goats and humans is found occasionally. No problem appears to exist
with brucellosis in Bulgaria. Financial well-supported brucellosis control progs of the European Union
that will include all countries, regardless of the magnitude of brucellosis incidence, are needed for
eradication and control of brucellosis (Taleski V, 2002).
Brucellosis has been reported in a number of African countries with a varying range of prevalence. The
reported prevalence in various countries include 3% in Malawi (Benard,, 1993); 2.27% in Sudan (
Mahmoud, 1991); 4.2% in Ethiopia (Tekelye - Bekele 1989); 5.45%-17.5% in Kenya (Waghela, 1977,
Ndarathi and Waghela, 1991); 9.5% in Somali (Wernery et al., 1979); 7%-50% in Nigeria (Eze, 1977);
37..9%-61.8% in Egypt (Refai, 1990).
In Togo, studies done in 2000 indicated that brucellosis is among the major zoonoses. A national
eradication proge was instigated to reduce the transmission of rabies. Good relations exist between
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veterinary and health personnel in the field but this level of interaction is absent at district and national
level. This has resulted in information not being transferred between the two disciplines and the lack of a
national strategy for the eradication of zoonoses in Togo. This represents the condition in many African
countries (Domingo, 2000).
In Tanzania, Evans (1935) first reported brucellosis in humans after reviewing the status of the disease in
the then Tanganyika. He stated that cultures obtained from humans had shown that B. abortus and B
melitensis occurred in the country. Further reports of human Brucellosis in the country were obtained
from monthly reports of the medical department of the Lake region and west region for 1959, 1960 and
1961 and from two patients at Kihesa village in Iringa region in 1962 (Anon, 1963). However, because
clinical symptoms of brucellosis in humans are similar to malaria and typhoid (Mutanda, 1998, Muruiki
et al., 1997), it is possible that some cases of brucellosis are recorded as malaria or typhoid. These
difficulties have contributed to the general lack of information on the disease in Africa (Anon, 1963).
In cattle, brucellosis was first diagnosed in 1928 from samples taken from aborted cattle at Engare
Nanyuki (Kitalyi, 1984). The existence of bovine brucellosis in Tanzania arose interest of researchers to
study its spread in the country (Anon, 1927/ Several surveys have been conducted in different parts of
the country (Table 3), with prevalence varying from 5% to 20%. However, these studies were conducted
in more intensive farming systems or in response to abortion problems and may therefore not be
representative of the majority of the indigenous cattle population, kept under traditional husbandy
systems.
A decline in the cattle growth rate from 3.4% in 1974 to 0.6% in 1984 was attributed to among other
factors by brucellosis (Anon, 1987), but the evidence is weak, however, brucellosis is thought to remain
endemic and widespread throughout Tanzania (Corbel, 1989).
The following is a table (Table 1) showing surveys of brucellosis in animals conducted in Tanzania, all
these used serum agglutination test. The findings show that brucellosis has been in Tanzania for a long
time at varying degrees.
Table 1. Surveys of Bovine brucellosis conducted in Tanzania

























The concentration of population in urban and peri-urban areas especially in the last ten years has
substantially increased the demand for milk, milk products and other animal products in such areas. This
together with the deterioration of veterinary services in the country is creating social, environmental and
public health problems within the community. Because the demand is higher than production, some milk
vendors and sellers of other animal products are forced to sell un-pasteurized milk and other animal
products, which are not or not properly processed (Corbel, 1989).
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Brucellosis, caused by a variety of Brucella species, is a disease of major socioeconomic importance in
animals worldwide, especially so in developing countries where disease control proges are either non¬
existent or inadequate. The disease also occurs in the wildlife, thus posing a danger of transmission
between domestic animals and wild animals in interphase areas (Anon, 1927j.
Devastation caused by Brucellosis
The disease is associated with abortion storms in newly infected herds; high degree of retained placenta
and hence endometritis which often result into reduced milk production and infertility. Costs of treatment,
loss of calf crop size and hence replacement of stock and concurrent human infection are other sequel of
animal infection (Corbel, 1989).
Humans succumb to prolonged periods of general body malaise, headache, backache, fever and chills. Due
to long illness, a lot of time is spent in seeking medical help in hospitals and in some areas local/traditional
healers instead of participating in economic activities. This coupled with large amount of funds used in
treatments, to a large extent worsen the economies of the people.
Arusha and Manyara regions
Arusha and Manyara regions are situated in the northeastern part of Tanzania. Before 2002 they were one
region called Arusha. Babati, Mbulu and Hanang districts are in Manyara region, Karatu and Ngorongoro
are in Arusha region. The major tribes in Arusha and Manyara regions include Maasai, Mbulus (Irakis),
Barbaigs and Sonjos. The Maasai and Barbaigs are primarily livestock keepers, these normally move from
one part of Tanzania to another with their cattle in search of pastures (pastoralists). The rest of the tribes
are essentially livestock keepers and also grow crops for their food (agro pastorals).
Methodology
A retrospective study was conducted in Karatu, Ngorongoro, Babati, Hanang and Mbulu districts in
Arusha and Manyara regions between July and September 2002. Review of Hospital records/data and
interview with district medical officers, hospital Incharge and clinicians were conducted. Hospitals visited
included Karatu Missionary hospital that serves the community in Karatu district and some parts of
Ngorongoro district, Mbulu district hospital in Mbulu, Katesh district hospital in Hanang, Hydom Lutheran
hospital that serves Mbulu district and neighboring districts of Arusha, Manyara and Singida regions. Also
visited were Dareda missionary hospital, Babati district hospitals in Babati and lastly Wasso and Endulen
missionary hospitals in Ngorongoro district. Babati, Katesh and Mbulu hospitals are government owned
district hospitals whereas Hydom, Karatu, Wasso, Endulen and Dareda hospitals are missionary hospitals.
Any person who presented to hospital with one or more of non specific symptoms such as fever, headache,
joint pain, backache, malaise etc. and who tested positive with serum agglutination test was treated as a
brucellosis case. Laboratory diagnosis was based on titres of agglutinins of 1/80 and above in all the
hospitals that use titration method.
Results
Brucellosis was found in 619 (0.36%) patients out 170,345 who attended to the hospitals in selected
districts in Arusha and Manyara regions in the year 2001. Most of the patients came from Endulen
hospital (182 patients) and Dareda hospital (165 patients) (Table 2).
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Table 2. Brucellosis patients in the year 2001
Hospita No. of Males Females Total Proport
cases attendance %
Kara tu 100 25 75 26,963 0.4
Mbulu 46 17 29 14,944 0.3
Hydom 51 13 38 88,265 0.05
Katesh - - - -
Babati 40 8 32 8,985 0.4
Dareda 165 46 119 9,297 1.77
Wasso 35 8 27 11,968 0.3
Endulei 182 70 112 9923 1.8
Overall 619 187(30%) 432(70%) 170,345 0.36
Of the brucellosis patients, 415 (67%) were females compared to 204 (37%) males (%2 =22.17, df=4,
P<0.01). Of these, 34 (5.4%) were 15 years of age and below, i.e. school age, 223 (36%) were 16-30 years
of age, 138 (22.3%) were 31-45 years of age, 179 (29%) of age 46-60 and 45 (7.3%) more than 60 years
of age (Table 3).
Table 3. Age and sex distribution of brucellosis cases in the year 2001
Age group (years) Number of patients
Males Female Total Percentage (%)
=< 15 15 19 34 5.4
16-30 66 163 223 36.0
31 -45 60 72 138 22.3
46-60 43 136 179 29.0
>60 20 25 45 7.3
Total 204 415 619 100.0
It was observed that most of the cases were seen in the beginning of the year and towards the end of the
year, this was more marked in the pastoral areas e.g. data from Endulen hospital. Comparing the two
seasons i.e. the first and last quarters versus the middle two quarters of the year there was a significant
difference in the number of cases (■£= 58, df=6, p<0.01). Cases increase towards the end of the year and
remain high in the beginning of the subsequent year when there is rain only to drop in the middle of the
year when most of the time it is dry (Table 4).
Table 4. Distribution of brucellosis cases in the year 2001
Hospital Jail - March April-June July - Sept. Oct. - Dec Total
Karatu 29 20 23 28 100
Mbulu 7 6 18 15 46
Hydom 9 13 10 19 51
Katesh - ....
Babati 8 12 9 II 40
Dareda 42 53 30 40 165
Endulen 56 23 39 64 182
Wasso 8 4 9 14 35.
Total 159 131 138 191 619
Discussion
Out of 170,345 people who attended health facilities in the study area in 2001, 619 (0.36%) were found to
have brucelosis. The proportion of people who attended to the hospitals in the year 2001 is a small
proportion of the total population of the two regions that is exposed to getting brucellosis. Since brucellosis
runs a chronic course then we expect the seroprevalence of brucelosis in the study area to be much more
than what we have obtained. Some patients can remain sick at home without seeking medical help until
condition allows them to go to hospital e.g. after they have sold their crops or they don't have any other
commitment e.g. cultivation. The majority of cases were reported in the first and last quarter of the year at
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this period it is rainy, and animals reproduce, hence there is plenty ofmilking and drinking of milk, which
can be important activities that favor transmission of brucelosis from animal to animal and subsequent
transmission to humans.
In most of African cultures women engage more with taking care of animals, milking and most importantly
assist animals during parturition, so they are more exposed to getting brucellosis in our setup than males.
Most of the patients were of the age between 16-30 years, few people in the Pre School, school and old age
were found to be suffering from brucelosis (table 3, fig 1). At the age of 16-30 years most of the people in
these areas have finished primary education, are married and actively involved in different home activities.
Relapse cases are not common though in some areas patients attend to hospital soon after completion of
medication to be tested for Brucella. These may go from one facility to another (hospital shopping) where
of course they will test positive if they were initially positive because antibodies will still be there. In
some cases where they don't have facilities for diagnosis e.g. antigen or due to reasons not clearly known
clinicians or doctors don't routinely request a test for Brucella, in this case patients succumb to prolonged
periods of illness. It was observed thatSince brucellosis presents with non-specific symptoms that
resemble malaria and typhoid, most of the patients have to be investigated for the diseases before they are
diagnosed as brucellosis cases. From interview with medical personnel, patients present to hospital late
e.g. with symptoms of more than one month, patients start treatment for malaria or typhoid but symptoms
persist forcing them to go to hospital for further investigation only to be found to have circulating
antibodies against brucellosis.
Conclusion
There is a need to carry out a study that will establish to exactly what extent brucellosis is a problem in
Arusha and Manyara regions and investigate the relationship between infection in animals and in humans.
Brucellosis runs a chronic course, so there might be a big proportion of people in communities that have
brucellosis infection but don't have symptoms that force them to go to hospital. There is a need to
investigate the prevalence of infection not only to population that presents to hospitals but also in the
community. Mfinanga et a/.. 2004 found out that the people in Arusha and Manyara regions have a habit of
consuming raw animal products that predispose them to getting tuberculosis. Burcellosis can be
transmitted in the same way. Factors that favor acquisition of brucelosis to animals and subsequent
transmission to humans must be investigated because we need to educate the community at risk on
different ways in which brucelosis can be acquired by both animals and human beings. This will reduce the
burden of brucellosis in the area.
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